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Abstract
Background: Invasive cervical cancer (ICC) is the second most common cancer
among women in developing countries where early age at first sexual intercourse
(AFSI) and first pregnancy (AFP) are prevalent events. The epidemiological
evidence of how these sexual and reproductive health (SRH) factors impact the
natural history of human papillomavirus (HPV) and ICC remain inconclusive. It
has been debated that a woman's risk for ICCwill depend more on the "high-risk"
sexual behaviour of the male partner than of her own behaviour. Passive smoking
in the context of couples is unclear. The aim is to study SRH factors in relation to
ICC risk in developing countries.
Methods: Study 1 evaluated the risk of ICC and its association with AFSI and
AFP in a pooled analysis of IARC case-control studies of ICC from eight
developing countries. Study 2 assessed these SRH factors and risk of HPV
persistence in a population-based natural history cohort study in Guanacaste,
Costa Rica. Study 3 characterised the male role in the aetiology of ICC among
couples in a pooled analysis of five ICC case-control studies and two cervical
carcinoma in situ (CIS) case-control studies.
Results: The ICC risk was 2.4-fold among those who reported AFSI and AFP :~a6
years compared with AFSI and AFP ~21 years. Decreasing AFP, not AFSI, was
associated with an increased risk of a-year persistence. Lifetime number of sexual
partners of the husband was the strongest predictor of CIS and ICC risk. The
absence of circumcision was significantly associated with an increased risk of CIS.
A a-fold increased risk of ICC was also found among couples with both ever
smoking men and women.
Conclusion: These data confirm AFSI and AFP as risk factors for ICC, but any
independent effects could not be distinguished. The association of AFP with HPV
persistence suggests that AFP may play a more relevant role in cervical
carcinogenesis. The combined effects of exposure to active and passive smoking
suggest its potential adverse role in cervical carcinogenesis.
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1 Introduction
Cervical cancer is the third most common cancer among women worldwide
(Ferlay et al, 2008). However, the problem disproportionately affects women in
developing countries and ranks as either the first or second most common cancer.
Human papillomavirus (HPV), a sexually transmitted infection, is a causal factor
for virtually all cases of invasive cervical cancer (ICC). Overall, the poorest women
that appear to initiate sex at an early age can subsequently become pregnant at an
early age, and have a large number of children, which are factors that have been
associated with an increased risk of HPV infection and ICC. These factors tend to
cluster in poor settings. Evidence suggests that these early sexual and
reproductive health (SRH) factors are associated with a greater risk of persistent
HPV infection and cervical cancer development because of the biological
predisposition of the immature cervix and cervical trauma experienced during
delivery of birth; however, the epidemiological evidence of how these factors
influence a woman's risk remain inconclusive. Besides the sexual behaviour of the
women, a women's risk may also be heavily dependent on the "high-risk" sexual
behaviour of the male partner rather than their own sexual behaviour,
particularly among lifetime sexually monogamous women, since men in general,
report more lifetime numbers of sexual partners than women.
1.1 Research aims
The overall aim of the work presented in this thesis is to study sexual and
reproductive health risk factors in relation to risk of cervical cancer in developing
countries.
The specific objectives are:
I. To characterise and provide robust estimates of the risk of cervical cancer
and its association with age at first sexual intercourse (AFSI), interrelated
characteristics such as age at first pregnancy (AFP) and age at first
marriage (AFM) in a pooled analysis of case-control studies on ICC from
eight developing countries (Algeria, Morocco, India, Philippines, Thailand,
Brazil, Colombia, Paraguay, and Peru)
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II. To evaluate the association between sexual and reproductive behaviour
factors (AFSI, AFP, and parity) and the prospective risk of HPV viral
persistence (as defined by type-specific HPV DNA) among women with
prevalent HPV infection in the Guanacaste, Costa Rica cohort
III. To characterize in depth the male role in the aetiology of cervical cancer in
different developing geographical settings in a pooled analysis of five case-
control studies (Brazil, Colombia, Philippines, Spain, and Thailand)
involving ICC and two case-control studies (Colombia and Spain) involving
cervical carcinoma in situ (CIS), of couples in which husbands or stable
partners of ICC and CIS case and control women participated.
1.2 Thesis outline
The PhD thesis is comprised of a literature review and three studies. This
thesis is presented in the style of "research papers" where some chapters or parts
of chapters are presented as published manuscripts, or work prepared for peer-
reviewed publication. There is often a word limit for manuscripts published in
peer-reviewed journals. However, to provide coherence to this thesis, additional
details and extended discussions are included as an extension to the publications.
Study 1 provides robust estimates of the risk of ICC and its association
with SRH factors (AFSI, AFP, and parity) in a pooled analysis of International
Agency for Research on Cancer (IARC) case-control studies of ICC from eight
developing countries (Figure 1.1). Study 2 subsequently evaluates these SRH
factors and risk of HPV persistence in a population-based cohort study of HPV
and cervical pre-cancer in Guanacaste, Costa Rica. Thus, Study 1 and Study 2
provide a more comprehensive natural history picture of SRH factors and their
associations with the three of the four major steps of cervical carcinogenesis from
HPV acquisition, persistence, pre-cancer (not evaluated), and ICC. Study 3
characterises in depth the male role in the aetiology ofICC in a pooled analysis of
five case-control studies involving ICC and two case-control studies involving
cervical carcinoma in situ (CIS), of couples in which husbands of ICC and CIS
case and control women participated. This research is presented in the following
chapters described below.
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Figure 1.1 Study 1,2, and 3 country study sites.
The present Chapter 1 summarises the rationale, the overall objectives, of
this thesis as well as outline the structure of this thesis. Chapter 2 provides a
comprehensive literature review to provide background for this research,
summarising the burden and epidemiology of HPV and cervical cancer in
developing countries in order to put into context the relevance of this research.
Chapter 3 presents Study 1, a pooled analysis of case-controls studies on
cervical cancer from eight developing countries to investigate the roles of AFSI,
AFP and AFM and cervical cancer risk. The results from Study 1 have been
published (Louie et al, 2009b). Based on the findings of Study 1, Study 2 aimed
at evaluating the impact of sexual and reproductive health factors (AFSI, AFP and
parity) on persistence of HPV in a prospective cohort of women from Guanacaste,
Costa Rica. Study 2 results are presented in Chapter 4 and this second study
was used to confirm whether our findings in Study 1 were also observed in a
longitudinal study, completing another major step of HPV and cervical
carcinogenesis. Chapter 5 presents Study 3, a pooled case-control study of
couples in which husbands or stable partners of women with cervical carcinoma
in situ or cervical cancer case and control women participated in. This study
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aimed at characterising the male role in the aetiology of cervical cancer in order to
clarify its contribution to the consequent risk of HPV infection and of cervical
cancer in their female partner. Chapter 6 presents an overall discussion of the
main findings of this thesis and the implications on cervical cancer prevention.
Chapter 7 summarises the dissemination of these PhD thesis results at
conferences, as published manuscripts in peer-reviewed journals, and other
publications and reports relevant to stakeholders working in cervical cancer
prevention.
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2 Background
2.1 Introduction
Cancer of the cervix uteri ranks as the second most common cancer in the
developing world (HPV Information Centre, 2010). The magnitude of the
problem has been under recognised and prioritised compared to other competing
health priorities such as diarrhoeal diseases, HIV/AIDS, malaria, and
tuberculosis because of lack of epidemiological data and poor awareness, lack of
human financial resources, non-existent cancer service policies and lack of
political will to address the complex problem (Denny et al, 2006; Parkin et al,
2008).
Organised screening and early treatment programmes have been effective in
preventing cervical cancer in developed countries but they are costly and difficult
to implement in resource-constrained settings. Despite our understanding of the
causal relationship of the human papillomavirus (HPV) and cervical cancer
(Bosch et al, 2002) and the availability of effective HPV vaccines to prevent
infection and disease (Lowy et al, 2008), the opportunity of these vaccines to
have an effective impact in developing countries will not materialise until they
become affordable and integrated within the framework of national immunisation
programmes (Kane et al, 2006).
This review aims to summarise the current epidemiology of HPV and
cervical cancer and the complexity of implementing prevention in developing
countries; to identify gaps of knowledge and to highlight the challenges and
opportunities for controlling cervical cancer.
2.2 Methods
A comprehensive synthesis review of peer-reviewed literature in databases
of the World Health Organization and Institute Catala d'Oncologia (WHO/ICO)
Information Centre on HPV and Cervical Cancer
(http://www,who,intlhpvcentre), the International Agency for Research on
Cancer (IARC) Screening Group (http;l/www.screnin~.iarc.fr). PubMed/Medline,
and reports from the World Health Organization (WHO), The following medical
subject heading (MESH) and text words were used alone or in combination:
'HPV', 'cervical cancer', 'cervical screening', and 'HPV vaccination'. This review
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summarises the evidence from recent systematic reviews, meta-analyses,
narrative reviews (non-systematic reviews), epidemiological studies, modelling
and related analyses and practice guidelines.
2.3 Global burden of cervical cancer
Cancer of the cervix is the third most common cancer among women
worldwide with an estimated 529,409 new cases and 274,883 deaths in 2008
(Ferlay et al, 2008). However, about 86% of cases occur in developing countries,
making it rank as the first or second most common cancer, and represents 13%of
all female cancers. The highest incidence rates are found in regions of sub-
Saharan Africa (age-standardised incidence rate, ASR of 31.7 per 100,000
women) Southern Asia (ASR=25.0), Melanesia (ASR=23.7), Latin America and
the Caribbean (ASR=23.5), and South East Asia (ASR=15.8) (Figure 2.1). In
contrast, the ASRs in Europe and North America are 10.6 and 5.7, respectively.
However, better cancer incidence data are needed to characterise the burden of
disease in developing regions. For example, at present, only a few population-
based cancer registries exist in Africa, covering 11% of the population and fewer
produce quality incidence data (Parkin et al, 2008). In the period 1998-2002,
only two cancer registries in the region, Kyadondo County in Uganda and Harare
in Zimbabwe produced high quality data and reported ASRs of 45.8 and 47.3 per
100,000, respectively (lARC, 2008).
When comparing the rates between developing vs. developed regions, the
incidence is about two-fold higher (ASR=17.8 in developing vs. ASR=9.0 in
developed, respectively). Globally, the mortality rates of cervical cancer are
substantially lower than incidence with a ratio of mortality to incidence of 52%;
similarly, the ratio in developing regions is 55.1%whereas in developed countries,
the ratio is 35.6%. The majority of cervical cancer cases are squamous cell
carcinoma (SCC) and adenocarcinomas (ADC) are less common. Cervical cancer,
is an important cause of lost years of life, which is responsible for 2.7 million
(age-weighted) years of life lost (YLL) world and it is the biggest cause of lost of
YLL in the developing world (Yang et al, 2004).
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Organised cervical screening programmes have been responsible for
significant declines in incidence of cervical cancer in many developed countries.
In contrast, the majority of developing countries have none or minimal
opportunistic screening services as seen in Africa or ineffective screening
programmes as seen in Latin America, leaving incidence rates unchanged. Future
projections highlight that developing countries will continue to bear a
disproportionate burden of cervical cancer in the world. If current incidence rates
of cervical cancer are constant over time and are applied to population forecasts,
it is estimated that by 2025, the global estimated number of new cases of cervical
cancer per year will be 720,060 with developing regions representing 93% of the
burden, which is a 36% increase from 2008 (Ferlay et al, 2008; HPV Information
Centre, 2010). Similarly, the global estimated number of cases of deaths per year
of cervical cancer will increase to 395,095, with developing regions representing
96% of the burden, which is also a 43% increase from 2008.
2.4 Epidemiology of HPV and cervical cancer
It has been well-established that infection with human papillomavirus
(HPV) is responsible for nearly all cases (99%) of cervical cancer (Bosch et al,
2002). The major steps in cervical carcinogenesis include infection with one of
the 15high-risk (HR) oncogenic types of HPV, viral persistence, and progression
of persistent infection to cervical pre-cancer and cancer (Figure 2.2) (Moscicki et
al, 2006). The prevalence of HR-HPV increases with disease severity, reaching
nearly 100% in cases of invasive cervical cancer. An underestimation of HPV
prevalence in cervical cancer is likely due to the limitations of HPV testing
methodologies. Since identifying HPV as the primary cause of invasive cervical
cancer (ICC), primary (prophylactic HPV vaccines) and secondary preventions
(including HPV testing in cervical screening programmes) now exist.
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Figure 2.2. Major steps in cervical carcinogenesis. The cervix becomes infected
with one of the carcinogenic HPV types. The vast majority of these infections are highly
transient and will spontaneously clear. The remaining infections will become persistent,
which can potentially lead to cervical pre-cancer and invasion with the possibility that
these abnormalities could also regress in the process. Adapted from (Schiffman & Kjaer,
2003)·
Over 100 HPV types have been identified, of which 40 types infect the
genital tract, primarily through sexual transmission. Of the HPV types, 16 and 18,
the two vaccine preventable types, are the most common types found in cervical
cancer representing about 70% of all ICC cases, between 41-67% of high-grade
cervical lesions and 16-32% of low-grade cervical lesions (Clifford et al, 2006).
HPV 16 and 18 show a greater risk of progression to pre-cancerous lesions than
other HR types (Khan et al, 2005; Schiffman et al, 2005). Local HPV type-
specific data are therefore useful for estimating the impact of HPV vaccines and
cervical cancer screening. In countries that lack HPV type-specific data, they can
be reassured that HPV vaccines would prevent against the majority of ICC cases
(67-70.8%) as HPV-16/18 were consistently shown to be the most prevalent types
in a retrospective cross-sectional study of 22,661 cases of invasive cervical cancer
from 38 countries across regions of Europe, North America, Central America,
Africa, Asia and Oceania (de Sanjose et al, 2010)
2.4.1 Prevalence of HPV in the general population
It is estimated that at any given point in time, about 11.4%of women with
normal cytology worldwide are positive for HPV infection (Table 2.1); however,
this is variable across regions with prevalence ranging from 22.5% in sub-Saharan
Africa, 22.3% in Eastern Europe and 17.6% in Latin America and the Caribbean
(Bruni et al, 2010; de Sanjose et al, 2007; HPV Information Centre, 2010).
Notably, the prevalence of HPV is highest in developing regions where rates of
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cervical cancer are also the highest. Overall, about 80% of sexually active women
will have been exposed to genital HPV infection at one point in their lifetime
(Myers et ai, 2000).
Table 2.1Overall HPV prevalence among women with normal cytology
Overall HPV prevalence
No. of women tested HPV prevalence,
% (95%CI)
World
Developing regions
Developed regions
Africa
Eastern Africa
Middle Africa
Northern Africa
Southern Africa
Western Africa
Americas
Latin America &
Caribbean
Caribbean
Central America
South America
Northern America
Asia
Central Asia
Eastern Asia
Southern Asia
South-Eastern Asia
Western Asia
Europe
Eastern Europe
Northern Europe
Southern Europe
Western Europe
Oceania
Australia &New Zealand -
Melanesia
Micronesia
Polynesia
436,430
120,008
315,573
8568
751
11.4 (11.3-11.5)
14.3 (14.1-14·5)
10.3 (10.2-10.4)
:n.3 (20.5-22.2)
33·6 (30.2-37.1)
863
2485
4469
112,675
42495
10.9 (8.9-13.2)
21.0 (19.4-22.6)
21.5 (20.3-22.8)
14.5 (14.3-14.7)
17.6 (17.3-18.0)
35.4 (29.1-42.2)
20.6 (20.1-21.1)
13.2 (12.7-13.7)
12.5 (12.3-12.8)
10.9 (10.7-11.1)
12.6 (12.3-12.9)
7.9 (7.5-8.2)
8.4 (7.6-9.2)
2.2 (1.5-3.1)
9.7 (9.6-9.9)
22.3 (21.0-23·6)
10.8 (10.6-11.0)
9·2 (8.9-9·4)
7·3 (7.1-7.5)
212
24783
17500
64504
84710
55365
23061
4849
1435
229,628
4053
97242
41726
77445
*Adapted from (HPV Information Centre, 2010).
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241.1 Age distribution of HPV prevalence
The global peak age distribution of HPV prevalence (24%) is found at
younger ages «25 years), which occurs soon after sexual debut, and then there is
a declining plateau in the middle ages (Figure 2.3) (Bruni et al, 2010; HPV
Information Centre, 2010). This peak is more pronounced in developing regions
(24.4%) than developed regions (19.3%) and is variable by geography. Among
women <25 years, Africa (32.1%), Asia (19.7%), and the Americas (24.5%), mainly
Latin America (17.6%) have a much higher estimate of HPV prevalence than
Europe (17.4%).
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Figure. 2.3 Age-specific HPV prevalence (crude) and 95% confidence
interval (grey shade) in women with normal cytology in the World
compared to developing and developed regions and five continents.
Reproduced from (HPV Information Centre, 2010).
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2.4.2 HPV type-specific prevalence
Figure 2.4 shows the ten most common high-risk HPV (HR) types among
women with and without cervical lesions in the world from a meta-analysis (HPV
Information Centre, 2010). After HPV 16/18, the six most common HPV types
among women with ICC are the same worldwide, namely 58, 33, 45, 31, and 52 in
descending prevalence; which account for an additional 20% of cervical cancers
worldwide (HPV Information Centre, 2010). The distribution between developed
and developing regions does not differ significantly but differ in ranking in
prevalence, which reflect the geographic variation of HPVs in the regions.
However, HPV-16 is the most common type across the spectrum of cervical
disease, ranging from normal cytology, to low-grade squamous intraepithelial
lesions (LSIL), high-grade intraepitheliallesions (HSIL) and ICC.
While HPV prevalence and type-distribution have been aggregated and
summarised for regions of the world, there are, however, large gaps in this
epidemiological picture with virtually no data available for Middle Africa; Central
and Western Asia; and Melanesia, Micronesia, and Polynesia regions. These data
would ideally be required to better understand the burden of HPV infection and
ICC in each country to inform local cervical cancer prevention strategies,
particularly to provide baseline data prior to the introduction of HPV vaccines in
order to measure long-term impact of the vaccine.
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Figure 2.4 Ten most frequent HPV types among women with and without
cervical lesions in the World compared to developing and developed regions.
Reproduced from (HPV Information Centre, 2010).
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2.4.3 Sexual and reproductive health factors and risk of HPV infection and
cervical carcinogenesis
Sexual behaviour has important implications on a woman's risk of HPV
infection. Initiation of sexual intercourse is an important indicator of exposure to
the risk of sexually transmitted infections (STIs). Age at first sexual intercourse
(AFSI) is an important determinant of exposure to HPV infection and pregnancy
as a determinant of risk for ICC. This is highly relevant in developing countries in
which young women initiate these two events at an early age and experience high
parity. Table 2.2 shows data on the total population of women and selected sexual
and reproductive behaviour factors for less developed countries where cervical
cancer rates are highest in the world. These indicators are proxy measures that
could be used to inform on cervical cancer prevention strategies (i.e. appropriate
age for HPV vaccination). Median AFSI ranges from 15.8 to 22 years in Africa,
16.1-20.8 in Latin America and the Caribbean, 15.7-21.6 years in Asia, and 15.6-
21.5 years in Oceania. In countries where there are no data on AFSI, age at first
marriage may reflect AFSI as sexual initiation for women occurs within marriage,
such as that in South Asia, Central, West, and East Africa (Wellings et al, 2006).
2.4.4 Biological immaturity of the cervix
Besides a woman's history of lifetime number of sexual partners, AFSI has
long been suggested to be associated with an increased risk of cervical cancer, but
previous findings have been inconsistent. There are several hypotheses on how
these behavioural factors may impact a woman's risk of progression to cervical
cancer. It has been speculated that women who initiate first coitus at a young age
are at an increased risk of HPV because of a biological predisposition of the
immature cervix during adolescence that may be more susceptible to persistent
HPV infections and therefore have a greater risk of cancer development.
The vulnerability of the cervix may be attributed to the maturational
period of the epithelial topography of the cervix (Hwang et al, 2009). The cervix
consists of both columnar and stratified non-keratinising squamous epithelia.
The squamocolumnar junction (SCI) is where these two meet and is located on
the ectocervix in neonates. The epithelium remains relatively dormant until
menarche, at which time squamous metplasia occurs and transforms basal cells of
the columnar epithelium into squamous cells. This transformation occurs in the
transformation zone. During the maturational process, a new SCI is formed more
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proximally at the endocervix as the ectocervix changes from a predominantly
columnar epithelium (considered immature) to a predominant squamous
epithelium (considered more mature). Columnar epithelium is a target site for
STIs and the transformation zone is the target site for HPV cell proliferation and
nearly all cervical neoplasia occurs here. This dynamic process is thought to be
triggered by the influence of oestrogens. Since the peak activity of metaplasia
occurs during adolescence and first pregnancy, it is highly plausible that early
AFSI and pregnancy can increase risks of cervical cancer.
A number of studies have identified an increased risk of high-grade lesions
and/or cervical cancer with early AFSI, whereas others have not (IARC, 2007).
However, many of these studies were conducted before HPV assessment was
feasible, and therefore, the association remains inconclusive. Age at first marriage
(AFM) is often used as a proxy measure for AFSI, particularly in societies where
the onset of sexual activity occurs within marriage, and those who engage in early
sexual intercourse may also consequently become pregnant at an early age. Early
childbearing has also been linked as a risk factor for cervical carcinogenesis and
attributed to the cervical trauma experienced during early age at first pregnancy
(AFP), or subsequently, by high parity births (IARCMonographs 2007). AFP and
cervical cancer have been less investigated, although AFSI and AFP are strongly
interrelated in most developing countries. The interpretation of the mechanisms
by which these sexual and reproductive health events occurring early in life might
affect ICC risk is not clear.
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2.4.5 Male role in the aetiology of cervical cancer
Understanding the burden of cervical cancer in women requires
recognising the role of men in sexual transmission of HPV.
A review of sexual behaviour highlighted that women who initiate coitus
during adolescence tended to have older male sexual partners (Table 2.2),
particularly in African countries, such as that seen in Cote d'Ivoire (average age
difference at first marriage between husband and wife=8.6 years), Malawi (8.6
years), and the Zambia (9.2 years). Similarly, the Demographic Health Surveys
found that the mean age gap differences between spouses were high in Africa
(ranging from 6.7-14.7 years) which significantly differed with developed
countries (1.9 in Australia and 2.2 in USA) (Wellings et al, 2006). These age gap
differences underscore the contribution of the male role in cervical carcinogenesis
as they act as carriers of HPV infection, and thus a woman's risk could be
dependent on their "high-risk" male partner rather than their own sexual
behaviour. In general, men report more lifetime sexual partners than women,
who are predominantly monogamous (Wellings et al, 2006). These sexual
behaviour patterns suggest that men are more likely than women to be the source
of STI transmission in marital relationships and sex within marriage is not
necessarily safe. It has been reported that condom use is not frequently reported
in such marital relationships except for other non-barrier methods of
contraception (Cleland et al, 2006). The prevalence of condom use in developing
countries is low (4.4%) (United Nations, 2007). If unprotected sex is practiced
among couples with monogamous women and uncircumcised men, in particular,
this may increase the risk of HPV infection and genital disease in their female
partners (Castellsague et al, 2002).
As HPV is involved in the cervical carcinogenic process, it is central to
understand patterns of sexual behaviour in HPV transmission including the
behaviours of both men and women. It has been debated that a woman's risk for
cervical cancer will depend more on the full sexual history of the male partner
than of her own behaviour (Skegg et al, 1982). This is particularly relevant in
societies where most women are virgins at marriage and monogamous thereafter,
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where the incidence of cervical cancer for a population may vary depending on
the behaviour of the male partner.
2.4.5.1 Male role hypothesis
Skegg et al. hypothesised that in an unscreened population, the risk of
cervical cancer will depend on three different sexual behaviour patterns (Skegg et
al,1982) :
Pattern A: a non-promiscuous society in which both women and men are
lifetime monogamous
Pattern B: a society in which women are expected to be lifetime monogamous
and men have many sexual partners (e.g, less developed countries as observed
in Latin America, Africa and Middle East)
- Pattern C: a permissive society where both men and women have several
sexual partners (e.g. more developed countries in North America and Europe)
It has been predicted that the lowest risk would be found in "Pattern A"
communities and the highest risk would be found in "Pattern B" communities. A
number of studies mostly involving monogamous women have observed an
association between lifetime number of sexual partners and history of contact
with sex workers of the husband and his wife's risk of cervical cancer while others
have not (Bosch et al, 1996; Brinton et al, 1989; Buckley et al, 1981; Munoz et al,
1996; Pridan & Lilienfeld, 1971; Thomas et al, 2001). In support of this
hypothesis, in Spain and Colombia, where women are predominantly
monogamous and the cervical cancer incidence rates are different by five-fold,
men from Colombia reported a three-fold higher number of sexual partners and a
frequency of use of sex workers than men from Spain (Bosch et ol, 1994). The
subpopulation of women practicing prostitution might act in these settings as a
"sexual network" of HPV and as a focal point for HPV exposure and spread. The
association between the number of sexual partners of the husbands and the risk
of cervical cancer in their wives was first shown in a study among mostly
monogamous Jewish women (Pridan & Lilienfeld, 1971). In two subsequent
studies among monogamous women, the risk of cervical cancer was reported to
be two to eight times for women with husbands who had multiple partners
(Brinton et ol, 1989; Buckley et al, 1981).
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2.4.5.2 Passive smoking in the couples context
Besides their sexual behaviour, other behavioural factors of the male
sexual partner, such as tobacco smoking have been less explored despite it being a
well-established risk factor for female cervical precancer and cancer (Munoz et al,
2006; Plummer et ai, 2003). Several reviews have summarised the
epidemiological and biological association of passive smoking on the risk of
cervical cancer (IARC, 2004; National Cancer Institute, 1999), however, the
evidence has been suggestive rather than sufficient to implicate the role of passive
smoking in the aetiology of cervical cancer among lifetime non-smokers. Among
the studies identified, most had small sample sizes of non-smoker controls and
cases of cervical cancer, specific information on HPVand sexual behaviour were
not available, and most studies obtained spousal history of smoking through
questioning of the women rather than the men.
Overall, the extent to which the male role contributes to a woman's risk of
cervical cancer has not been fully evaluated.
2.4.6 Natural history of HPV
The most relevant step in cervical carcinogenesis is not acquisition of the
infection, but the step in which infection will lead to relevant clinical lesions.
Current evidence from longitudinal studies indicate that the majority of HPV
infections are transient with about 90% of women, particularly young women,
clearing infection within two years, and only a minority of women will harbour
persistent HPV infection and develop cervical pre-cancer (Moscicki et ai, 2006).
Persistent infection with high-risk oncogenic HPV types is strongly linked to
cervical pre-cancer and progression to invasive cervical cancer (Moscicki et al,
2006).
Although infection with HPV is necessary for the development of cervical
cancer, infection alone is not sufficient. It has been well-established that a
number of cofactors, long-term oral contraceptive use (~5 years), smoking, high
parity, and co-infection with HIV along with HPV infection are necessary for the
carcinogenic process to invasive cervical cancer (Munoz et ol, 2006). The
prevalence of these cofactors in developing countries is described in Table 2.2.
High parity is particularly relevant as developing countries have some of the
highest levels of fertility in the world (Table 2.2) and adolescent childbearing is
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common. Total fertility ranges from 0.8 to 7.3 in less developed countries.
Besides these exogenous and endogenous factors, sexual and reproductive
behaviour factors (International Collaboration of Epidemiological Studies of
Cervical Cancer, 2009; Louie et al, 2009a), such as early AFSI and early AFP,
have also been associated with invasive cervical cancer. It is unclear at what stage
of the carcinogenic process do these factors playa role.
Prospective cohort studies have evaluated the effects of oral contraceptive
use (Brisson et al, 1996; Castle et al, aoozb: Richardson et al, 2005) and smoking
(Giuliano et al, 2002; Ho et al, 1998; Richardson et al, 2005; Silins et al, 2005),
and their associations with persistent HPV infections, but the results have been
inconclusive. The effects of HIV appear more conclusive (Ahdieh et al, 2000;
Palefsky et al, 2006; Sun et al, 1997; van der Burg & Palefsky, 2009) although
most of the data come from developed rather than developing regions, such as
Africa, where the burden of HIV is endemic. Parity as a cofactor of HPV
persistence has also been studied but mostly among study populations in
developed countries where high parity is less prevalent (Brisson et ol, 1996; Castle
et al, 2002b; Giuliano et al, 2002; Richardson et al, 2005). However, one
prospective study in a less developed area of Colombia did find that the rate of
HPV persistence was increased among parous women who were positive for HPV
infection and had normal cytology at enrolment (Molano et al, 2003).
Cumulatively, the associations between persistent HPV infections, AFSI, and AFP
have been less studied.
2.4.7 Determinants of HPV viral persistence
The viral features of HPV, such as infection by specific types (high-risk vs.
low-risk), coinfection with multiple HPV types, and HPV viral load could also
influence HPV persistence. For instance, high-risk HPV 16 and 18 types show a
greater risk of progression to pre-neoplastic lesions compared to other types. The
to-year cumulative incidence rate of developing high-grade lesions is 17%among
HPV-16 positive women and 13% among HPV-18 positive women. By contrast,
women positive for high-risk types other than HPV-16 or -18 have a 10-year risk
of 3.0% to develop high-grade lesions (Khan et al, 2005). In addition, the amount
of HPV DNA in the cervical epithelium, which is defined by the number, size, and
state of HPV-associated disease, is also associated with development of lesions.
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Low viral loads are associated with a normal cervix and low risk of developing
pre-cancer / cancer; whereas the association of high viral loads and cervical cancer
is less clear (Carcopino et ai, 2011; Cuzick et ai, 2006; Rousseau et al, 2007).
Logically, the association of high viral loads is expected to be associated with an
increased risk of developing pre-ccancer/cancer, but some of the highest viral
loads are also associated with regression of low-grade cervical lesions (Lorincz et
al, 2002). The measurement of viral load can also be complicated with
coinfection with multiple HPV types. About 20% of women with cervical
infections are infected with more than one HPV type (Bruni et ol, 2010). It is also
unclear whether these multiple HPV coinfections modify the persistence of a
given HPV type or with progression. Given the variable interpretations of viral
cofactors in the natural history of HPV. their roles remain uncertain. Studies
have evaluated viral HPV factors and cofactors separately. and only one cross-
sectional study has evaluated cofactors with HPV infection in the development of
cervical cancer (Wang et al, 2009). This study identifies current smoking to be
associated with type-specific HPV-16 cervical intraepithelial neoplasia grade 2
and 3 (CIN-2/3) and multiparity to be associated with CIN-3 without HPV type
specificity. Both HPV viral cofactors and sexual and reproductive health risk
factors need to be considered prospectively in order to determine the risk
associations in modulating HPV persistence and cancer development.
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2.5 Summary
Cervical cancer is the second most common cancer among women in the
developing world. Overall, the poorest women appear to initiate sex at an early
age, and can subsequently become pregnant at an early age, and have a large
number of children, putting them at an increased risk of HPV infection and
cervical cancer. Data suggest that women who initiate first coitus and first
pregnancy at a young age are at an increased risk of HPV because of a biological
predisposition of the immature cervix and cervical trauma experienced during
pregnancy delivery that may be more susceptible to persistent HPV infections and
therefore have a greater risk of cancer development. The epidemiological
evidence of how these sexual and reproductive health factors impact the natural
history of HPV and cervical carcinogenesis is not clear since previous studies were
conducted before HPV assessment was feasible. This thesis hypothesized that the
biological associations of these sexual and reproductive health factors and ICC
can be confirmed with strong epidemiological evidence that fully addresses the
role of HPV. The objective of this PhD thesis was to characterize and provide
robust estimates of the risk of cervical cancer and its association with AFSI, its
interrelated characteristics such as AFP and AFM, as well as characterize the
contribution of male factors to a woman's risk. Findings from this research may
provide clues to additional biological mechanisms and molecular events that are
important for progressive disease in the natural history of HPV and cervical
cancer, as well as make suggestions in improving the design and assessment of
cervical cancer prevention measures.
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3 Study 1. Early age at first sexual
intercourse (AFSI), marriage (AFM),
and first pregnancy (AFP) and risk of
cervical cancer
3.1 Introduction
Early age at first sexual intercourse (AFSI) has been associated with an
increased risk of high-risk human papillomavirus (HPV) infection, a sexually
transmitted infection, that in susceptible women, is responsible for virtually all
cases of invasive cervical cancer (ICC) (Bosch et al, 2002). Since sexual behaviour
determines exposure to HPV, AFSI is of particular interest as it has been
associated with riskier sexual behaviour, such as having unprotected sex, having
multiple sexual partners, as well as a woman's partner having multiple partners.
It has also been speculated that the increased risk of HPV is due to a biological
predisposition of the immature cervix during adolescence that may be more
susceptible to persistent HPV infections and therefore have a greater risk of
cancer development (Kruger-Kjaer et al, 1998). A number of studies have
identified an increased risk of high-grade lesions and/or cervical cancer with
early AFSI while others have not (IARC, 2007). However, several of these studies
were conducted before HPV assessment was feasible and different statistical
methodologies were used to evaluate HPV, and therefore, the associations remain
inconclusive. Age at first marriage (AFM) is often used as a proxy measure for
AFSI, and those who engage in early sexual intercourse may also consequently
become pregnant at an early age. Besides early AFSI, early childbearing has also
been linked as a risk factor for cervical carcinogenesis and attributed to the
cervical trauma experienced during early age at first pregnancy (AFP), or
subsequently, by high parity births (IARC, 2007). The interpretation of the
mechanisms by which these sexual and reproductive events occurring early in life
might affect ICC risk three or more decades later is not straightforward. The
objective of this study was to further characterise and provide robust estimates of
the risk of cervical cancer and its association with AFSI, interrelated
characteristics such as AFP and AFM in a series of studies that fully considered
the association of HPVwith cervical cancer.
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3.2 Methods
The program of HPV and cervical cancer studies has been coordinated by
the International Agency for Research on Cancer (IARC) in Lyon, France and the
Institut Catala d'Oncologia (ICO) in Barcelona, Spain. They included a series of
case-control studies on invasive cervical cancer from eight developing countries
with a broad range of rates of incidence of cervical cancer that were pooled for
analysis. Regions covered include Morocco (Chaouki et al, 1998) and Algeria
(Hammouda et al, 2005) in Africa; the Philippines (Ngelangel et al, 1998)
Thailand (Chichareon et ai, 1998) and Madras, India in Asia; and Brazil (Eluf-
Neto et al, 1994), Colombia (Munoz et ol, 1993), Paraguay (Rolon et al, 2000),
and Peru (Eluf-Neto et ai, 1994) in South America. Although Spain (Munoz et al,
1993) was part of the series of case-control studies, the sexual and reproductive
behaviour of this population was heterogeneous to the other countries Gate AFSI
and low parity) and the study site was therefore excluded from this analysis.
Methods of each study have been described elsewhere. Briefly, women with
histologically confirmed incident invasive squamous cell carcinoma,
adenocarcinoma or adenosquamous-cell carcinoma were recruited from reference
hospitals before treatment. Written informed consent was obtained from those
who agreed to participate. Hospital-based controls were frequency-matched to
case patients by five-year age groups.
3.2.1 Study questionnaire
A standardized questionnaire was administered to participants by a
trained interviewer that included questions about socio-demographic factors,
sexual and reproductive behaviour, smoking habits, Pap screening history,
hygienic practices, and history of sexually transmitted diseases.
3.2.2 Specimen collection and testing
Two samples of cervical exfoliated cells were collected with wooden
spatulae and endocervical brushes. After preparation of one Papanicolaou smear,
the remaining cells were eluded in saline, centrifuged and frozen at -70°C until
shipment to the central laboratory for HPV DNA testing. A tumor-biopsy sample
was obtained from cases and frozen. Cytology and histology diagnosis were
reviewed and confirmed by a panel of expert pathologists that agreed on a
diagnosis by consensus or majority.
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3.2.3 HPV DNA testing
Detailed descriptions of the polymerase-chain-reaction (peR) assays used
in these studies have been described elsewhere. HPV DNAdetection was detected
by peR amplification of a small fragment of the Lt gene using MY09 and MYll
consensus primers for the study in Colombia (Hildesheim et al, 1994)and
GP5+/6+ general primer system for the other studies (de Roda Husman et al,
1995; Jacobs et al, 1995; Walboomers et al, 1992a). Beta-globin primers were
used to amplify the beta-globin gene to assess the quality of the DNA in the
specimen. HPV DNA in peR products were analyzed with the use of a cocktail of
HPV-specific probes and genotyped by hybridization with type-specific probes for
33 HPV types. Samples that tested positive for HPV DNA but did not hybridize
with any of the type-specific probes were labelled as HPV X.
3.2.4 Statistical analysis
Unconditional logistic regression was used to estimate odds ratios (DRs)
and 95% confidence intervals (95% Cl).
To assess the association of AFSI with the risk of invasive cervical cancer,
three different statistical models to adjust for HPV DNA detection were computed
and compared: 1) one model included all patients and controls, and it was not
adjusted for HPV DNA status, 2) a second model included all patients and
controls, and included a variable to adjust for HPV DNA status, and 3) a third
model was restricted to HPV DNA positive cases and controls. As described
earlier, results from previous studies have been inconclusive since studies were
conducted before HPV assessment was feasible. These three models were used to
clarify previous inconsistent associations.
To control for potential confounding, final models were adjusted for age,
country, lifetime number of sexual partners (1, >1), parity (0, 1-4, ~5), and
educational level (never, primary, secondary or higher). Each variable included
in the adjustment models was assessed for interaction with AFSI. Test for trend
was performed when appropriate using the log likelihood ratio test. Only
subjects who reported ever having been married and/or ever having had children
were included in the analyses of A.FM and AFP.
We evaluated other potential confounding factors such as smoking (never,
ever), oral contraceptive use (never, 1-4 years, ~5 years), history of pap smears
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excluding those in the 12 months prior to enrolment (never, ever), having had
first coitus before menarche and the timing of first coitus relative to age at
menarche (Table 3.1), but they were not adjusted for in the final analysis since
they did not contribute any change to the odds ratio estimates for AFSI in the
adjusted models.
Table 3.1Univariate analysis of risk factors associated withAFSIand risk of
ICC
Cases/Controls
Odds ratios
(9S%CI)*
History of first sexual intercourse before
first menarche
No
Yes
Time from first sexual intercourse from
first menarche
>=5yrs
3-4yrs
r-z yrs
oyrs
<0 years
Missing
2090/2079
223/147
1.00
1.88 (1.36-2.61)
946/1299
489/376
466/298
189/106
8z/40
1.00
1.93 (1.63-2.28)
2.37 (1.98-2.83)
2.70 (2.07-3.52)
3.61 (2.42-5.38
*Age and centre adjusted
3.2.4.1 Sub-analysis of male factors
A sub-analysis was conducted among women (from Brazil, Morocco,
Algeria, Philippines, and Thailand) who had information on the age of their first
male sexual partner.
3.2.5 Ethical approval
The multi-centric case-control study protocol was approved by the IARC
and local ethics and research committees in each study country. Additional
approval for this research was obtained from the Lead Principal Investigator, F
Xavier Bosch and the Steering Committee of the IARC Cervical Cancer Study
Group. PhD Co-Supervisor, Silvia de Sanjose, for this thesis is also part of this
steering committee. A letter granting access to the data for collaborative analyses
is attached (Appendix 6), This research was also approved by the ethical review
boards at the London School of Hygiene and Tropical Medicine (Appendix 7).
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3.3 Results
3.3.1 Patient characteristics
Table 3.2 describes some characteristics of the 1864 invasive cervical
cancer cases and 1719 corresponding controls that entered the final analysis.
Ninety-five percent of case patients and 17% of controls tested positive for HPV
DNA The majority of cases (92%) had" squamous cell carcinoma (SCC). Case
patients were older than controls with a median age of 49 (range 20-84 years) vs.
48 (18-82 years), respectively. Median AFSI was earlier in case patients (17; range
6-45 years) compared to controls (19; range 6-42 years) and this was consistently
found in each country.
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3.3.2 AFSI and risk of cervical cancer
Table 3.3 shows the risk of ICC by AFSI according to the three different
adjustment models. An increase risk of ICC was consistently observed with
decreasing AFSI (p-trendco.ooi). Compared to AFSI ~21 years, the odds ratios
of ICC was 1.80 (9S%CI: 1.S0-2.16) for AFSI 17-20 years, and 2.31 (9S%CI: 1.8S-
2.87) for AFSI s16 years, after adjusting for age, centre, lifetime number of sexual
partners, parity, and education level in the HPV-unadjusted model. According to
the different model adjustments, women reporting AFSI s16 years of age had a
2.3 to 2.S-fold risk of ICC and 1.8 to z.r-fold risk for AFSI 17-20 years of age
(Table 3.3). Given the consistent association of AFSI and the risk of ICC across
the different models, HPV-unadjusted models were used for the remainder of the
results.
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We calculated the risk of ICC for each country study, and, in general, each study
country showed an increasing risk of ICC with decreasing AFSI (Table 3.4). There
was no evidence of heterogeneity with respect to study country (p=o.S8).
Table 3.4 Association between age at first sexual intercourse and risk of ICCby
country
No. of Odds ratio Odds ratio
Country cases[controls {2S%CI}* <2Q%CI)t
Brazil
l!!:21 38/83 1.00 1.00
17-20 86/69 2·73 (1.66-4.49) 2.35 (1.36-4.05)
:sa6 63/38 3.62 (2.08-6.32) 2.65 (1.41-4.98)
p-trend 0.002
Morocco
l!!:21 7/44 1.00 1.00
17-20 50/58 4.11 (1.66-10.17) 1·52 (0.46-4.97)
~16 131/74 7·39 (3·08-17.74) 2.08 (0.63-6.90)
p-trend 0.16
Paraguay
l!!:21 11/25 1.00 1.00
17-20 41/45 2.24 (0.97-5.18) 0.52 (0.17-1.59)
~16 60/16 9.11 (3.66-22.67) 1.29 (0.38-4.44)
p-trend 0.46
Philippines
l!!:21 122/210 1.00 1.00
17-20 165/136 2.09 (1.52-2.88) 1.67 (1.18-2.37)
~16 77/34 3.92 (2.47-6.22) 2.32 (1.40-3·86)
p-trend <0.001
Thailand
l!!:21 92/126 1.00 1.00
17-20 220/108 2.80 (1.90-3.99) 2.15 (1.47-3.16)
~16 66/25 3.62 (2.12-6.17) 2.24 (1.25-3.99)
p-trend <0.001
Peru
l!!:21 24/51 1.00 1.00
17-20 71/64 2.36 (1.31-4.26) 1.94 (1.04-3.64)
~16 101/60 3.58 (2.00-6.40) 2.46 (1.26-4·82)
p-trend 0.01
Madras, India
l!!:21 17/30 1.00 1.00
17-20 88/98 1.59 (0.82-3.08) 1.27 (0.61-2.63)
s16 82/56 2.60 (1.31-5.17) 1.41 (0.66-3.04)
p-trend 0·39
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Algeria
;;0;21
17-20
s16
p-trend
Colombia
;;0;21
16/46
SO/47
76/S2
1.00
3.33 (1.62-6.86)
4.76 (2.32-9.78)
1.00
2.12 (0.94-4.80)
2.41 (1.01-S.74)
0.08
17-20
s16
p-trend
14/41
42/42
S4/41
1.00
2.93 (1.39-6.16)
3.86 (1.8S-8.08)
1.00
2.S3 (1.13-S.64)
2.43 (1.07-S.S2)
0.04
*Adjusted for age and study centre
t Adjusted for age, study centre, lifetime number of partners (1, ;;0;2),parity (0, 1-4, ;;o;S),and
education (never, primary, secondary)
We stratified the analysis according to the established risk factors for ICC and the
positive association of ICC with decreasing AFSI remained at each level of
exposure for each of these characteristics (Table 3.5). Similar associations were
observed for AFP. No interaction was observed between any of the examined risk
factors and AFSI. Although not statistically significant, the risk linked to AFSI
appeared stronger among parous women compared to nulliparous women.
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3.3.3 AFSI,AFM,andAFP
AFP and AFM were both directly correlated with AFSI in these populations
(P<O.OOl). Approximately 92% of women reported AFSI to be the same as AFM.
One-quarter of women reported AFP to be the same as AFSI. Cumulatively,
62.4% of women reported giving birth within the first year of AFSI. Among
women with AFSI ~16 years, 52-4% were pregnant within the first year of coitus.
Figure 3.1 shows the high correlation of AFSI and AFP and the similar decreasing
risk of ICC with increasing age of AFSIj AFP. Given the high correlation between
the two variables, we did not adjust for AFSI in the AFP final model and vice
versa.
10
9
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II~ 3 t ~I;;a 'f h2 It tt .t
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• Age at first sexual intermurRe 95" ooofideIu:.e iuterYal
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Figure 3.1. Age at first sexual intercourse and age at first pregnancy are
highly correlated with the risk of invasive cervical cancer (p-tr-end-oo.ooa),
Models were adjusted for age, centre, lifetime number of sexual partners (1,
>1), parity (0, 1-4, ~5), and education (never, primary, secondary).
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We further evaluated the combined effect of AFP and AFSI on the risk of
cervical cancer (Table 3.6). An increased risk emerged in subsequent strata of
decreasing AFP with decreasing AFSI.
Table 3.6. Interaction between age at first pregnancy and age at first
sexual intercourse in the risk of cervical cancer
Ageat first pregnancy
Ageat sexual debut ~21 17-20 :sa6
~21yr 1.00
17-20yr 1.58(1.22-2.03) 1.93(1.58-2.36)
:S16yr 2.17(1.35-3.47) 2.28(1.74-2.99) 2.36(1.82-3.07)
t Adjusted for age, study centre, lifetime number of partners (1,~2),parity (0, 1-4,~5),
and education (never, primary, secondary).
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Given this combined effect, we assessed the latency period (AFP - AFSI)
between these two events to clarify whether it affected cervical cancer risk.
Although there was no statistical difference across strata, the data suggested that
women with AFSI s16 years and a latency period for a subsequent pregnancy of
less than 2 years may be at a slight increased risk compared to women with a
larger time gap (Table 3.7).
Table 3.7 Association between AFP-AFSI and risk of cervical cancer
No. of years difference
between AFP-AFSI Cases/Controls Odds ratio (95% CI)*
AFSI ~21
~2
1
o
AFSI17-20
~2
1
o
AFSI s16
94/202
117/225
115/187
1.00
0.97 (0.68-1.39)
1.17(0.81-1.69)
268/226
285/247
250/175
1.00
1.01(0.78-1.32)
1.15(0.87-1.52)
~2 330/187
1 235/132
o 134/68
1.00
1.11(0.82-1.50)
1.06(0.73-1.53)
AFP, age at first pregnancy; AFSI, age at first sexual intercourse
*Adjusted for age, study centre, lifetime number of partners (1,~2), parity (0, 1-4,~5),
and education (never, primary, secondary)
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3.3.4 Sub-analysis of age difference with the first male partner
Age difference with the first male sexual partner at the time of the women's
first sexual intercourse was identified as a risk factor for ICC (Table 3.8). Among
the subset of women reporting the age of her first male sexual partner, we
observed a decrease in age difference with the first male sexual partner with
increasing AFSI (Figure 3.2), highlighting the fact that younger women tend to
have older partners at sexual initiation or at first marriage.
Table 3.8. Age at first sexual intercourse (APS}) and risk of cervical
cancer according to age difference with the first male sexual partner
No. of
AFSI cases/controls
Odds ratio
(95%CI)*
Age difference of sa years
~21 164/301
17-20 113/175
s16 26/47
Age difference of 3-7 years
~21 139/60
17-20 . 161/210
s16 91/148
Age difference of C!8 years
~21 66/49
17-20 137/180
s16 103/207
p-heterogeneity=o.55
1.00
2.78 (2.05-3.78)
3.58 (2.10-6.12)
1.00
3·03 (2.08-4.42)
4·55 (2.97-6.97)
1.00
1.84 (1.19-2.85)
3·27(2.04-5.23)
Odds ratio
(95% CI)t p-trend
1.00
1.87(1.34-2.61)
1.64 (0.91-2.95) 0.002
1.00
2·52(1.68-3.79)
3·31(2.04-5.39) <0.001
1.00
1.54(0.96-2.48)
2·32 (1.37-3.94) 0.001
*Adjusted for age and study centre
t Adjusted for age, study centre, lifetime number of partners (1,~2), parity (0, 1-4,~5),
and education (never, primary, secondary)
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About half of the cases and one-third of the controls (47.5% and 33.7%,
respectively) with an age gap of :::8 years with their first male sexual partner
initiated sexual intercourse at sI6 years. In contrast, about 12%of cases and 6.0%
of controls who had a smaller age gap of S2 years initiated first intercourse at SI6
years (Table 3.8). No heterogeneity was observed between the age gap difference
among monogamous women and women with more than one lifetime number of
sexual partners (p=0.18). The odds ratios vs. age difference with the first male
sexual partner of S2 years was 1.11(9S%CI: 0.90-1.37) among women with an age
difference of 3-7 years, and 1.44 (9S%CI: 1.15-1.80) for :::8years, after adjusting
for age, centre, AFSI, lifetime number of partners, parity, and education.
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3.4 Discussion
The IARC/lCO series of case-control studies remain the largest set of
aetiological investigations on invasive cervical cancer that fully addresses the role
of HPV DNA and of the independent established cofactors. This is probably also
the largest dataset reporting on invasive cervical cancer in the developing world
where early AFSI, AFP and high parity are prevalent phenomenons. The results
show that early age at first sexual intercourse and early age at first pregnancy are
risk factors for cervical cancer, irrespective of other known risk factors for the
disease. The data presented show a possible additional increase in risk when the
early event of first sexual intercourse is shortly followed by a pregnancy.
The mechanism by which the early experience of first coitus and first
pregnancy could influence the risk of cervical carcinogenesis may be explained by
the steroid hormonal influence on HPV infection and on the host's immune
response to HPV during preadolescence and adolescence. The transformation
zone of the cervical epithelium has been recognized as the site for which HPV
infection tends to cause cancer and the susceptibility of this area is believed to be
related to its desnudation of the stratified epithelium, thus facilitating exposure of
the basal layer to HPV with minimal trauma. Biological immaturity during
adolescence has also been proposed as an additional susceptibility factor (Elson et
al, 2000; Moscicki et al, 1989; Singer & Monaghan, 2000). During adolescence
and pregnancy, the cervix is exposed to augmented levels of hormonal changes
(Singer & Monaghan, 2000), in which oestrogen stimulation facilitates
acidification of the vaginal cavity, a determinant of squamous metaplasia when
the endocervical epithelial everts (Elson et al, 2000). When this estrogen-
stimulated metaplastic transformation occurs in the presence of HPV, the
probability of cell transformation increases, resulting in neoplastic changes
(Elson et al, 2000; Hwang et al, 2009; Shai et al, 2007; Shai et al, 2008). This
phenomenon is dependent primarily on parity, and is more likely to occur during
the first pregnancy rather than subsequent pregnancies (Singer & Monaghan,
2000). Although it has been postulated that these metaplastic changes are also
influenced by the trauma and repair experienced during delivery, no increased
risk for cervical carcinoma was observed in this same dataset when traumatic
partition was evaluated (Munoz et al, 2002).
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Increased risks of cervical carcinoma have been identified in women with
long-term use of hormonal steroids (Moreno et al, 2002)and those who are highly
parous (Munoz et al, 2002). In addition, HPV-16 transgenic mouse models have
shown that those treated with longer durations of oestrogen were more likely to
develop larger tumours and have a significantly higher number of tumours than
those treated with a shorter duration (Arbeit et ol, 1996; Brake & Lambert, 2005;
Elson et al, 2000; Mitrani-Rosenbaum et al, 1989), supporting the human
observations of a susceptible cervix to carcinogenic progression by continuous
exogenous oestrogen exposure (e.g. oral contraceptive use) or increased
endogenous oestrogen levels (e.g. pregnancy). If indeed oestrogen is needed for
cervical carcinogenesis, close follow-up of young women and of their early
pregnancies may be relevant to further understanding the role of steroids in the
acquisition and persistence of HPV infections.
The influence of oestrogens on immune response may offer another
explanatory effect (Arbeit et al, 1996; Mitrani-Rosenbaum et al, 1989),
particularly during the follicular phase of the ovarian cycle and pregnancy, when
levels of estrogens are increased up to 3-8 fold normal levels (Duncan et al, 1994;
Jabbour et al, 2006; Marzi et al, 1996). Immune response against early HPV16 E2
and E6 oncoproteins has been shown to be severely impaired or be absent in
patients with cervical cancer (de Jong et al, 2004).The higher density of
oestrogen receptors and their expression in the transformation zone may
synergize with the effects of HPV oncoproteins, decreasing levels of cytotoxic
cytokines that may down-regulate the cervical cell-mediated immune response,
which favour persistent HPVinfections instead of clearance (de Jong et al, 2004;
Giannini et al, 1998; Giannini et al, 2002; Jacobs et al, 2003; Marzi et al, 1996).
During pregnancy, oestrogens appear to suppress Thi (T helper 1) cell-mediated
immune responses and stimulate Th2 humoral immune response that may
contribute to the increase rate of HPV proliferation and the decrease rate of
apoptosis (Marzi et al, 1996). It has been suggested that development of
squamous intraepithelial lesions is associated with decreased levels of cytotoxic
cytokines that may down-regulate the cervical cell-mediated immune response
during pregnancy, favouring persistent HPV infections instead of clearance
(Giannini et al, 1998). Additional research is needed to further understand the
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interaction between oestrogens and the regulation of immunomodulators, which
may contribute to anti-tumour immunity.
The varying results between the studies concerning the role of AFSI and
AFP may reflect the true differences between the study populations in relation to
sexual and reproductive behaviours. In our study populations, the similar
increased risks shown for AFSI and AFP may reflect, in general, the behaviour
patterns of most developing countries where women initiate both sex and
childbearing at an early age and experience high parity, making the effects of
these two events difficult to distinguish from one another. In contrast, studies in
more developed countries where there is a longer latency period between sexual
initiation and AFP, like in Spain, the United States or in Italy (Brinton et al, 1987;
Parazzini et al, 1989), the results tend to show an increased risk with early AFSI
but not with AFP as first pregnancies tend to occur much later. Interestingly, in
countries like the UK, where the rates of teenage pregnancies are high, women
with AFSI of S17 years had a 2-3 fold increased risk for cervical cancer compared
to those with AFSI ~20 years. Consistently, women with an early AFP 15-19years
had a a-fold increased risk for cervical cancer compared to those with AFP ~25
years (Green et al, 2003). These observations merit further exploration but in
aggregate, tend to indicate a significant increase in risk of neoplastic
transformation and progression when early sexual initiation occurs (surrogate of
early HPV exposure and a period of increased cervical susceptibility) and is
followed closely by an early pregnancy (surrogate of early exposure to high
oestrogen levels).
3.4.1 Sexual behaviour
Irrespective of their lifetime number of sexual partners, women have a
similar increased risk of ICC with early AFSI as shown by the z.a-fold risk among
monogamous women with AFSI s16 years as compared to the a.a-fold risk among
women with >1 lifetime number of sexual partners. These results support that
among lifetime monogamous women, their risk may be more dependent on the
sexual history of their male partner in addition to their own behaviour. This is
particularly relevant in conservative societies where most women are virgins at
marriage and monogamous thereafter, where the incidence of cervical cancer for
a population may vary depending on the behaviour of the male partner. Seventy-
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percent of the women in our study were monogamous. As summarized earlier
(Chapter 2), several studies among monogamous women, the risk of cervical
cancer was reported to be two to eight times for women with husbands who had
multiple partners (Brinton et al, 1989; Buckley et ai, 1981; Pridan & Lilienfeld,
19'71).
3.4.2 Male role factors
The sexual history of the male partner was not evaluated in this analysis,
however, promiscuity, history of other STIS, and lack of male circumcison are
factors that have been associated with the male role in cervical carcinogenesis
(Castellsague et al, 2003). The full evaluation of the male role is presented in
Study 3 (Chapter 5). However, the results presented in Figure 3.2 and Table 3.4
contribute to a different angle to this interesting association and clearly show that
women with an early sexual debut tend to have partners who are older and this
age gap difference was an independent predictor of risk for ICC. In our study, the
median age of the male partner among women with AFSI s16 was 26 years,
whereas the median age was 23 for women with AFSI 17-20 and 22 for women
with AFSI ~21. When analysed by country, the age difference was particularly
relevant in Brazil, where the age gap was the widest in this analysis (data not
shown). Age of the first partner is likely to be another descriptor to the male role
in cervical carcinogenesis in addition to the already established factors
(Castellsague et al, 2003). The age gap between partners at the time of first sexual
intercourse may act as a surrogate estimate of the probability of HPV exposure.
The variability of the age-specific HPV prevalence among men has not been
adequately described. In some high-risk countries, it has been shown to be
consistently high (51-61%) across all age groups (18-70 years) (Giuliano et al,
2008), whereas in other countries, it appears to follow a similar age-related
profile as is consistently observed in women (de Sanjose et al, 2007). It thus
seems that these associations are highly population-dependent and generalisation
of these observations should be done with caution.
3.4.3 Study caveats
In the interpretation of our results, we cannot emphasize the difficulty in
fully disentangling a woman's sexual and reproductive health profile and her
cancer risk (Schroder et al, 2003). We cannot exclude the possibility of
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misclassification bias if AFSI and the number of sexual partners were inaccurately
reported, leading to some residual confounding, However, the presence of
established risk factors for ICC, use of oral contraceptives, smoking, and Pap
smear history did not appear to significantly affect the strength of the association
we found between AFSI, AFP, and risk of ICC.
3.4.4 Different HPV adjustment methodologies
We examined the different stratified methodologies (unadjusted, HPV-
adjusted, and HPV-positive restricted) used to evaluate the association of AFSI
and risk of ICC traditionally employed in the literature. This was done to exclude
any spurious association related to statistical adjustment and to clarify
inconsistent findings of the association found in previous studies, Although in
strict terms, restriction of analyses to HPV positive cases and controls seemed
preferable, the consistency of the results across the three different methods
provide convincing evidence of the risk associated with AFSI. The magnitude of
the association was shown to be a a-fold risk of ICC among women with AFSI s16
years. Furthermore, these results indicate that for the evaluation of other risk
factors, adjusting for HPV status is not necessary as the adjustments do not
contribute to remove any confounding effect.
3.4.5 Social implications
Sexual practices in the world indicate that very early intercourse
might be occurring in adolescents with 44%, 45% and 52% of girls between the
ages of 13-19 years reporting being sexually experienced in Argentina, Botswana
and Nigeria, respectively (Brown et al, 2001). In a number of case studies among
young females, first sexual intercourse has been reported as forced in 596 to 15%
of cases, and in some extreme cases worldwide, the estimates range from 21%
among out-of-school adolescents in Botswana, 20% among secondary schools in
Peru, and 41% among young urban females attending night schools in Peru.
Among 15-30% of sexually active girls between 15-19 years report forced first
sexual intercourse (Brown et al, 2001). Previous studies assessing the risk for
STIs after coercive sexual intercourse found that sexually abused children to be at
risk for Chlamydia, gonorrhoea (Beck-Sague & Solomon, 1999), HN (Lindegren
et ai, 1998) and HPV (Gutman et al, 1992; Kahn et al, 2005; Siegfried et al, 1998).
Sexual abuse is unfortunately common also in developed countries (Bechtel,
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2010) and has been shown to be a predictor of HR-HPV infection (Wingood et al,
2009). It is likely that the partners of these adolescents who report sexual
coercion are adult males who are sexually experienced (Wellings et ol, 2006) and
at high-risk to HPV exposure. Globally, these exposures might affect a high
proportion of very young girls in areas of human strife, and thus, adding to the
burden of child sexual abuse above the burden of a lifetime increased risk of
genital cancer.
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3.5 Conclusions
This study shows that women who initiate first sexual intercourse and
experience their first pregnancy at a young age are at an increased risk of cervical
cancer. The implications of this study are particularly important for populations,
where age at first sexual intercourse and pregnancy occur early. The importance
of HPV vaccination programmes targeting young adolescents prior to first sexual
intercourse can have great impact in decreasing the incidence of cervical cancer.
Cervical cancer prevention measures require additional efforts in the fields of
family planning and sexual education adapted to the extremely variable
sociocultural contexts in the world.
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4 Study 2. Sexual and reproductive health
factors and risk of HPV persistence in
the Guanacaste Cohort
4.1 Introduction
Persistent infection with high-risk oncogenic human papillomavirus (HPV)
types is strongly linked to cervical pre-cancer and progression to invasive cervical
cancer (Moscicki et al, 2006). Although infection with HPV is necessary for the
development of cervical cancer, infection alone is not sufficient. Long-term oral
contraceptive use (~S years), smoking, and high parity are well-established
cofactors for the carcinogenic process to invasive cervical cancer (Munoz et al,
2006). Few studies have tried to distinguish the risk factors for viral persistence
from neoplastic progression. The two stages of the cervical carcinogenic process
are not identical and need to be separated. Long-term persistence without
progression to cervical neoplasia is believed to be uncommon. The intermediate
stage, HPV persistence, between HPV acquisition and cervical neoplasia is not
well understood.
HPV persistence is the most important stage in cervical carcinogenesis as it
is a precursor to progressing to relevant clinical lesions. Longitudinal studies
indicate that the majority of HPV infections are transient with the majority of
women clearing infection within two years, and only a minority of women will
harbour persistent HPV infection to develop cervical pre-cancer (Moscicki et al,
2006). Inconclusive associations with HPV persistence have been found for oral
contraceptive use (Brisson et al, 1996; Castle et al, 2002b; Richardson et al,
200S) and smoking (Giuliano et al, 2002; Ho et al, 1998; Richardson et al, 2005;
Silins et al, 2005). Parity as a cofactor of HPV persistence has also been studied
but mostly among study populations in developed countries where high parity is
less prevalent (Brisson et al, 1996; Castle et al, 2002b; Giuliano et al, 2002;
Richardson et ai, 200S).
Sexual and reproductive health (SRH) behaviour factors, such as early age
at first sexual intercourse (AFSI) and first pregnancy (AFP), have been associated
with invasive cervical cancer as described in Study 1 (Chapter 3). However, it is
unclear whether AFSI and AFP continue to play a relevant role throughout the
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different stages of the natural history of HPV and cervical cancer, specifically
HPV persistence. The objective of this study was to evaluate the role of AFSI and
AFP on a-year persistence of prevalent HR-HPV infections and to confirm the
role of these established factors for cervical carcinogenesis in a longitudinal
cohort.
Page 174
4.2 Methods
4.2.1 Study population
This study was conducted in Guanacaste (Figure 4.1), a rural province in
Costa Rica with 240,000 inhabitants in 1993, which represented 8% of the
country's population, of whom 58% were at least 18 years old. Detailed study
design and methods of the Guanacaste Cohort have been reported (Bratti et al,
2004; Herrero et al, 1997). The main objective of the population-based cohort
was to study the natural history of HPV infection and cervical neoplasia in an area
with a high incidence of cervical cancer (age-standardized incidence rate of 33 per
100,000 women). Incidence in this region was higher than the national average in
Costa Rica and four- to five-fold higher than that found in the United States
(Herrero et al, 1997), highlighting the disparities between a less developed
country compared to a developed country. Despite having a national health care
system that provided cervical cancer screening services, coverage was low and
mainly only women in the target population were screened if they were attending
family planning and prenatal clinics. In addition, the lack of high quality cytology
laboratories and adequate follow-up, referrals and treatment of women with
cervical abnormalities may partially explain the sustained high rates of cervical
cancer in Guanacaste throughout the decade prior to study commencement.
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Figure 4.1 Map of Costa Rica. The study was carried out in the northwest province of
Guanacaste with two field offices in Liberia and Nicoya,where two regional hospitals
were located. Central headquarters of the Guanacaste natural history cohort study was in
San Jose, the capital ofCostaRica.Reproducedfrom (Herrero et al, 1997)
Prior to the start of the study, population enumeration was conducted
between February and March 1993 by visiting every house in a random election
of 178 of.1038 censal segments in Guanacaste, which would provide the target
sample size of 10,000 women (Bratti et al, 2004; Herrero et al, 1997). Population
characteristics (age group, province of birth, nationality, social security affiliation,
province of residence in the previous 5 years, educational level obtained, marital
status, employment, and number of live children) of the study censal s gm nts
were comparable to the census. Women aged 18 years or older by 1 July 1993
were invited by mail or personal visits were made to invite women to participat
in the study. Women were given appointments to attend the clo est gOYrnm nt
clinic to participate in the study which included cervical creening. Tho who did
not attend their first appointment were visited at home, provided with more
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information and offered transportation to the clinic with study vehicles to
increase study participation. Women identified as mentally incompetent or
unable to speak Spanish were excluded from the study since they were unable to
provide informed consent. Eligible women were provided with written
information on study procedures and the risks and benefits of the study were also
discussed. Those who agreed to participate in the study signed informed consent
forms.
Between June 1993 to December 1994 women aged 18 to 97 years old (n=l1,
742) were randomly selected and screened in June 1993 to December 1994 from
Guanacaste, Costa Rica. Among 10,769 women who were eligible for study,
10,049 were enrolled and followed-up for seven years up to 2001. At enrolment,
women were screened by cervicography, three types of cytological tests
(conventional, liquid-based, and computer-assisted Papnet) and visual inspection
by a trained nurse. In addition, women were screened with Hybrid Capture Tube
(HCI') test (Digene, Gaithersburg, MD, now Qiagen) which detected 11oncogenic
HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, and 58) at a threshold of 10
pg/ml, of DNA from exfoliated cervical cells. Women presenting with any
abnormal screening test except for HCI' were referred for colposcopy and biopsy
of the worse appearing lesion and were censored from study follow-up.
Diagnosis at enrolment categorized the study participants into two groups
for follow-up based on their perceived risk for developing cervical intraepithelial
neoplasia grade ~2 (CIN ~2): active or passive follow-up (Figure 4.2). Women
with cytological evidence of LSIL or histological diagnosis of CIN-1 were followed-
up every 6 months (n=492). Annual follow-up was done for women who had
ASCUS or Cervigrams suggestive of minor lesions (n=980), positive for HCf
(n=303), or reported having had five or more sexual partners (n=344). A random
sample of women with normal cytology (n=537) and 410 virgins who were s26
years at enrolment were also followed-up annually. The remaining group of
women with normal cytology were assigned to a passive cohort and were referred
to routine screening. However, at five to six years after enrolment, a random
sample of this passive cohort was invited for follow-up screening.
The active follow-up group returned for screening every 12months. At any
point during follow-up, if a woman presented with LSIL, she was switched to a
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more intense 6-months screening interval. In addition, if at any point during
follow-up, a woman presented with CIN-2+, she was censored from the study and
referred for appropriate follow-up. The passive cohort were screened at 5-7 years
and if they presented with any cytological abnormalities, they would also switch
to a more intense 6-months screening interval until they completed 7 years of
follow-up. To ensure their safety, those women who continued to have cytological
abnormalities at the end of study were followed outside the study.
ENROLLMENT PHASE OF GUANACASTE COHORT (GC)
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Figure 4.2 Enrolment phase of the Guanacaste Cohort (GC). The active follow-
up cohort was followed-up at either 6 months or annually which included women with
low-grade intraepitheliallesions (LSIL)/cervical intraepithelial neoplasia grade 1 (CIN-
1), ASCUS or Cervigram positive (Po or PI), Hybrid-Capture Tube (HCT) positive,
women with >5 sexual partners, a random sample of women with normal cytology, and
virgins (:526years). The passive follow-up cohort was women with normal cytology and
HCT-negative who were followed up at Year 5, 6, or 7 of the study.
4.2.1.1 Selected Study 2 sub-population
For the purposes of this study objective, a sub-population was further
selected for analysis (Figure 4.3). At enrolment, 955 women (with hysterectomy,
histologically confirmed cervical cancer, and CIN2+) were censored from follow-
up. Women with no follow-up exam (i.e. virgins at enrolment who did not become
sexually active during the study) or did not return for at least one follow-up visit
were excluded (n=1327). In addition, women with no adequate baseline (except
for virgins) or at least one adequate follow-up HPV DNA PCR result were
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excluded (n=143). 7624 women (n=278s, active cohort and n=4839, passive
cohort) would be available for follow-up analysis. For this thesis, we will focus on
the active cohort who was sexually active at time of study enrolment. Therefore,
virgins were further excluded (n=248). Of the n=2S37 sexually active women, 613
(24.2%) were infected with prevalent HR-HPVat time of enrolment.
Enrolled into flat cohort
n=)0,049
adequate follow-up
HPV DNA PCR,.tsnlt
U=13!!
'·\'Ti1hout adequate
bnsehue
at leest 1
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Figure 4.3 Consort diagram
4.2.2 Ethical approval
Ethical approval for this study was obtained from the Institutional Review
Boards of Costa Rica and the United States (US) National Cancer Institute (NCI)
(Appendix 8). Study 2 planned secondary data analyses were approved by the US
Principal Study Investigator, Mark Schiffman, MD MPH. A letter of data transfer
agreement was submitted to the NCI for study approval on 9 February 2010 and
data was transferred to K. Louie, the investigator of this project on 1 July 2010
(Appendix 9). Additional ethical approval was also granted by LSHTM for this
PhD project (Appendix 7).
4.2.3 Visit procedures
4.2.3.1 Study questionnaire
At enrolment, a standardised detailed questionnaire on demographics (age),
sexual and reproductive health history (age atfirst menarche, age atfirst sexual
intercourse, lifetime number of sexual partners, history of pregnancy, age at
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first pregnancy, number of pregnancies and live births, history of stillbirths,
miscarriages, tubal or ectopic pregnancies, or caesarean sections), medical
history (history of sexually transmitted infections (ST/s)) were collected by
trained interviewers (Bratti et al, 2004; Herrero et al, 1997). At subsequent
follow-up visits, a shortened version of the enrolment questionnaire was
administered to capture the risk factor history since the previous visit. All
interviews were coded and double-entered with the Keyentry III Program at the
central office in San Jose. Databases were sent electronically to WESTAT Inc. in
Rockville, Maryland for data quality checks. Hard copies of the questionnaires
were reviewed if there were discrepancies to resolve.
4.2.3.2 Pelvic examination and cytological screening
All sexually active women were asked at enrolment and follow-up to
undergo pelvic examination for cytological evaluation (by conventional, liquid-
based (ThinPrep; Cytyc Corporation, Marlborough, MA), or computer-assisted
PapNet) and visual inspection by a trained nurse.
Specifically, exfoliated cervical cells were collected using a Cervex brush
(Unimar, Conecticut) that was rotated five times in the ecto- and endocervical
area to prepare the conventional smear. After preparation of the smear, the
Cervex brush was swirled in 20 mL of methanol-based PreservCyt solution. This
solution was refrigerated and kept until it was sent to the US to prepare the
liquid-based Pap smear. In addition, a Dacron swab over the ectocervix and
rotated in the endocervical canal was used to collect cervical cells for HPV DNA
testing. The swabs were stored in Virapap DNA transport medium (Digene,
Gaithersburg, MD, now Qiagen) tubes and were frozen at -30°C at the regional
offices on the day of sample collection, and then transported weekly to the central
office in San Jose to be stored at -70 DC. Periodic batch shipments of the
specimens on dry ice were made to the NCI repository. After these cytological
specimens were collected, the cervix was rinsed with 5% acetic acid and two
photographic images of the cervix (Cervigrams) were taken. The undeveloped film
was sent to US National Testing Laboratories in Fenton, Missouri for evaluation.
Conventional slides were stained and interpreted by local cytotechnologists
and cytopathologists in Costa Rica. After smear interpretation, slides were sent to
Neuromedical Systems in New York for computerised screening and preparation
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of PapNet videos and interpretation were done at Johns Hopkins Hospital in
Baltimore, Maryland. The PreservCyt samples were sent weekly to Tufts
University in Boston, Massachusetts for ThinPrep smear preparation and
interpretation. All three cytology results were reported and classified with the
Bethesda System (National Cancer Institute Workshop, 1989). Cytological
diagnosis was reported as normal; normal with reactive changes; atypical
squamous cells of unknown significance (ASCUS); low-grade intraepithelial
neoplasia (LSIL); high-grade squamous intraepithelial neoplasia (HSIL); and
further classified as cervical intraepithelial neoplasia grade 2 or 3 (CIN-2 or CIN-
3); squamous carcinoma; and adenocarcinoma. Cervigrams were categorised as
negative (no lesion found); atypical (lesion found but colposcopy was not
recommended based on the site/morphology); positive (colposcopy
recommended); and technically defective (not positive and inadequate
evaluation). Positive cervigrams were further classified as Po (normal), PI-PtA
(low-risk disease but colposcopy recommended as lesion extended into the canal),
P2 (compatible with CIN-2 or CIN-3), or P3 (compatible with cancer).
4.2.3.3 Colposcopy and treatment
Women were referred for colposcopy or biopsy if they had abnormal
results upon Pap smear (ASCUS or worse) or positive for Cervigram (Po+), Any
women with HSIL or worse with any screening test were censored from the study
and referred to Social Security health services for further local clinical
management. Women who presented with cancer were referred for appropriate
treatment (i.e. hysterectomy or radiotherapy) as needed. At any point during
follow-up, women presenting with low-grade intraepithelial neoplasia (LSIL) or
histological abnormalities were more intensely screened at 6 months rather than
12months.
Histology diagnosis was reviewed locally in Costa Rica. At the end of study
follow-up, all slides were reviewed by one of two US pathologists who were
blinded to all other study data. A final diagnosis was given by the majority
diagnoses and if there was disagreement, a joint review was held in the US to
reach a consensus.
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4.2.3.4 HPV DNA testing
Initial HPV DNA testing was done with HCI' as described earlier. However,
since HCI' only detected 11carcinogenic HPV types, specimens were retested with
polymerase chain reaction (PCR) test at Albert Einstein College of Medicine in
New York. Detailed descriptions of the PCR assays have been previously
described (Castle et al, 2002a; Herrero et al, 2005). DNA was extracted from
exfoliated cells and HPV DNAwas detected by PCR amplification of the L1 gene
using My09/MY11 primer system with AmpliTaq Gold polymerase (TaqGold;
Perkin-Elmer-Cetus, Norwalk, CI'). HPV DNA in PCR products were analysed
using type-specific probes for the following types: HPV 2, 6, 11,13, 16, 18, 26, 31-
35,39,40,42-45,51-59,61,62,64,66-74,81-85, and 89. Thirteen HPV types 16,
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 were considered carcinogenic
(Bouvard et ai, 2009; !ARC, 2007; Munoz et al, 2003).
4.2.4 Field experience
In July 2011, a field visit was made to the Projyecto Bpidemiologico
Guanacaste (PEG) Centre in Liberia, Costa Rica. I worked with the Local
Investigator Dr. Ana Cecilia Rodriguez on identifying the appropriate sub-group
from this analysis as well as data cleaning of the longitudinal data.
Although the natural history cohort study ended in 2001, the regional
office in Liberia continues to be the central Centre for coordinating the long-term
follow-up of women immunised in the Phase III Clinical Trial of the bivalent HPV
vaccine against HPV 16 and 18 (Herrero et al, 2008) and carry out other cancer-
related research in Guanacaste. For these reasons, much of the complex
organisational infrastructure established during the natural history study has
been maintained. Briefly, about 100 staff members currently operate PEG and
were also required to follow-up 10,000 women in the natural history study. There
were three field teams for data collection, operating out of one of the Liberia,
Nicoya or San Jose field offices. A PEG Investigator, Siliva Jimenez gave me a
tour of the study clinic in Liberia. Each study clinic is staffed with a field
supervisor, a registered nurse, a nurse's aide; three or more interviewers, a driver
and an office manager. To motivate participation, all the nurses, nurse's aides and
interviewers were women. Each office is equipped with a four-wheel drive vehicle,
a -30°C freezer for specimen storage, a computer, and a -20°C freezer for storage
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of ice packs. At the time of the study, there was also a mobile colposcopy clinic
equipped with a Zeiss 2000 colposcope and computer image system that was run
by a colposcopist, a nurse's aide and two interviewers. Each day, the field teams
would visit the selected censal segments of Guanacaste to recruit and enrol
women into the study and/or transport participants to their clinic visits.
Typically, field teams would return to the Liberia central office each day to
turnover data (i.e. questionnaire data and biological specimens) collected to other
teams for data entry, sample processing, storage and analysis.
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4.2.5 Statistical analysis
4.2.5.1 Definition of prevalent infections and HPV persistence
Prevalent infection was defined as the infection that was detected at
baseline enrolment. Persistence of HPV infection was defined as detection of the
same HPV type at i-year and a-years,
4.2.5.2 Classifying follow-up time
In order to standardise time for each prevalent infection, each clinic visit
was assigned three time-bins (0 (baseline), 1, and 2 years). For baseline prevalent
infections, time-bin was o.
If a type-specific HPV infection was tested more than once in the same time-
bin because she had a more intense 6-month follow-up because of cytological
abnormalities, and the HPV DNA result was discordant, the overall result was
assumed to be positive to assume the possibility of measurement error. In
addition, when classifying persistent infection, if a woman missed a study visit in
time-bin 1but attended the following study visit in time-bin 2 and her prevalent
HPV infection from baseline was still positive, then we assumed that she was
persistent at time-bin 1and time-bin 2. A total of 226 type-specific changes were
made for the a-year study period.
Similarly for the risk factor data, if the woman responded to two
questionnaires in the same time-bin, the overall result was assumed to be the
"worse" response. For example, for the question, "have you had a history of an
STI since the last study visit?" the discordant response was assumed to be yes.
4.2.5.3 Descriptive analyses
First, each continuous potential risk factor (e.g. age at first sexual
intercourse, lifetime number of sexual partners, number of pregnancies, etc.),
was converted into quantile groups where possible, otherwise into tertile groups.
Then the proportion of women with HPV infections and HR-HPV infections was
calculated as well as the number of infections in each category.
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4.2.5.4 Generalised estimating equation models
The associations of SRH factors (independent variables) were evaluated for
persistence at i-year and a-years time-points (dependent variables). Persistence
was defined as a binary outcome (yes and no). Robust variance models were
constructed using logistic generalised estimating equation (GEE) with an
independent correlation structure to evaluate whether baseline SRH factors was a
predictor of HPV persistence at 1 year and 2 years (liang & Zeger, 1986). Age-
adjusted odds ratios (OR) and 95% confidence intervals (Cl) between persistent
HPV at visit (t) and persistence at visit (t-i) were calculated to measure the
magnitude of the longitudinal associations.
The individual history of each HR-HPV infection was considered separately
for HPV alpha species 7 (Appendix 10.1), 9 (Appendix 10.2), and alpha species 5
and 6 (Appendix 10.3) so a woman could contribute more than one HPV-type if
she was co-infected with multiple types. Persistence of each HR-HPV infection
was considered to be independent of other co-infected types since previous
analyses have shown no interaction between types when a woman was infected
with multiple types (Plummer et al, 2007; Rodriguez et al, 2010; Schiffman et al,
2005). However, since the sample size of individual HR-HPV infections was
small this precluded an analysis at the type-specific level that would provide
informative results.
To assess the association of selected SRH factors and risk of HPV
persistence, the following three statistical models were computed and compared
for prevalently detected infections:
(i) persistence of all pooled 13 HR-HPV infections (HPV-16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59, 68);
(ii) persistence of pooled HPV-16/18 infections (the two most common types
found in invasive cervical cancer and found to have the greatest risk for
progression to invasive cervical cancer); and
(iii) persistence of other HR-HPV infections (non-HPV-16/18)
Page 185
4.3 Results
Of the 2785 women in the active cohort available for analyses, 42.1%
(n=1398) were positive for any HPV, 24.2% (n=613) were positive for HR-HPV at
enrolment. These women represented 805 prevalent HR-HPV infections. A
quarter of women were co-infected with more than one HPV-type (Figure 4.4)
1 2 3
No. of HR-HPV types perwoman
4
74·9%
5·5%
Figure 4.4 Proportion (%) of 613 women infected with prevalent single
or multiple high-risk human papillomavirus (HR-HPV) types
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4.3.] Age-specific distribution
Figure 4.5 shows the age-specific distribution of women with prevalent
HR-HPV infections according to positivity for any HPV and HR-HPV. The age-
specific distribution of women with prevalent infections presents a bimodal curve.
The curve is skewed to the left with a peak HR-HPV prevalence of 56.2% and
37.5% of women positive for HPV and HR-HPV in the 18-28 years age group,
respectively. The bimodal curve for prevalent infections declines with increasing
age and a second peak is observed in the 2:49 year age group .
• HPV+ HR-HPV+
56.2
18-28 years 37-48 years29-36 years <!49 years
Figure 4.5 Age-specific distribution (%) of women with prevalent human
papillomavirus (HPV) and high-risk human papillomavirus (HR-HPV)
infections.
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4.3.2 Type distribution of prevalent HR-HPVinfections
Figure 4.6 shows the type-distribution of 805 prevalent HR-HPVtypes
identified at baseline enrolment. The most prevalent type was HPV-16 (15.7%),
followed by HPV-51, 58, 52, and 31. HPV-18 ranked as the sixth most prevalent
HR-HPV type in this population.
HPV-16j18 represented 24.2% of the prevalent HR-HPVtypes and 75.8%
of the types were other HR-HPV (not HPV-16jI8).
18
16 15·7
14
~12
=0'f 10
o 8e 6
~
4
2
0
16 51 58 52 31 18 56 39 45 35 33 59 68
Prevalent HPV type
Figure 4.6 Type-distribution of 805 prevalent high-risk human
papillomavirus (HR-HPV) types
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4.3.3 Sexual and reproductive health characteristics at baseline
Table 4.1 shows SRH characteristics of 2537 sexually active women in the
active cohort by HPV detection status at enrolment. Median age at first menarche
and AFSI was 13 years and 17 years, respectively. Of the sexually active women,
about 2% first had sex before starting menarche. Compared to women with AFSI
~21 years, women AFSI :S20 had a higher prevalence of HR-HPV (19% vs. 25%,
respectively). The median number of lifetime number of sexually partners was
two and they had higher prevalence of HR-HPV than those with one and ~3
partners.
Nearly all women (95%) were ever pregnant. The median AFP was 19
years. About 5% were nulliparous at time of enrolment and the median number
of pregnancies was 3. Compared to women with :S3pregnancies, women with >3
pregnancies had a higher prevalence of HR-HPV. Among 2405 parous women,
more than a quarter have experienced pregnancy complications: 7.7% stillbirths,
28.8% miscarriages, 16.9% tubal or ectopic pregnancies, and 15.3% caesarean
sections. Compared to women with no pregnancy complications, women with
pregnancy complications appeared to have a lower prevalence of HR-HPV. About
5% of women had a history of an STI and they had a higher prevalence of HPV,
but when compared to women without a history of an STI, the proportion
infected with HR-HPV was similar (-25%).
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Table 4.1. Select sexual and reproductive health characteristics of
sexually active women (n=2537) in the Guanacaste cohort
according to human 2a)!i11omavirus{HPV)status at enrolment
TotaIno.
TotaIno. ofHR-
Subject Total no. of HPV+ HPV+
characteristics of women women % women %
Age at enrolment
18-28 years 674 379 56.2 253 37·5
29-36 years 615 249 40·5 137 22·3
37-48 years 662 204 30.8 101 15·3
~49years 586 236 40·3 122 20.8
Age at first menarche 1068 613
~15years 506 202 39·9 ll4 22·5
14 years 480 188 39·2 97 20.2
13 years 620 266 42·9 151 24·4
saa years 929 410 44·1 250 26.9
Age at first sexual intercourse
zzr years 407 141 34.6 80 19·7
18-20 years 687 306 44·5 171 24·9
16-17years 719 317 44·1 179 24·9
SIS years 724 304 42.0 183 25·3
Time of first sexual intercourse from first menarche*
>0 years 2333 980 42.0 564 24·2
o years 151 65 43·0 35 23·2
<0 years 53 23 43·4 14 26.4
Lifetime number of sexual partners*
1 ll10 396 35·7 229 20.6
2 504 248 49·2 153 30·4
~3 923 424 45·9 231 25·0
Pregnancy*
Never 132 77 58.3 53 40.2
Ever 2405 991 41.2 560 23·3
Age at first pregnaneyt
zai years 722 278 38·5 148 20·5
18-20 years 850 366 43·1 213 25·1
16-17years 558 227 40.7 137 24.6
SIS years 274 120 43.8 62 22.6
Missing
Number of'pregnanciess
0 132 77 58·3 53 40.2
1-3 1156 525 45·4 315 12.8
4-5 498 180 36.1 97 19·5
~7 751 286 38.1 148 19·7
Live Births
0 158 91 57.6 54 34·2
1-2 1283 566 44·1 346 27·0
3-5 458 169 36·9 85 18.6
~6 638 242 37·9 128 20.1
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No. of stillbirths
Never 2221 911 41.0 523 23·5
Ever 184 80 43·5 37 20.1
No.ofnrlscWMMages
0 1712 708 41·4 422 24.6
1 437 181 41.4 87 19·9
2+ 256 102 39.8 51 19·9
No. of tubal or ectopic pregnancies
Never 2129 932 43.8 537 25·2
Ever 407 136 33·4 76 18·7
Caesarean section
Never 2018 842 41·7 488 24·2
Ever 367 138 37.6 71 19·3
History of STI*
No 2419 1011 41.8 582 24·1
Yes 11Z 56 ~Z·2 ao 25.6
*HR-HPV, high-risk human papillomavirus infection; S11, sexually transmitted infection
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4.3.4 Risk of a-year follow-up persistence of prevalent HR-HPV infections
according to patient characteristics
Table 4.2 shows the risk of a-year persistence of prevalent HR-HPV
infections according to patient characteristics. For the specific SRH factors of
interest, there was no statistically significant association with AFSI and a-year
persistence; whereas, there was an increasing risk of i-year and a-year
persistence with decreasing AFP among women infected with prevalent HPV-
16/18. Compared to women with AFP ~21 years, the odds ratio of prevalent HPV
16/18 persistence at a-years was 1.32 (95% CI: 0.65-2.69) for AFP 18-20 years,
1.54 (95% CI: 0.70-3.38) for AFP 16-17 years, and 2.03 (95% CI: 0.76-5.43) for
AFP SI5 years.
As compared to women with one lifetime sexual partner, women with two
lifetime sexual partners had a nearly 3-fold increase risk of a-year persistence
(OR=2.96; 9596CI: 1.26-6.97).
Women positive for any HR-HPV and ever had a history of one
miscarriage was 1.8 times likely to have a-year persistence but this association
ceased at a-years. Interestingly, an inverse association with a-year persistence
was found among women positive with any HR-HPV with a history of tubal or
ectopic pregnancy (OR=O.54; 9596 CI: 0.33-0.89). This association was more
pronounced among those infected with other HR-HPV (non-HPV-16/18)
(OR=0.49; 95% CI: 0.26-0.92).
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4.4 Discussion
The Guanacaste Cohort remains the largest natural history cohort to have
been conducted in a less developed country where investigations fully evaluated
the role of HPV DNA and the role of risk factors. This provided a dataset that
would allow full evaluation of SRH factors and risk of HPV persistence, which
would complement the investigations carried out in the !ARC multi-centric case-
control studies described in Study 1 (Chapter 3). The results from this Study 2
support the role of decreasing age at first pregnancy with increasing risks of 2-
year HPV persistence among women infected with prevalent HPV-16/18. Risks
were increased by two-fold among women with AFP ~15 years compared with
AFP ~21 years. It was not surprising that a positive association with z-year
persistence was found with increasing lifetime number of sexual partners as it has
been found to be associated with risk HPV acquisition and invasive cervical
cancer.
Other prospective natural history studies evaluating the risk of HPV
persistence have been carried out in young women from populations in developed
countries where the risk of cervical cancer is low (Brown et al, 2005; Ho et al,
1998; Maucort-Boulch et al, 2010; Moscicki et al, 2001; Winer et al, 2005;
Woodman et al, 2001) and SRH factors significantly differ. Previous studies did
not differentiate between risks of prevalent and incident infections or considered
whether there were differences by type-specific HPV infections (HPV-16/18 vs.
other HR-Hpv). However, similar to this study, one prospective study conducted
in Colombia, a high-risk area for cervical cancer, did not identify any associations
neither between AFSI, parity and risk of HR-HPV persistence over a median
duration of 9-year follow-up (Munoz et al, 2009).
4.4. t Age at first pregnancy
The majority of women (7996) in this cohort who initiated first coitus were
also pregnant within the same year. This observation was similar to that observed
in Study 1 and reflects the close temporal sequence of events of early AFSI and
AFP occurring in developing countries. No association was found between AFSI
and HPV persistence. In contrast, Study 1 identified similar increased risk
associations between invasive cervical cancers with both AFSI and AFP, which
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made it difficult to disentangle any possible independent associations (Chapter
3). These findings in Study 2 suggest that AFP may playa more relevant role in
cervical carcinogenesis than AFSI and highlight the potential biological
susceptibility of the cervix during adolescence and pregnancy when exposed to
increased levels of hormonal changes (Singer & Monaghan, 2000). As discussed
previously, augmented levels of exposure to oestrogens in the presence of HPV
may increase the probability of persistence, resulting in neoplastic changes (Elson
et al, 2000; Hwang et al, 2009; Shai et al, 2007). This phenomenon is primarily
dependent on the first pregnancy rather than subsequent pregnancies (Singer &
Monaghan, 2000) which may partially explain the lack of association with
multiparity.
Increased risks of invasive cervical cancer have been identified with high
parity (International Collaboration of Epidemiological Studies of Cervical Cancer,
2006; Munoz et ol, 2002) and long-term use of oral contraceptives (Moreno et al,
2002) suggesting that continuous endogenous oestrogen levels (pregnancy) and
exogenous oestrogen exposure (oral contraceptive use) may modulate immune
response to favour HPV persistence rather than clearance (Giannini et al, 1998;
Giannini et al, 2002; Jacobs et al, 2003; Marzi et ai, 1996). However, parity was
not associated with HPV persistence in this study. It has been hypothesised that
short-intervals between pregnancies might sustain these elevated levels of
oestrogens that may influence HPV persistence (Mukherjee et ai, 1994;Munoz et
al; 2002). The cohort did not have detailed data to measure the time between the
first and subsequent pregnancies to clarify whether this could explain the lack of
association with persistence.
4.4.2 Pregnancy complications
The associations between HPV persistence and cervical trauma
experienced during pregnancy remains unclear. Similar to previous findings in
the pooled case-control studies of invasive cervical cancer, women who reported
caesarean deliveries appeared to show a protective effect although not statistically
significant (Munoz et al, 2002). Pregnancy miscarriage has not been found to be
associated with invasive cervical cancer (Munoz et al, 2002), however, there
appears to be a weak positive association with HPV persistence for women with a
history of miscarriages/abortions. A plausible role of HPV in pre-term births (Zuo
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et al, 2011) and spontaneous abortions (Hermonat et al, 1997) has been
suggested. Similar to other hormonal hypotheses, these associations may be
explained by the impaired immune response during pregnancy when there is an
increased production of oestrogen that causes up-regulation of HPV gene
expression.
Interestingly, there was an inverse association between tubal/ectopic
pregnancy and HPV persistence. This finding could be due to the effects of
random chance. However, risks of ectopic pregnancy have been linked to luteal
phase defect which could reduce levels of mid-luteal follicle-stimulating hormone
(FSH), luteinising hormone (LH), estradiol (E2) and progesterone (Guillaume et
al, 1995). The mechanical barrier of an ectopic pregnancy, like that of tubal
ligation (Li &Thomas, 2000), could alter blood supply to the ovary which reduces
the gonadotrophin signal to the ovary, altering hormone levels and therefore
disrupting ovarian stimulation. The reduction of oestrogen levels could interfere
with the efficiency of HPV to facilitate metaplastic transformation in the cervix
that would result in cervical neoplasia, thus showing a protective effect.
Furthermore, data from a WHO collaborative study of Neoplasia and Steroid
Contraceptives hospital-based case-control study collected in eight countries
show that tubal ligation does not increase the risk of cervical cancer (Li &
Thomas, 2000). This study suggested that tubal sterilisation may offer an
alternative management strategy to hysterectomy for treatment of cervical
precancerous lesions and secondary prevention of cervical cancer; however,
further research is warranted.
4.4.3 Prevalent HR-HPV infections
Given the possible differences in natural histories for prevalent and newly
detected or "incident" HR-HPVinfection, the analysis concentrated on evaluating
the risk of prevalent infections. Prevalent HPV infections identified at enrolment
may represent longer duration of infections since one point prevalence estimate
does not inform when the infection was acquired. Among young women, it could
be speculated that these infections were newly acquired if time since first sexual
intercourse and study enrolment was short. For older women, it is difficult to
disentangle what these prevalent HPV infections represent when taking into
account their full sexual history. These infections could be newly acquired
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infections, persistent infections, or latent infections that have re-activated. It is
also possible that these prevalent and newly detected infections are persisting at
undetectable low-levels and may have a longer duration of persistence than
observed, which has been shown particularly for HPV-16 (Weaver et al, 2011). It
could be hypothesized that possible HPV reactivation of these infections may
occur at a later stage of the natural history, which may explain why our observed
associations were not consistent with the established association between parity
and invasive cervical cancer.
4.4.4 Type-specific HR-HPV infection
Interestingly, the associations of AFP and lifetime number of sexual
partners were mainly observed among women with HPV-16/18 and not other HR-
HPV infections. This further supports the differences in types-specific risks of
HPV persistence and of natural histories. It has been shown in a study in the US
that the to-year cumulative risks for ~CIN-3 were 17.6% among women positive
for HPV-16, 13.6% for HPV-18 and only 3% for women with other HR-HPV (not
HPV-16/18) (Khan et al, 2005). These results have recently been corroborated in
a study conducted in Taiwan that showed ie-year cumulative risks for cervical
cancer among women positive for HPV-16, HPV-58 (without HPV-16) or other
HR-HPV (not HPV-16/S8) were 13.5%, 10.3% and 4%, respectively (Chen et al,
2011). This study also found z-year persistence to be a biomarker of chronic or
long-term infection that was predictive of an increased risk of subsequent cancer
development. The increased type-specific risks of HPV-16/18 suggest that
different cervical screening modalities could be considered for those specifically
infected (Cuzick et al, 2008). For example, partial typing for HPV-16/18 may
provide risk stratification management for clinicians to manage separately those
HPV-16/18 positive from those who are other HR-HPV-positive (not HPV-16/18)
and HPV-negative.
4.4.5 Methods of estimating HPV persistence
Measuring HPV persistence is not straightforward. Assumptions were
made to accommodate incomplete data produced in natural history studies where
HPV infections may be missing at certain time points. For example, a patient may
have skipped their study visit for unknown reasons but the type-specific HPV
infection may still be present at the conclusion of the study but this patient was
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censored. This may have contributed to our weakened associations with follow-up
time as shown for AFP. Also, to cope with intermittent missing HPV results, an
assumption was made about a woman who is HPV positive when a study visit is
missed following her baseline positive result and she returns with a positive HPV
result at the subsequent study visit (as described in section 4.2.5.2). These
assumptions cannot exclude the potential contribution of bias when estimating
the duration of HPV persistence (Mitchell et al, 2011).
4.4.6 Strengths and limitations of the study
Strengths of this study include its population-based design, the long-term
follow-up period of women (median duration 7 years), the detailed information
collected on SRH factors and the full assessment of HPV DNA to adequately
evaluate the persistence of prevalent HR-HPV infections. A limitation of this
study is the older age range recruited in the cohort (~18 years), which didn't allow
us to evaluate young women who began AFSI and AFP at an early age (SIS years)
and follow their early pregnancies closely to understand the role of hormonal
changes on HPV persistence.
4.5 Conclusions
In summary, this study identified early AFP on imparting a different risk of
HPV persistence depending on the prevalence of HPV-16jI8. Findings provide
evidence of the role of early AFP in HPV persistence, a critical step in cervical
carcinogenesis that would lead to progression of clinically relevant cervical
neoplasia. Further assessment of whether AFP is associated with progression to
cervical pre-cancer would complete its contribution to the spectrum of the natural
history of HPV from acquisition, to persistence, and to progression of cervical
pre-cancer and cancer. The protective effect of tubal jectopic pregnancies against
HPV persistence provides increasing culminating evidence of the role of female
reproductive hormones involved in immune response to HPV infection and the
cervical carcinogenic process. Additional research is needed to elucidate the role
of oestrogens on HPV which could potentially be translated into treatment
strategies for management of cervical neoplasia (i.e. control hormone levels to
prevent HPV infection sequelae).
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5 Study 3. Male role in the aetiology of
cervical cancer
5.1 Introduction
Behavioural risk factors of the man have important implications in the
consequent female partner risk of human papillomavirus (HPV) acquisition and
of invasive cervical cancer (ICC). As HPVs involved in cervical carcinogenesis are
sexually transmitted, it is central to understand patterns of sexual behaviour in
HPV transmission including the behaviours of both men and women. It has been
debated that a woman's risk for cervical cancer will depend more on the full
sexual history of the male partner than on her own behaviour (Skegg et al, 1982).
This is particularly relevant in societies where women tend to be virgins at
marriage and monogamous thereafter. Epidemiological studies have tried to
characterise the male role and the consequent female partner risk of HPV
acquisition and of cervical cancer (Bleeker et al, 2005; Castellsague et ol, 2003;
Hernandez et al, 2008; Partridge & Koutsky, 2006). While a number of studies
mostly involving monogamous women have observed an association between the
number of sexual partners of the husband and his wife's risk for cervical cancer
(Brinton et al, 1989; Buckley et al, 1981; Pridan & Lilienfeld, 1971), other studies
have not (Bosch et al, 1996; Kjaer et al, 1991; Munoz et al, 1996; Thomas et al,
2001). Other inconclusive associations with history of contact with sex workers
have been identified (Bosch et al, 1996; Kjaer et al, 1991; Munoz et al, 1996;
Thomas et al, 2001).
Besides sexual behaviour, other male factors, such as tobacco smoking has
been less explored despite it being a well-established risk factor for cervical pre-
cancer and cancer (Munoz et al, 2006; Plummer et al, 2003). Several reviews
have summarised the epidemiological and biological association of passive
smoking on the risk of cervical cancer (IARC, 2004; National Cancer Institute,
1999; U.S. Dept. of Health and Human Services & National Center for Chronic
Disease Prevention and Health Promotion, 2006), however, the evidence has
been suggestive rather than sufficient to implicate the role of passive smoking in
the aetiology of cervical cancer among lifetime non-smoking women. Among the
studies identified, the recognised limitations include small sample sizes of non-
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smoker controls and cases of cervical cancer, lack of specific information on HPV
and sexual behaviour and most studies obtained spousal history of smoking
through questioning of the women rather than the men. Furthermore, most of the
studies involved cervical intra epithelial neoplasia grade 3 (CIN-3)/carcinoma in
situ (CIS) rather than invasive disease, which is a relevant distinction since
evidence suggests that smoking acts in the stages of progression from CIS to
invasive cancer (Plummer et al, 2003).
To evaluate the male role in the aetiology of cervical cancer, and
specifically the risk related to passive smoking in the context of couples, we
performed a pooled analysis of five case-control studies involving ICC and two
case-control studies involving CIS, of couples in which husbands or stable
partners of ICC and CIS case and control women participated. The studies were
conducted in three continents, mainly in developing countries, and were
coordinated by the International Agency for Research on Cancer (lARC) in Lyon,
France and the Catalan Institute of Oncology (lCO) in Barcelona, Spain. The
lARC/ICO series of case-control studies remain the largest dataset of sexual
couples on etiological investigations of ICC that fully addresses the role of HPV
DNA and of independent cofactors. Some of the associations with risk factors (i.e.
penile HPV infection and male circumcision) have been assessed in subsets of the
participants in this analysis (Bosch et al, 1996; Castellsague et al, 2002;
Castellsague et al, 1997; Franceschi et al, 2002; Munoz et al, 1996; Plummer et
al, 2003). For this study, we characterize in-depth male factors, the role of
passive smoking in the context of couples with the full dataset on HPV and their
associations with invasive cervical cancer.
5.2 Methods
The lARC/ICO case-control program included a series of studies on ICC and
CIS from eleven countries with a broad range of cervical cancer incidence rates.
Among these, seven studies conducted in five countries, enrolled husbands or
stable partners of women with CIS or cervical cancer and control women were
pooled for these analyses. Methods of each study and primary results related to
women have been published previously. Countries included Brazil (Eluf-Neto et
al, 1994) and Colombia (Bosch et al, 1996; Munoz et ol, 1993: Munoz et al, 1996),
the Philippines (Ngelangel et al, 1998), Thailand (Chichareon et al, 1998) and
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Spain (Bosch et al, 1996; Bosch et al, 1992). Briefly, women with
histologically confirmed incident cervical CIS, invasive squamous cell carcinoma,
adenocarcinoma or adenosquamous-cell carcinoma were recruited from reference
hospitals before treatment. Control women were recruited from the general
population in two of the studies of ICC in Spain and Colombia and from the same
hospitals as the cases for the other studies. Control women were frequency-
matched to case patients by five-year age groups.
Current husbands or stable partners (herein referred to as husbands) of
enrolled women were defined as men who reported having had regular sexual
intercourse with the women for at least six months, irrespective of whether or not
they were married or lived together.
Informed consent was obtained from both men and women who agreed to
participate.
5.2.1 Study questionnaire
A standardised questionnaire was administered to participants by a
trained interviewer that included questions about socio-demographic factors,
sexual behaviour, hygienic practices, and history of sexually transmitted
infections (STIs). For specific questions on smoking habits, subjects were first
asked to classify themselves as life-time never smoker, ex-smoker (defined as a
former smoker who stopped smoking at least 1year prior to the interview) or
current smoker. Ever smokers were also asked at what age they started smoking
regularly, the duration and how many cigarettes per day they smoked. Additional
questions were asked on the type of tobacco (blond, black, or other) and type of
filter (filter, no filter, or both) used. Ex-smokers were asked the age at which they
stopped smoking.
5.2.2 Penile and cervical HPV DNA sampling
Two samples of exfoliated cells were obtained from the penis: one from the
distal urethra with the use of a very thin, wet, cotton-tipped swab and one from
the external surface of the glans and coronal sulcus with the use of a standard-
sized wet, cotton-tipped swab.
Two samples of cervical exfoliated cells were collected with wooden
spatulae and endocervical brushes. After preparation of one Papanicolaou smear,
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the remaining cells were eluted in saline, centrifuged and frozen at -70 °C until
shipment to the central laboratory for HPV DNA testing. A tumor-biopsy sample
was obtained from cases and frozen. Cytology and histology diagnosis were
reviewed and confirmed by a panel of expert pathologists that agreed on a
diagnosis by consensus or majority.
5.2.3 Detection of HPV DNA
Detailed descriptions of the polymerase-chain-reaction (PCR) assays used
in these studies have been described elsewhere. HPV DNAwas detected by PCR
amplification of a small fragment of the Li gene using MY09 and MYll consensus
primers for the studies in Spain and Colombia (Hildesheim et al, 1994) and
GP5+/6+ general primer system for the other studies (de Roda Husman et al,
1995; Jacobs et al, 1995; Walboomers et al, 1992b). Beta-globin primers were
used to amplify the beta-globin gene to assess the quality of the DNA in the
specimen. HPV DNA in PCR products was analysed with the use of a cocktail of
HPV-specific probes and genotyped by hybridization with type-specific probes for
33 HPV types in the case of cervical samples and for at least 6 HPV types (6, 11,
16, 18, 31, and 33) in the case of the penile samples. Samples that tested positive
for HPV DNA but did not hybridise with any of the type-specific probes were
labeled as HPV X.
5.2.4 Ethical approval
All relevant ethical approvals was obtained from !ARC, the Lead
Investigator from the !ARC multi-centric case control studies on cervical cancer
and LSHTM as described in Chapter 3.2.5 (Appendix 6 and 7).
5.2.5 Statistical analyses
5.2.5.1 Univariate and multivariate analyses
To evaluate the association between male risk factors, smoking habits and
risk of CIS or ICC, we first used age- and country-adjusted univariate logistic
regression analyses to determine the effects of each of the following potential
male factors using an alpha-level of 0.05: age, education, sexual history (age at
first sexual intercourse, lifetime number of sexual partners, history of contact
with sex workers, history of STIs, and history of anal sex), hygienic practices (i.e,
pay attention to uncover penis and to wash the region, able to fully uncover
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spontaneously or by pulling the penis from the skin prepuce, and wash before and
after sexual intercourse), male circumcision status, and history of smoking (non-
smoker, current smoker, or ex-smoker, lifetime pack-years, and use of tobacco
and filter type); and to control for potential confounding of male characteristics
and risk of cervical cancer. Final models were adjusted for male factors that
contributed a ~1096 change to any of the estimated odds ratios (OR) and 9596
confidence intervals (CI). Factors identified as being significant in univariate
logistic regression models were further selected in multivariate models. Only
significant multivariate models are presented.
Lifetime number of sexual partners (a significant risk factor of exposure to
Hpv) was identified to be heterogeneous across study countries and an
interaction term combining lifetime number of sexual partners and country were
included in the fully adjusted multivariate models (refer to Section 5.3.4).
5.2.5.2 Potential confounders of the woman
To control for additional potential confounding by characteristics of the
women, female risk factors (education, age at first sexual intercourse, lifetime
number of sexual partners, history of pap smear 12 months prior to study
enrolment, use of oral contraceptives, parity, and smoking) for cervical cancer
were fitted into the final multivariate models a) for the CIS adjusted models if
they contributed to any change to the OR estimates for male characteristics; and
b) for the final ICC adjusted models as they are well-established risk factors
known to be associated with ICC. However, when we adjusted the OR estimates
with all female risk factors in the CIS model, the estimates did not significantly
differ (data not shown).
5.2.5.3 CIS vs. ICCmodel
A statistically significant interaction between some male risk factors (e.g.
age at first sexual intercourse, lifetime number of sexual partners, history of
sexual intercourse with a sex worker, and HPV-positivity status) and case status
(i.e. ICC versus CIS) justified the use of two separate models for each disease
stage. This is in agreement with our current understanding of the natural history
of CIS, as it has been estimated that about 3196of CIS cases will develop cancer
within 30 years, leaving a proportion of CIS cases that will not advance to
invasive disease (McCredie et al, 2008). Thus, some of the risk factors associated
Page 1104
with CIS incidence !llay differ from those associated with progression from CIS to
ICC. However, for male circumcision we present the pooled analysis of CIS/ICC
as well as the stratified models of CIS and ICC since we did not find heterogeneity
with this risk factor and disease status as compared to the other male risk factors
as described above. This is consistent with what was previously published
(Castellsague et al, 2002) .
Furthermore, to better clarify the relationship between male characteristics
and cervical cancer in their female partners, we removed the potential effect of
previous male partners the woman may have had by calculating and comparing
two different statistical models for CIS and ICC: one included all study couples
and the second model included only couples with monogamous women.
5.2.5.4 Passive smoking classification
Besides the two models of all study couples and only couples with
monogamous women, a third model was constructed for couples with lifetime
non-smoking monogamous women when evaluating the role of passive smoking
in the couples context. The third model was restricted to 765 couples with lifetime
non-smoking monogamous women. In addition, the men's smoking history was
further reclassified according to the risk period for which the woman would have
been exposed to HPV infection (a necessary factor in cervical carcinogenesis),
passive smoking and risk of progression to cervical cancer (Figure 5.1). Ninety
male ex-smokers (n=44 cases and n=43 controls) of couples with monogamous
women were reclassified as non-smokers, and the duration of exposure to passive
smoke and smoking pack-years were recalculated (Table 5.1.).
Table 5.1. Reclassification of male smoking status according to period of risk of
exposure as defined in Figure 1
Couples with with
monogamous women (n=98t)
Couples with non-smoking
monogamous women (n=z65)
Reported Reclassified
smoking smoking
status status
Reported
smoking
status
Reclassified
smoking status
Cases/Controls Cases/Controls Cases/Controls Cases/Controls
Non-smoker 98/148 142/194 71/126 112/167
Ex-smoker 100/113 56/67 80/94 39/54
Current
Smoker 223L222 22aL222 207/186 2OzL186
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5.3 Results
5.3.1 Patient characteristics
Table 5.2 describes selected characteristics of the male and female
subjects. Of the 291 CIS and 692 ICC cases and 936 control women, 59.8%,
70.9%, and 81.2%, were monogamous, respectively. In general, husbands were
older than their wives, and husbands and wives of CIS cases and controls were
younger than those of ICC.
Table 5.2. Characteristics of both corresponding husbands of (a) women
and without CIN-a/CIS (b) invasive cervical cancer
Total no. of Ageofhusbands* Ageofwives*
husbands
Cases Controls Cases Controls Cases Controls
a. Cervical intraepithelial neoplWliagrade 3/ Carcinoma in situ
Colombia 127 164 40 41.5 36 35
~~ ~ ~ ~ ~ ~ ~
Pooled 291 348 38 39 34 35
b. InvWlive cervical cancer
Brazil 72 76
Colombia 91 89
Philippines 155 111
Spain 146 139
Thailand 228 173
Pooled 692 588
*Median
52
47
46
50
46
50
53·5
52
46
50
46
50
46
43
46
50
46
45
48
44
44
52
47
46
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5.3.2 Penile HPV prevalence
Table 5.3 shows penile HPV prevalence among husbands of cases and
controls of CIS and ICC by history of smoking and country. Penile HPV detection
was doubled in husbands of cases than controls of CIS and was higher among
cases than controls of ex-smokers (2.4% vs. 0%) and current smokers (13.9% vs.
3.8%). Similar penile HPV detection was found in husbands of cases and controls
of ICC (17.6% vs. 16.2%), which was also similar among cases and controls of ex-
smokers and current smokers. However, penile HPV was more prevalent among
husbands of cases than controls of ICC (9.7% vs. 6.6%, respectively).
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5.3.3 Male characteristics and their univariate associations with risk of CIS and
ICC
Table 5.4 presents selected male characteristics and their univariate
associations with risk of CIS and ICC, stratified by all couples and couples with
monogamous women. In general, similar associations were observed in all
couples and couples with monogamous women models, except for associations of
CIS with education and smoking status. Hygienic practices (able to fully uncover
spontaneously or by pulling the penis from the prepuce and washing before and
after sexual intercourse) and history of anal sex were not associated with CIS or
ICC in univariate analyses (data not shown). The following husband's risk factors
were found to be associated with a woman's increased risk of CIS or ICC: early
age at first sexual intercourse, history of sexual intercourse with a sex worker
(ever and while with current wife), history of gonorrhoea, increasing number of
STIs, being a current smoker and increasing lifetime smoking pack-years. Lack of
education was associated with an increased risk of ICC but not CIS, whereas the
absence of circumcision and being penile HPV-positive were associated with an
increased risk of CIS but not ICC. An inverse relation between use of "black"
tobacco type, as compared to "blond" tobacco type among smokers, and the risk
of CIS was observed, as well some hygienic practices such as lack of attention to
uncover the penis to wash the region and the risk of ICC.
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5.3.4 Lifetime number of sexual partners
Table 5.5 shows the varying association between lifetime number of sexual
partners and risk of CIS or ICC by country. An increased risk of CIS was observed
for both Colombia (statistically significant) and Spain with increasing lifetime
number of sexual partners in the age-adjusted models of all couples and couples
with monogamous women, but only Spain showed a significant increased risk (p-
trendco.ooi) in the fully adjusted multivariate model. An increased risk of ICC
with increasing lifetime number of sexual partners was observed for the
Philippines and Spain (p-trendsco.oi): whereas, no statistically significant
increased risk was observed for Brazil, Colombia, and Thailand in both univariate
and multivariate models except for the univariate model for Thailand.
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5.3.5 Multivariate associations of male characteristics and risk of CIN-3/CIS
Table 5.6 shows the association between significant male characteristics
and cervical CIS in multivariate analyses after adjusting for both male and female
risk factors. Generally, similar associations were identified in the two analyses of
all couples and only couples with monogamous women, therefore we will describe
our findings herein forward according to the all couples model. An increased risk
for cervical CIS was observed for women with men who were positive for penile
HPV (odds ratio, OR=2.17; 95% confidence interval, CI: 1.06-4.44) and men who
were uncircumcised (OR=2.67; 95% CI: 1.31-5.45).
Table 5.6. Multivariate associations between male characteristics and risk of
CIS
Odds ratio (95% CI)
Couples with monogamous
Male characteristics All couples • women>
Cireumcision
Yes 1.00 1.00
No 2.67(1.31-5.45) 2.25(0.92-5.53)
HPVresuit
Negative 1.00 1.00
Positive 2.17(1.06-4.44) 2.44(0.97-6.12)
No HPV result/inadequate 1.07(0.74-1.53) 1.35(0.87-2.10)
'Adjusted for all variables in the table, age of the husband and wife, study country, age at
first sexual intercourse of the wife, wife's lifetime number of sexual partners.
bAdjusted for all variables in table except for circumcision, age ofthe husband's wife and
age at first sexual intercourse of the wife.
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5.3.6 Multivariate associations of male characteristics and risk of ICC
Lack of education, having a history of gonorrhoea, and having had at least
one STI were also associated with an increased risk of ICC (Table 5.7).
Table 5.7. Multivariate associations between male characteristics and risk of
ICC
Male characteristics Allcouples • Coupleswith monogamous
women>
Odds ratio (95% Cl) Odds ratio (95% CI)
Education
~Secondary
Primary School
No School
p-trend
History of STls b
Never
Syphilis only
Gonorrhea only
Herpes only
Condyloma only
Other STl only
~2STIs
Number of STlse
Never 1.00
1 1.41(1.01-1.96)
<t2 0.88 (0.54-1.45)
1.00
1.63(1.18-2.26)
2.82 (1.68-4.75)
0.001
1.00
0.61 (0.23-1.62)
1.49(1.00-2.22)
0.75 (0.10-5.39)
1·73(0.59-5.05)
1.53(0.87-2.69)
0.88 (0.54-1.45)
1.00
1.59(1.09-2.32)
2.74 (1.51-4.98)
0.001
1.00
0.64 (0.21-1.97)
1.72(1.08-2.74)
0.64 (0.08-5.50)
1.86 (0.56-6.18)
1.69(0.85-3.35)
0.94 (0.52-1.70)
1.00
1.58(1.07-2.32)
0.94 (0.52-1.70)
STI, sexually transmitted infection
•Adjusted for age of the husband and wife, centre, and all variables in the table, level of
education of the wife (zsecondary level, primary level, no schooling), age at first sexual
intercourse of the wife (~21years, 17-20years, s16 years), lifetime smoking pack-years of
the wife (non-smoker, low, medium, and high smoking lifetime-pack-years), oral
contraceptive use (never, 1-4 years, ~5 years), parity (nulliparous, 1-6, <t7) pap smear
history 12months prior to study enrollment (never, ever), and lifetime number of sexual
partners of the wife (1, <t2). Number of STls and smoking history of smoking were not
included in the final model.
b Did not adjust for number of STls
b Did not adjust for history of STIs
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5.3.7 Male circumcision
To further clarify the different associations of circumcision and a woman's
risk for CIS or ICC, we stratified the analysis according to the male's sexual
behaviour, similarly to a previous analysis of the present data (Castellsague et al,
2002) in order to support the evidence that the elevated risk of CIS or ICC linked
to the absence of circumcision would be greater among women whose male
partners were at a higher risk for HPV exposure.
Table 5.8 shows the association between circumcision and risk of CIS or
ICC stratified by sexual behaviour characteristics of the men. Overall, women
with uncircumcised men were at an increased risk of CIS (OR=2.67i 95% CI: 1.31-
5.45), but not ICC (OR=1.09i 95% CI: 0.67-1.79). The positive association
between uncircumcised men and the risk of CIS was stronger among women
whose partners had a history of sexual intercourse with a sex worker, initiated
sexual intercourse at an early age (s16 years vs. 21 years), and more weakly
associated with increasing sexual behaviour index with a four-fold risk among
those with a high risk index. Although these positive associations between
uncircumcised men and the risk of ICCwere similarly observed when stratified by
sexual behaviour characteristics of the husband, the ORs did not reach statistical
significance. In the overall combined analysis of CIS/ICC, there was a moderate
increased risk of marginal statistical significance (OR=1.43i 95% CI: 0.98-2.09)
among women with uncircumcised men. Consistent to the CIS model, in the
combined analysis, we observed an increased risk of CIS/ICC linked to the
absence of circumcision when stratified by sexual behaviour characteristics, but
the magnitude was slightly smaller as compared to the risks reported for CIS.
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5.3.8 Passive smoking
Table 5.9 shows the association between selected male smoking
characteristics and cervical CIS and ICC in multivariate analyses. Generally,
similar associations were identified in the two analyses of all couples and only
couples with monogamous women, therefore we will describe our findings herein
forward according to the all couples model. No statistically significant increased
risk of CIS was observed for women whose partners had a history of smoking. An
increasing risk of ICC was observed with decreasing time since smoking cessation
with current smokers having the highest risk (OR=1.61; 95% CI: 1.16-2.24),
suggesting passive smoking as a potential risk factor for cervical cancer. No
increased risk of ICC was observed for women with male partners who used a
specific tobacco type or filter. An increased risk of ICC was observed for women
with partners who smoked at least a low number of smoking pack-years
(OR=1.62; 95% CI: 1.14-2.29).
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Table 5.9. Multivariate associations between selected male smoking
characteristics and risk of cervical intraepithelial neoplasia grade a (CIN-a)/
carcinoma in situ (CIS) or invasive cervical cancer (ICC)
Odds ratio (95% CI)
Male characteristics All couples
Couples with
ClN-a/CIsa
monogamous
women
Time since smoking cessation
Non-smoker
Ever smoker
Exsmoker >11years
Exsmoker :S10 years
Current smoker
Use of tobacco type by smokers
Blond
Black
Both
Others
Use of smoking filter type by smokers
Filter
No filter
Both
Others
Smoking lifetime pack-years e
Non-smoker
Low no. of pack-years
Medium/High no. of pack-years
1.00
1.33 (0.89-1.99)
1.51(0.53-4.31)
1.17(0.58-2.34)
1.36 (0.88-2.07)
1.00
0.49 (0.23-1.06)
0.49 (0.24-0.99)
0.89 (0.12-6.39)
1.00
0.76 (0.29-1.96)
0.78 (0.45-1.32)
1.63 (0.25-10.73)
1.00
1.18 (0.75-1.85)
1·52(0.93-2.47)
1.00
1.16 (0.71-1.88)
0.84 (0.22-3.19)
0.67 (0.24-1.87)
1.26 (0.76-2.09)
1.00
0.33 (0.12-0.88)
0.36 (0.14-0.91)
1.03 (0.07-15.53)
1.00
0.49 (0.14-1.68)
0.61 (0.31-1.18)
2.79 (0.21-36.93)
1.00
0.89 (0.51-1.57)
1.45 (0.53-2.56)
Invasive cervical cancer b
Time since smoking cessation
Non-smoker
Ever smoker
Exsmoker >11years
Exsmoker :S10years
Current smoker
p-trend
Use of tobacco type by smokers
Blond
Black
Both
Others
Use of smoking filter type by smokers
Filter
No filter
Both
Others
1.00
1.57 (1.15-2.15)
1.46 (0.84-2.52)
1.50 (0.95-2.37)
1.61 (1.16-2.24)
0.006
1.00
0·91 (0.27-3.04)
1.42 (0.40-5.10)
0.85 (0.32-2.27)
1.00
1·34 (0·55-3.27)
1.41 (0.72-2.72)
0.98 (0.38-2.55)
1.00
1.55 (1.07-2.23)
1.11(0.60-2.07)
1.59 (0.95-2.67)
1.6a (1.11-2.40)
0.01
1.00
0.63 (0.17-2.33)
0.83 (0.:U-3.31)
0.66 (0.21-2.08)
1.00
0·95 (0.33-2.69)
1.31 (0.63-2.71)
0.83 (0.27-2.54)
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Smoking lifetime pack-years d
Non-smoker 1.00
Low no. of pack-years 1.62 (1.14-2.29)
Medium/High no. of pack-years 1.48 (1.03-2.12)
1.00
1.64 (1.09-2.47)
1.39 (0.91-2.10)
CI, confidence interval; STIs, sexually transmitted infections
a CIS multivariate model was adjusted for age ofthe husband and wife, study country, interaction
terms (husband's lifetime number of sexual partners*study country and circumcision status*study
country ), age at first sexual intercourse of the wife (~21 years, 17-20 years, :5:16years), wife's
lifetime number of sexual partners (1,~2);and husbands with monogamous women model was
adjusted for all variables in the table except for circumcision, interaction term (husband's lifetime
number of sexual partners*study country), age of the husband's wife and age at first sexual
intercourse of the wife.
h ICC model for all husbands and husbands with monogamous women were adjusted for age of
the husband and wife, study country, interaction term (husband's lifetime number of sexual
partners*study country), level of education of the husband and wife (zsecondary level, primary
level, no schooling), history of sexually transmitted infections, age at first sexual intercourse of
the wife (~21 years, 17-20 years, :5:16years), lifetime smoking pack-years of the wife (non-smoker,
low, medium, and high smoking lifetime-pack-years), oral contraceptive use (never, 1-4 years, ~5
years), parity (nulliparous, 1-6, ~7) pap smear history 12months prior to study enrollment (never,
ever), and lifetime number of sexual partners of the wife (1,~2).
C CIN-3/CIS model: smoking lifetime pack-years for the all husbands model is defined as low
(36.5-6022.5 pack-years) and medium/high (6132-56611.5 pack-years); and for the husbands with
monogamous women model, low (36.5-6716 pack-years) and medium/high (6825.5-38963.8
pack-years)
d ICC model: smoking lifetime pack-years for the all husbands model is defined as: low (36.5-
7300 pack-years) medium/high (7354.8-43435 pack-years); and for the husbands with
monogamous women model, low (36.5-7665 pack-years) medium/high (7829.3-43435 pack-
years)
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Table 5.10 shows the association between passive and active smoking
history and risk of ICC after reclassifying smoking status of the husband
according to Figure 1. As compared to the active smoking model, we did not
observe an association between male smoking habits and risk of cervical cancer
among couples with lifetime non-smoking monogamous women.
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Table 5.10. Association between passive and active smoking history and risk
of invasive cervical cancer after reclassification of smoking status of the
husband
Passive Smokin~ Active smokinJlb
Couples with non-smoking Couples with
monoaamous women monoaamous women
Cases/ Odds ratio Cases/ Odds ratio
Controls ~2:i%CIlc Controls (2:i%CI~,d
Smoking status
Non-smoker 112/167 1.00 357/407 1.00
Ever 246/240 1.28 (0.88-1.85) 134/84 1.77 (1.23-2.56)
Ex-smoker 39/54 1.01 (0.56-1.83) 38/31 1.48 (0.83-2.65)
1·94
CU1Tentsmoker 207/186 1.34 (0.91-1.96) 96/53 (1.26-2.98)
Duration of exposure to smoking
o years 112/167
1-20 years 101/108
:i!:21years 137/124
No. of cigarettes
per day
Non-smoker 112/167
1-10 cigarettes/day 96/84
2:11 cigarettes/day 144/152
Smoking lifetime pack-yearss
Non-smoker 112/167
Low 77/81
Medium 72/78
High 84/70
1.00
1·51(0.93-2.45)
1.13 (0.73-1.75)
1.00
1·51(0.95-2.39)
1.10 (0.73-1.66)
1.00
1.44 (0.88-2.36)
1.12 (0.68-1.83)
1.25 (0.76-2.05)
357/407
52/35
43/30
357/407
73/46
24/17
357/407
29/24
35/18
31/21
1.00
1.58 (0.91-2.73)
1.56 (0.88-2.79)
1.00
1.63 (t.07-2.46)
1.30 (0.91-1.84)
1.00
0.56 (0.12-2.56)
4.14 (0.96-17.8)
0.55 (0.14-2.25)
ct, confidence interval
• For the passive smoking models, characteristics of the husband's smoking history were classified
according to the wife's risk period of exposure to HPV and passive smoking as outlined in Figure 1.
b For the active smoking models, the risk of cervical cancer is based upon the woman's history of
smoking
c Models were adjusted for age of the husband and wife, study country, level of education of the
husband and wife, lifetime number of sexual partners of the husband, history of sexually
transmitted infections, age at first sexual intercourse of the wife, oral contraceptive use, parity,
and pap smear history 12months prior to study enrollment.
dHusband's history of smoking (smoking status, duration of smoking, no. of cigarettes per day
and smoking lifetime pack-years) were adjusted for in the final model accordingly to the woman's
smoking habits.
•Husband's moking lifetime pack-years for the passive smoking model is defined as: low (36.5-
3832.5 pack-years) medium (3942-7884 pack-years) and high (7938.75-67890 pack-years); and
the women's smoking lifetime pack-years for the active smoking model is defined as: low (18.25-
930.75 pack-years), medium (1022-3558.75pack-years), and high (3577-19710pack-years).
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Although passive smoking was not independently associated with risk of
ICC, there was an increased OR from 1.23 to 2.26 when women were exposed to
passive smoking alone or to both active and passive smoking. The interaction
term was however not statistically significant (P=O.77) (Table 5.11).
Table 5.11. Risk of cervical cancer according to the husband's and wive's
smoking status among couples withmonogamous women
Cases/Controls Odds ratio (95%CI)
Both non-smokers
Female non-smoker/Male ever-smoker
Female ever-smoker/Male non-smoker
Both ever-smokers
p-trend
112/167 1.00
245/240 1.23(0.85-1.77)
30/27 1.63(0.83-3.22)
104/57 2.26(1.40-3.64)
0.001
Page 1127
5.4 Discussion
This study systematically reviewed the contribution of male factors in
relation to cervical cancer risk. We found lifetime number of sexual partners to be
the most consistent predictor of a woman's risk for CIS and ICC. This is not
surprising as increasing lifetime number of sexual partners is a proxy measure of
an increased probability of being exposed to HPV. Being positive for penile HPV
and the absence of circumcision were significantly associated with an increased
risk of CIS, whereas, lack of education and history of gonorrhoea were other
male-related risk factors associated with an increased risk of ICC in the partner.
In addition, a two-fold increased risk was found among couples with both ever
smoking men and women. The difference in risk factors identified may reflect
different stages of the natural history of cervical carcinogenesis with risk factors
for CIS reflecting risk of exposure to HPV and risk factors for ICC reflecting risk
of progressing to invasive disease.
Overall, since more than three-quarters of couples were with monogamous
women, it is likely our results are a conservative evaluation of the male's role in
cervical carcinogenesis. However, this conservative approach allowed us to
explore the male risk factors in depth and to limit any potential residual
confounding that may exist if women were not monogamous. In addition, our
results may also represent societies in which women report lifetime monogamy
and multiple partnerships are more common among men, which is a pattern that
is generally seen in developing countries rather than in developed countries.
5.4.1 Risk factors of CIS
Although the absence of circumcision did not appear to be an independent
male risk factor for ICC, we cannot exclude its contribution to the risk of cervical
cancer by acting at the early stages of the oncogenic process, namely HPV
acquisition. The strong positive association with CIS may likely reflect the early
events of exposure and acquisition since prospective cohort studies have
suggested that the time lag between infection to high-grade precancerous lesions
could be within a few months of incident infection in prospective studies and
estimated up to 7-15 years in cross-sectional studies (Moscicki et ai, 2006). Once
a woman has been exposed to infection and progressed to CIS, it is unlikely that
circumcision status of the partner (which remains unchanged) at that stage would
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affect a women's potential to progress to invasive cervical disease, suggesting
other exogenous cofactors are involved in the disease process, which are
discussed later.
Recent evidence suggests that circumcision may decrease the acquisition of
high-risk (HR) oncogenic HPV and multiple HR-HPV infections (Gray et al,
2010). As seen in our data, the highest risk of CIS was among women with
uncircumcised men who had high-risk sexual behaviour. In addition, two studies
have shown a reduced clearance of penile HPV infection in uncircumcised men
(Gray et al, 2010; Hernandez et al, 2010), increasing the probability of
harbouring penile HPV infection and exposing their female partners; thus,
explaining the high HPV prevalence observed among uncircumcised men
compared to circumcised men (8.3% vs. 2%, respectively) in our study. The
biological mechanisms by which male circumcision plays an important role in
modulating HPV risk is likely multi-factorial and hypothesized to include post-
circumcision anatomical, immunological, and microbiological changes. One
recent study suggests that circumcision could decrease the amount of bacterial
microenviroment that may otherwise exist under the foreskin, mediate genital
mucosal inflammation and coinfections of STIs; therefore, the loss of the foreskin
inner mucosa may help reduce the risk of HPV acquisition in circumcised men
(Price et al, 2010). These results collectively support conclusions that male
circumcision may be protective against HPV infections. The World Health
Organization (WHO) has already recommended male circumcision as an
important intervention to reduce the risk of HIV acquisition in heterosexual men,
and this could in effect provide additional prevention against transmission of
HPV (Averbach et al, 2010; Smith et al, 2010; WHO, 2007b) particularly when
some data now suggest that HPV infections may also increase the likelihood of
HIV acquisition (Averbach et al, 2010; Smith et al, 2010).
5.4.2 Risk factors for ICC
The consistent finding of low education of the woman and of the male
partner as a risk factor for ICC (Franceschi et al, 2009), may be explained by
similar patterns of mixing with partners of similar socioeconomic (SES) (Burchell
et al, 2006) standing, as the majority of wives were with husbands who had
obtained either the same or lower education level; for example, 96% of men with
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primary level schooling were with Wives who had equal or less schooling. The
woman's level of education and early age at first sexual intercourse strongly
attenuated a substantial fraction of the husband's education gradient on cervical
cancer risk in our study (data not shown), which could explain this excess risk of
ICC (Franceschi et al, 2009; Louie et ol, 2009a).
In this study, information on time of diagnosis of N. gonorrhoea was not
available, so the temporal sequence of infection with HPV or N. gonorrhoea could
not be established. Data suggest that there is a lack of innate and adaptive
immune response to induce a protective response when exposed to N.
gonorrhoea infection, suggesting that co-infection with HPV could impair
subsequent immune responses, favouring persistence rather than clearance of
HPV (Sheung et al, 2008; Song et al, 2008; Sparling, 2008). Therefore,
concomitant infection with HPV could potentially be responsible for persistent
infection and cervical carcinogenesis, and could be further complicated by high
recurrence of gonorrhoea. Consequently, this would also increase the probability
of transmission of both HPV and N. gonorrhoea in their sexual partners.
Although misreporting of self-history of gonorrhoea cannot be excluded, among
those who reported gonorrhoea and had an adequate HPV test result, 19.9%were
positive for penile HPV infection. In this study, 39 ICC couples both self-reported
history of gonorrhoea, of whom 61.5% (n=24) were couples with monogamous
women. Conversely, if women with persistent HPV infection were subsequently
infected with N. gonorrhoea, it could be speculated that the association in this
study identifies N. gonorrhoea as a risk factor that modulates the oncogenic
potential of persistent infection to progress to invasive disease. Studies are
needed in prospective cohorts to better understand the mechanisms of N.
gonorrhoea to modulate the natural history of HPV infection.
5.4.3 Penile HPV detection
The interpretation of the lack of association between penile HPV
prevalence, male behaviour and a women's risk of ICC are difficult to elucidate
from our data. Firstly, we cannot rule out the contribution of penile HPV to a
woman's risk of ICC as detection of HPV at study enrolment does not necessarily
represent the time-point of exposure as the current understanding of the natural
history of HPV in men shows that HPV is more readily transmitted from men to
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women than from women to men, and these infections are less likely to persist
among men with approximately 75% likely to clear infection at one year (Giuliano
et al, 2008). In addition, we cannot exclude the possibility of reverse causality
since HPV-infected husbands could clear HPV, and be re-infected by their wives
who have cervical cancer and have been replicating HPV prior to the onset of
cancer. Among 116 ICC case husbands who reported no history of sex with a sex
worker or a casual partner while with their wife, 6 were HPV-positive (of whom 5
women reported lifetime monogamy) making it impossible to know who the
source of HPV exposure came from if there was no underreporting. Secondly,
detection of penile HPV DNA (17%) in our study was lower than recently reported
prevalence estimates in men and this may result from incomplete sampling of the
male genitalia as it has been suggested that for optimal HPV detection, sampling
should include multiple anatomic sites of the penile shaft, glans penis/coronal
sulcus, scrotum, anus, or perianus with optimal detection found in the penile
shaft (Nielson et al, 2007). Although we did not sample the scrotum nor the
penile shaft, we believe our samples from the coronal sulcus and glans penis
adequately assessed HPV status as these two sites are in direct contact with the
cervix.
5.4.4 Passive Smoking
This study showed no independent association of passive smoking and risk
of cervical cancer in the absence of active smoking. In the first two models of all
couples and couples with monogamous women, the lack of association with CIS
and the significant association with ICC suggests that passive cigarette smoking
could potentially acts as a late carcinogen in the transition from persistent
infection/pre-invasive lesions to invasion. These findings are not new and are
consistent with previous findings (IARC, 2004; Tay & Tay, 2004; Trimble et al,
2005; U.S. Dept. of Health and Human Services & National Center for Chronic
Disease Prevention and Health Promotion, 2006). However, when we considered
the possibility of misclassification bias in our third model of couples with lifetime
non-smoking monogamous women and reclassified the men's smoking status
according to the risk period for which the woman would be exposed to both HPV
infection and passive smoking, no independent association could be found. The
greatest risk estimate was more than two-fold for couples who were both ever-
smokers.
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5.4.4.1 Misclassification of smoking status
The contradicting results as shown in the different models highlight the
distortion of estimates probably resulting from misclassification of smoking
status. This suggests that a model considering only the time period of exposure to
HPV and passive smoking should be used to determine susceptibility to
carcinogenesis. The timing of exposure to tobacco smoke relative to cervical
cancer development is important in defining exposure. Since we had detailed
information on smoking and sexual history we were able to define and calculate
exposure based on a series of responses. The strict definitions of exposure to
tobacco smoke in our analyses showed associations with risk of cervical cancer
that were obscured by using simpler definitions. Non-smoking monogamous
women with men classified as ex-smokers who have quit smoking prior to
initiating a sexual relationship may not be as susceptible to passive smoking. In
addition, the men's lifetime duration of smoking does not necessarily include the
whole period of the couple's relationship if he stops smoking during the
relationship or he starts and stops smoking during the relationship. Although the
possibility of misclassification of the women's smoking status cannot be excluded,
we do not believe inclusion of non-smokers who were actually true smokers
would cause substantial bias since female smoking prevalence in these study
countries is low (WHO, 2009b). In epidemiologic studies of cervical cancer
etiology, the definitions of exposure should reflect a model of risk to HPV
infection and cervical carcinogenesis.
5.4.4.2 Strength of evidence for passive smoking
This study strengthens the current evidence for several reasons. First, this
study has the largest dataset of couples with non-smoking women to measure
passive smoking. Since our study obtained direct information from interviews
with both the husband and wife, our results are considered reliable as previous
studies have found good agreement in responses concerning spousal smoking
status to range from 90 to 100 percent (U.S. Dept. of Health and Human Services
& National Center for Chronic Disease Prevention and Health Promotion, 2006)
and previous cotinine studies of never-smokers have validated the use of spousal
history as a marker of exposure to tobacco smoke and people who live with
smokers tend to mix with smokers outside the home (IARC, 2004). In contrast,
previous studies had small sample sizes with small numbers of non-smokers.
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Secondly, previous studies lacked adequate information on HPV and sexual
behaviour indicators to control for potential confounding, and we were able to
control for both male and female risk factors. Thirdly, as we currently understand
the natural history of cervical cancer, not all pre-cancerous lesions will progress
to invasive cervical cancer (McCredie et ol, 2008), we were able to evaluate the
effect of passive smoking by stage of disease (pre-invasive vs. invasive).
Previous studies did not evaluate the combined effects of different
exposure of active and passive smoke (non-smokers, female ever-smoker/male
non-smoker, and female non-smoker/male ever-smoker). Although the other
combinations showed an increased risk, only the combination of ever-smoking
couples showed a statistically significant increased risk. The lack of an
independent association with passive smoking does not necessarily discount its
contribution to ICC risk. This may suggest that the direct effect of active smoking
outweighs the indirect carcinogenic effects passive smoking may have. One of the
limitations of epidemiological studies using questionnaire data is its decrease in
sensitivity or power of a study to show a positive association when the effect may
only be moderately related to passive smoking (U.S. Dept. of Health and Human
Services & National Center for Chronic Disease Prevention and Health
Promotion, 2006). In addition, lifetime number of sexual partners of the men
largely attenuated the observed effect of passive smoking on ICC risk.
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5.4.4.3 Biological plausibility of passive smoking
A biological mechanism by which active and passive smoking could
influence cervical carcinogenesis is not clearly understood. However, tobacco
smoke contains known carcinogens such as polycyclic aromatic hydrocarbons
that could potentially have a direct transformation effect on the cervix or could
cause immunosuppression, allowing HPV infections to persist and progress to
cancer (IARC, 2004). Detectable levels of nicotine and cotinine, a measurement
of smoke exposure, have been found in cervical mucus as well as DNA adduct
levels in the cervical epithelium of non-smokers, supporting the evidence that
these chemicals can reach distant sites such as the cervix (National Cancer
Institute, 1999). Another hypothesis includes mutagenic semen due to smoking is
plausible and direct cervical contact with semen of smoking partners may
represent another source of exposure (U.S. Dept. of Health and Human Services
& National Center for Chronic Disease Prevention and Health Promotion, 2006).
This study lacked data measurement levels of cotinine/nicotine in the cervix,
therefore, additional studies are needed to obtain these data to complement our
epidemiological findings.
Penile HPV detection was more prevalent among current smokers
compared to ex-smokers and non-smokers which is consistent to previous
findings (Vardas et al, 2011). This suggests that smokers may be more likely to
have persistent infections compared to non-smokers, making them more likely to
expose their wives to HPV infection. However, the interpretation of penile HPV
detection at study enrolment is not straightforward (as discussed in Section
5.4.3). Other studies have not found smoking to be associated with penile HPV
acquisition nor persistence (Kjaer et al, 2005; Lu et al, 2009).
5.4.4.4 Social implications of passive smoking
There are 1billion active smokers worldwide and one third of adults are
regularly exposed to passive smoke with the burden of tobacco-related disease,
disability and death being the highest in developing regions. Moreover, the rate of
increase in cigarette consumption in developing countries is ten times that of
industrialised countries (WHO, 2010). This burden is likely to increase in the
coming decades if current trends persist with more than 9096 of the world's
population not protected by comprehensive smoke-free policies and there is low
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compliance (2%) in countries where there are comprehensive smoke-free laws
(WHO, 2009b). Globally, there is an increasing trend of females aged 13-15
smoking in recent years (WHO, 2010), which needs to be considered along with
reported median age at first sexual intercourse to occur for most women is 15-19
years (Wellings et al, 2006) when assessing risk of ICC. The data presented here
support that in addition to female tobacco smoking as an established cofactor for
cervical carcinogenesis, there is a potential role of passive smoke on ICC, which
suggest that the estimated burden of tobacco-related diseases may increase and
magnify the need for effective tobacco control, notably in developing countries.
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5.5 Conclusions
In conclusion, male circumcisioncouldbe an effectiveprevention measure
against CIS, particularly in developing countries, where HPV vaccines are
predominantly unavailable and cervical screening is largely ineffectiveor non-
existent. The burden of tobacco-related diseases is projected to increase
dramatically in the developingworld with increasing rates of exposure to active
and passive smoking. If more sufficient evidence confirms the causation of
passive smoke on cervical cancer, the estimated burden of tobacco-related
diseases will only increase, magnifying the need for both effective tobacco and
cervicalcancer control.
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6 Overall discussion and implications
6.1 Introduction
This thesis presents a set of robust analyses to evaluate the associations of
sexual and reproductive health (SRH) risk factors and risk of cervical cancer in
developing countries. The culmination of work involved the use of the best
available data possible to investigate the natural history of human papillomavirus
(HPV) and invasive cervical cancer (ICC) with a range of different statistical
method approaches to fully characterise and address the inconclusive SRH
associations with ICC risk. The IARC/ICO series of case-control studies is the
largest set of aetiological investigations that fully addresses the role of HPV DNA
and of the independent established cofactors with a standardised protocol (Study
1and 3). In addition, these investigations were conducted in developing countries
where ICC burden is the highest and data are often limited. Similarly, the
Guanacaste Study was the largest population-based longitudinal cohort study of
HPV and cervical neoplasia in the world (Study 2). The intense effort to
systematically evaluate and follow-up 10,000 women over a period of 7-years
provided a richness of data that would allow time-dependent assessment of
factors to be linked to different stages of cervical carcinogenesis, specifically, HPV
persistence. In aggregate, these two datasets provide an opportunity to fully
evaluate SRH factors throughout the natural history of HPV from stages of
acquisition of infection, to persistence, cervical neoplasia and cervical cancer.
Each chapter for Study 1 (Chapter 3), Study 2 (Chapter 4), and Study 3
(Chapter 5) has included its own individual discussion. This chapter will
highlight key results and present a general discussion about the findings in this
thesis. The implications of this research for primary and secondary cervical
cancer prevention will also be discussed as well as provide some foresight into
future research directions.
6.2 Did the thesis address the hypothesis?
This thesis aimed to evaluate the associations of SRH factors and risk of
cervical cancer. One of the main hypotheses was that early age at first sexual
intercourse (AFSI) and first pregnancy (AFP) are associated with cervical cancer,
placing an HPV-positive woman at higher susceptibility for HPV persistence and
greater risk of cervical cancer development. This research confirmed AFSI and
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AFP as independent risk factors for cervical cancer, irrespective of other
established cofactors (Study 1). However, any independent effects of these two
events could not be distinguished. There is a possible additional increase in risk
when early initiation of first sex (:5>15years) is followed by a pregnancy. The
mechanisms of these associations may include the immature cervix and increased
levels of exposure to hormonal (oestrogens) levels during adolescence and
pregnancy that may facilitate HPV persistence. In order to confirm these findings
in a cohort study to complete another stage in the natural history picture of HPV
from acquisition to persistence, it was hypothesised that these SRH factors would
be confirmed in a longitudinal analysis.
Research presented in Study 2 showed that there was an increasing risk of
a-year persistence with decreasing age at first pregnancy among prevalent HPV-
16/18 infections. The highest risk was found among women with AFP SIS years.
These results provide additional evidence of the contributing role of early AFP
and its affect on cervical cancer risk. Findings also support the different natural
histories that may exist for type-specific HPV infections. HPV-16 is the most
prevalent type worldwide and presents the greatest magnitude of risk of
progression to cervical cancer if persistent. Interestingly, ectopic pregnancies also
appeared to show a protective effect against HPV persistence. It is possible that
luteal phase deficiency is causing these ectopic pregnancies which impairs
ovarian stimulation and disrupts the efficiency of HPV to persist and cause
cervical metaplastic changes and neoplasia. This highlights the increasing
evidence of the role of female sex hormones in cervical carcinogenesis.
Another hypothesis of this thesis was that a woman's risk of cervical cancer
depended less on her sexual behaviour than on that of her husband or male
partner. Women who initiate sexual intercourse during adolescence tend to have
older male sexual partners and men report more lifetime number of sexual
partners than women who are predominantly monogamous. This research
identified the age gap difference (~8 years) between couples was an independent
predictor of risk of ICC, particularly among girls with AFSI s16 years (Chapter
3). Sexual behaviour patterns suggest that men are more likely to be the source
of STI transmission in marital relationships, which is particularly relevant in
developing countries where most women are virgins at marriage and remain
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lifetime monogamous. Although there is evidence of rapid change in sexual
behaviour (i.e. pre-marital sex), these changes are more notably in developed
countries (Wellings et ai, 2006).
Increasing lifetime number of sexual partners of the male partner was a
predictor of CIS and ICC risk depending on country, which is characterised by the
varying sexual behaviour patterns in the population. This finding was not
surprising as increasing lifetime number of sexual partners is a proxy of increase
probability of being exposed to HPV. Being HPV DNA positive in penile
specimens and the absence of circumcision were significantly associated with an
increased risk of CIS; whereas lack of education, having a history of gonorrhoea
were other male-related risk factors associated with ICC. Besides the husband's
sexual behaviour, other lifestyle behaviour, in the context of couples, identified a
two-fold increased risk of ICC among couples with both ever smoking men and
women. Passive smoking was not identified as an independent risk factor cervical
cancer; however, the combined effects of active and passive smoking suggest its
potential adverse role in cervical carcinogenesis. The difference in male factor
profiles for risk of CIS and ICC may reflect different steps of the natural history of
cervical carcinogenesis with risk factors for CIS reflecting risk of exposure to HPV
and risk factors for ICC reflecting risk of progressing to invasive disease.
6.3 Natural history ofHPV and cervical cancer
There is now a dearth of research demonstrating clear aetiological
associations between SRH factors and risk of cervical cancer. As a few expert
HPV etiologists (Schiffman et ai, 2011) suggest, "We do not need to question the
sexual correlates of HPV infection" since it is well-established that infection with
HPV is common and sexually transmitted. Furthermore, "depending on regional
social/sexual practices, low education and age at first sexual intercourse can
plausibly be linked to higher risk of acquisition. Apart from sociologic analyses, as
etiologists, we do not need to question the sexual correlates of HPV infection."
The research in this thesis did not question the plausible link of these SRH factors
with HPV infection. Rather this research tried to clarify how the role of these
factors contributed throughout the natural history of HPV.
This thesis confirmed the. aetiological association of SRH factors with
cervical cancer in large pooled analyses that provide more conclusive agreement
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than previously understood. These specific pooled analyses with a common
protocol has also allowed us to study the role of each AFSI and AFP with finer
detail than previously possible and compared to other pooled analyses with
differing protocols and data collected (International Collaboration of
Epidemiological Studies of Cervical Cancer, 2009). A unique aspect of the
research presented was the separation of risk factors associated with critical
transition states in the natural history of HPV and cervical cancer - persistence,
pre-cancer and invasive disease. A summary of factors consistently reported to
playa role at different stages in the natural history of HPV and cervical neoplasia
has been presented previously (Moscicki et al, 2006). Additional SRH factors
identified in this thesis are highlighted in Figure 6.1.
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Figure 6.1 Overview of factors reported to play a role at different stages of
the natural history of HPV and cervical neoplsia and additional sexual and
reproductive health factors (red) identified in this thesis. Ageat first pregnancy
(AFP) and increasing lifetime number of sexual partners were associated with z-year
HPV persistence; and ectopic pregnancy showed a protective effect from HPV
persistence. Male-related factors, absence of male circumcision, increasing lifetime
number of sexual partners, and penile HPV-positivitywere associatedwith carcinoma in
situ. Ageat first sexual intercourse (AFSI)and AFPwere associatedwith invasive cervical
cancer (ICC).Combinedeffectsof activeand passive smoking suggest an increased risk of
ICC. Other male-related factors, lifetime no. of sexual partners, lack of education and
history of gonorrhoea, were also associated with ICC. Adapted from (Moscicki et al,
2006).
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No new studies regarding sexual correlates with HPV infection may be
needed but ongoing pooled analyses such as the ones presented in this thesis will
continue to provide relevant information and elucidate other remaining questions
of the natural history. These research results have raised biological hypotheses
from these epidemiological findings as well as support the increasing role of
female sex hormones in the role of cervical carcinogenesis. Recent publications
on time since first sexual intercourse (Plummer et al, 2011) and the contribution
of endogenous sex steroids (Rinaldi et ol, 2011) on the risk of cervical cancer,
underscores that there are still remaining questions about the role of AFSI and
AFP but they are in the process of being clarified.
Moreover, additional questions remain about the molecular mechanisms
(e.g. steroidal hormones) by which SRH behavioural factors and host factors
interact with HPV to cause progression to invasive disease and why the host
immune response is not effective in controlling the infection. The research
paradigm of understanding the natural history is shifting. Rather than addressing
determinants of HPV infection and cervical cancer, researchers are now working
on providing scientific evidence about how these factors affect the basic biology,
virology, and immunology of HPV in order i) to elucidate plausible mechanisms
for epidemiological findings and vice versa; ii) to understand its role in altering
the natural history of HPV; and iii) to therefore feed the potential pipeline for
new targets for interventions and therapeutic vaccines for cervical cancer
prevention and control.
6.4 Methodological issues
This research was partially motivated by the inconsistent results identified
in previous studies and different methodological approaches were applied to
clarify these varying associations. In Study 1 (Chapter 3), three HPV-
adjustment models (HPV unadjusted, HPV-adjusted, and restricted to HPV DNA
positive cases and controls) were constructed to estimate the impact of these
different strategies on associations between SRH factors and cervical cancer risk.
Comparison of these methods have been applied previously on evaluating
associations between parity, oral contraceptive use and smoking and ICC risk
(Castellsague & Munoz, 2003). Similarly, regardless of the adjustment method
used, the same conclusion regarding the direction of association and statistically
significant association were found. Of the three adjustment methods, because
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HPV is a necessary cause for cervical cancer, it was originally argued that the
HPV-restricted model is a better strategy than the other two methods as it was a
strict approach to getting rid of residual confounding. The other strategies would
ineffect underestimate the magnitude of the associations.
However, as a counter argument, adjusting for HPV status is not necessary
as the adjustments do not contribute to removing any confounding effect. Nearly
all cases of ICC are positive for HPV DNA (Bosch et al, 2002). Cases that are
HPV-negative are believed to be associated with the limitations of HPV detection
methodologies. Adjusting for HPVwhen it is assumed to be ubiquitous in all cases
of ICC is unnecessary. In addition, restriction to only HPV-positive cases and
controls is not appropriate as detection of HPV at one time-point for controls
does not necessarily represent the same time-point in which a case was exposed
and acquired infection.
In Study 3 (Chapter 5), to better clarify the relationship between passive
smoking characteristics and cervical cancer in their female partners, three
different models were computed to include all couples, couples with monogamous
women and a third model included couples with lifetime non-smoking
monogamous women. In the third model, we were able to remove the potential
effect of previous male partners and the effect of the woman's active smoking
behaviour. Furthermore, the men's smoking history was reclassified to reflect the
risk period for which the woman would have been exposed to HPV infection,
passive smoking and risk of progression to cervical cancer. Ninety male ex-
smokers of couples with monogamous women were reclassified and the duration
of exposure to passive smoke and smoking pack-years were recalculated. The
contradicting results in previous studies and as shown in the different models
compared in this study highlight the distortion of estimates probably resulting
from misclassification of smoking status. Since the objective was to explore
associations between cofactors among HPV-exposed women, a model considering
only the time period of exposure to HPV and passive smoking should be used to
determine the susceptibility to cervical carcinogenesis.
6.5 Public health implications
Well-characterisation of SRH factors and other cofactors in the natural
history of HPV and cervical cancer has led to the development of primary and
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secondary cervical cancer prevention tools. Stakeholders working in cervical
cancer prevention need to integrate our understanding of these SRH behaviour
patterns in monitoring and implementing effective prevention programmes. It is
also important to understand how these SRH behaviour factors fit into the
broader social and cultural context and contribute to the burden of cervical
cancer. Much of the work that lies ahead is utilising what is understood about
cervical cancer and operationalising the tools that exist for cervical cancer
control.
6.5.1 Monitoring sexual behaviour and HPV prevalence in general populations
Aetiological studies on sexual behaviour may not be needed, but ongoing
surveys on sexual behaviour trends and the prevalence of HPV are needed to
assess interventions, particularly in the era of HPV vaccination. Since HPV
infection often occurs soon after first sexual intercourse, AFSI is a reasonable
proxy measure of exposure. Similar to UNAIDS using AFSI as one of the
indicators for highlighting prevention priorities for HIV, it could be similarly used
for prevention of HPV and cervical cancer. The WHO/ICO Information Centre on
HPV and Cervical Cancer has aggregated available data to summarise the burden
of HPV infection and cervical cancer and IARC has conducted a large number of
population-based HPV prevalence surveys carried out mainly in less developed
countries with unscreened populations covering four continents. These data will
be useful in providing baseline data from the pre-vaccination era. Additional HPV
surveillance studies should be carried out in the post-vaccination era to measure
the long-term impact of vaccination on the burden of cervical cancer in order for
each country to consider the most cost-effective prevention strategy (i.e,
vaccination alone, vaccination plus cervical screening albeit at different screening
intervals, or cervical screening alone). Repeated measurements over time of these
SRH indicators and of HPV prevalence will inform policy makers on progress of
reducing the burden of cervical cancer.
From another perspective, the global variation of sexual behaviour
(Wellings et al, 2006) and HPV prevalence (Bruni et al, 2010) has been used to
explain not only the heterogeneity of cervical cancer rates between developed vs.
developing countries but also heterogeneity within developing regions (Louie et
al, 2011). It has been shown that the global variability among adolescents first
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initiating sexual activity is influenced by many factors that include economic
inequalities (Nahmias & Nahmias, 2011). Patterns of early AFSI and AFP (Louie
et al, 2009a) and low education (de Sanjose et al, 1997; Franceschi et al, 2009)
highlight the existing social inequalities that may also need to be addressed when
planning prevention programmes.
6.5.2 Primary prevention of cervical cancer
The availability of prophylactic HPV vaccines gives new promises for a
primary prevention strategy, particularly in developing countries where lack of
infrastructure and resources have been able to provide none or ineffective cervical
screening programmes. The risks associated with early AFSI and AFP, two highly
prevalent events in developing countries highlight the urgency to provide access
to vaccines for girls prior to sexual debut. There is additional evidence that first
sexual intercourse for very young girls in developing countries is forced, and in a
vulnerable sub-population of adolescent girls sexual coercion can be as high as
4096 (Brown et al, 2001), placing young women at great physical vulnerability.
Moreover, it is likely that the partners of these adolescents who report sexual
coercion are sexually experienced and at high risk for HPV infection.
The bivalent and quadrivalent vaccines have shown ;::9596efficacy in
preventing vaccine HPV types and related cervical neoplasia (Schiller et al,
2008); and more recently, clinical trials have shown that the HPV quadrivalent
vaccine to be 8596 efficacious in preventing HPV persistent infections in boys
aged 16-26 (Giuliano et al, 2011). Inclusion of boys into routine immunisation
programmes is under high debate. At the individual-level, vaccination of boys
would offer herd immunity at the population level as well as reduce their own risk
of HPV-related morbidities, such as genital warts and other related neoplasias at
the anus (Palefsky et al, 2011) and possibly also the penis. There is still a question
about the magnitude of herd immunity that would be conferred to girls if boys
were also vaccinated. The cost-effectiveness of including males and the additional
reduction of morbidity and mortality gained as a result of vaccinating both
females and males remain unclear.
The opportunity of these vaccines to have an effective impact in developing
countries, where the burden is the highest, will not be realised until they become
affordable and integrated within the framework of national immunisation
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programmes (Kane et al, 2006). WHO recommends vaccination of girls aged 9-
13 years through national immunisation programmes where cervical cancer is
considered a public health priority and where vaccine introduction is feasible and
finance can be secured, sustained and be considered cost-effective (WHO,
2009a).
The GAVI Alliance, a public-private organisation dedicated to increase
children's access to vaccines in developing countries, recently committed to
supporting the introduction of HPV vaccines as well as received a commitment
from the quadrivalent HPV vaccine manufacturing company, Merck & Co Inc., to
offer the HPV vaccine at US$S per dose. GAVI can offer the vaccine at a
subsidised price to the world's poorest countries, increasing the likelihood of
reaching the girls most at risk for HPV.
6.5.3 Secondary prevention of cervical cancer
Cytology screening programmes have been successful in curbing the
incidence of ICC in developed countries but they have largely failed in most
developing countries due to other competing health priorities and lack of
resources including health infrastructures (trained cytotechnologists,
laboratories, and services for diagnosis and treatment), human and financial
resources (Denny et al, 2006; Sankaranarayanan et al, 2001).
VIA (visual inspection with acetic acid) or VIU (visual inspection with
Lugo's iodine) are less laboratory dependent strategies and have been advocated
as screening alternatives in developing countries. However, visual inspection
methods are highly subjective and require good provider training and sustained
quality assurance in order to achieve substantial gains in prevention of cervical
cancer in routine settings (Cuzick et al, 2008).
A more objective and reproducible screening test is testing for HPV DNA
that has shown to be more sensitive than cervical cytology to detect high-grade
lesions (Dillner et al, 2008). A rapid HPV DNA test that can provide a patient
with a result within the same visit would be the most effective approach to impact
low resource settings where loss to follow-up is often the primary factor for an
ineffective screening programme. A number of inexpensive rapid HPV DNA
screening technologies have been under development and evaluation but it is
unclear when these tests will become commercially available (Gravitt et al, 2008).
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Results from Study 2 (Chapter 4) provided additional evidence of the
different type-specific risk of HPV persistence and of natural histories. These
results corroborate with other studies that identified HPV-16/18 infections to be
at greater risk for HPV persistence and for cancer development (Chen et al, 2011;
Khan et al, 2005). Different screening technologies that discriminate for HPV-
16/18 and other HR-HPVare under evaluation and may offer a greater positive
predictive value of risk for cervical neoplasia; have the potential to increase
specificity; and provide an objective output (Gravitt et al, 2008). A number of
technologies suggested for screening management may include HPV genotyping,
measuring HPV-16 viral load, and p16 enzyme linked immunosorbent assay.
However, many of these technologies are currently highly complex, expensive,
and require high quality control laboratories to perform these tests; and
therefore, not appropriate for low-resource settings unless these tests become
inexpensive, were able to provide results at the same time as the screening visit
and easy to perform.
6.5.4 Other cervical cancer prevention measures
In settings where cervical cancer control with primary (vaccination) and
secondary (screening) prevention measures is not possible, male circumcision
could offer an alternative prevention strategy to reducing a woman's risk of
cervical cancer. Study 3 (Chapter 5) showed that the absence of circumcision
increased a woman's risk of CIS. A recent systematic review and meta-analysis
showed that circumcised men are at substantially lower risk of prevalent HPV
infections than uncircumcised men (Larke et al, 2011). Also, data from
randomised-controlled clinical trials have shown that a substantial reduction in
risk among female partners becoming infected with HR-HPV was found among
couples with circumcised men (Wawer et al, 2011). Circumcision services are
being expanded in sub-Saharan Africa as an HIV prevention strategy and may
represent an additional opportunity to reduce HPV as well as HIV in men (Larke
et al, 2011). Approximately 3096 of the world's male population ~15 years are
circumcised (WHO, 2007a). Circumcision could be another intervention to
reduce HPV infection in men and reduce a woman's risk of HPV acquisition.
Additional research is needed to evaluate strategies to integrate male
circumcision services in the broader context of STI prevention and cervical cancer
control.
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6.6 Conclusions
In summary, cervical cancer ranks as the second most common cancer among
women in the developing world. The problem disproportionately affects women
most vulnerable to early age at first sexual intercourse and first pregnancy and
high parity. The investigations presented in this thesis show that AFSI and AFP
are not only linked to age at first HPV exposure but also linked to the natural
history of cervical carcinogenesis. The role of men contributing to a woman's risk
cannot be underestimated. The uncertainties of the role of these SRH factors have
been clarified through this body of work that evaluated different assumptions on
methodologies that may have previously provided inconsistent results. The
evidence presented can conclude with confidence that these sexual and
reproductive health behaviour and lifestyle factors (e.g. active and passive
smoking) can plausibly drive the biological mechanisms of HPV and the
carcinogenic pathway. The general steps of this pathway are understood but there
are still fine details (e.g. role of oestrogens) that need to be revealed and these
investigations are underway.
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7 Dissemination of research findings
,.1 Conference presentations
7.1.1 The literature review has been presented as a poster presentation
Louie KS, de Sanjose S, Mayaud P. The under prioritised burden of cervical
cancer in sub-Saharan Africa. Programs and Abstracts of the 25th International
Papillomavirus Conference and Clinical Workshop; May 8-14, 2009; Malmo,
Sweden. Abstract P-30.33.
7.1.2 Study 1results have been presented as a poster presentation
Louie KS, de Sanjose, Diaz M, Castellsague X, Herrero R, Meijer CIL, Shah K,
Franceschi S, Munoz N, Bosch FX. Sexual debut and pregnancy are risk factors
for cervical cancer. Programs and Abstracts of the 25th International
Papillomavirus Conference and Clinical Workshop; May 8-14, 2009; Malmo,
Sweden. Abstract P-30.09.
7.1.3 Study 3 results have been presented as poster presentation
Louie KS, Castellsague X, de Sanjose S, Herrero R, Meijer CI, Shah K, Munoz N,
Bosch F.X, for the International Agency for Research on Cancer Multicenter
Cervical Cancer Study Group. Smoking and passive smoking in cervical cancer
risk. Programs and Abstracts of the 21h International Papillomavirus Conference
and Clinical Workshop; September 17-22, 2011; Berlin, Germany
7.1.4 Extended research
Findings from this thesis research have initiated further research into the subject
of sexual and reproductive risk factors and risk of cervical cancer for which I am
involved. Results have been presented as poster presentations at the following
conferences.
Louie KS, Pineda S, Castanon A, Almonte M. Sexual behaviour factors and
cervical cancer rates in Latin America. Programs and Abstracts of the 21h
International Papillomavirus Conference and Clinical Workshop; September 17-
22, 2011; Berlin, Germany (Oral Poster Presentation)
Ferrer E, Louie KS, Bruni L, Diaz M, Albero G, Munoz J, de Sanjose S, Bosch
F.X, Castellsague X. Systematic review: cervical cancer awareness in sub-Saharan
Africa. Programs and Abstracts of the 25th International Papillomavirus
Conference and Clinical Workshop; May 8-14, 2009; Malmo, Sweden. Abstract p,
22.27·
Louie KS, Albero G, Munoz J, Bruni L, Ferrer E, Diaz M, Castellsague, Bosch
F.X, de Sanjose S. HIV, fertility and cervical cancer rates in Africa. Programs and
Abstracts of the 24th International Papillomavirus Conference and Clinical
Workshop; November 3-9, 2007; Beijing China. Abstract PSB-21.
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7.2 Peer-reviewed publications
7.2.1 Literature review
Louie KS, de Sanjose, Mayaud P. The burden of human papillomavirus (HPV)
infection and cervical cancer in sub-Saharan Africa: prevention opportunities and
challenges. Tropical Medicine & International Health 2009; 14 (10): 1287-1302.
7.2.2 Study 1
Louie KS, de Sanjose, Diaz M, Castellsague, Herrero R, Meijer CJL, Shah K,
Franceschi S, Munoz N, Bosch F, for the International Agency for Research on
Cancer Multicenter Cervical Cancer Study Group. Early age at first sexual
intercourse and early pregnancy are risk factors for cervical cancer in developing
countries. British Journal of Cancer 2009; 100 (7):1191-7.
7.2.3 Study 3
Louie KS, Castellsague X, de Sanjose S, Herrero R, Meijer CJ, Shah K, Munoz
N, Bosch FX, for the International Agency for Research on Cancer Multicenter
Cervical Cancer Study Group. Smoking and passive smoking in cervical cancer
risk: pooled analysis of couples from the !ARCmulti-centric case control studies.
Cancer Epidemiology, Biomarkers & Prevention 2011; 20(7):1379-1390.
7.3 Other publications and reports
The results from this PhD thesis project have been summarised or partially
republished in other publications and reports to disseminate information to
relevant stakeholders working in cervical cancer prevention, particularly in
developing countries.
7.3.1 Literature review
Louie K, Didelot, MN, Damay A, Nagot N, Mayaud P, Segondy M.
Papillomavirus humains (HPV) et cancers associes: aspects epidemiologiques (In
French). Revue Francophone des Laboratoires 2008; 38(45): 27-34.
7.3.2 Study 1
Louie KS, de Sanjose S, Mayaud P. Cervicalcancerprevention inAfrica. Africa
Health (2009); 32 (1): 27-29.
Louie KS. Preventing Cervical Cancer in sub-Saharan Africa. Programme for
Research & Capacity Building in Sexual & Reproductive Health & HIV in
Developing Countries; Fact Sheet, October 2009. Access at: http://www.srh-
hiv.org/
Louie KS and Mayaud P. Feature: Challenges in introducing vaccination for
human papillomavirus (HPV) infection to prevent cervical cancer in sub-
Saharan Africa. IDS Health and Development Information; Health Reporter,
October 2009.
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Summary OBJECTIVES To "kmufy the gap' of knowledge and h.ghhght the hallcngcv and opporrumne for
controlling cervical cancer In sub-Saharan Afn a (SSA).
MfTHODS A c ornprchenovc review uf peer-reviewed hrcrarure to vummanze thr cprdenuological darn
on human paprlkimavrrus (lIPV) and mvasrvc cervical Cancer 0 I hy HTV status to rCVk'W fen"!>I,,
and effecuve cervical recrung strategies. and ro rdennfy barners In the mrroducnon of HP va cmauon
in SSA.
RESULTS I ~ mcioe oce In SA I~ one of the highesr rn the world with on age-vtandardrzed mctdence rate
of 31.0 per 100 000 women. The prevalence of HPV 16/18, the rwo voccme preventable-types among
women WIth I ., does not appear co differ by IflV status on n small case series. However, there nre
hnutcd data on the role of HIV m the natural h,swry of III' mfectlon In S. \. ervicnl screenmg
coverage range. from 2.0'}" co 20.2 % in urban areas and 0.4% to 14.0,}" m rural area •. There nre few
large scale rrunativcs to mtroduce population-based screening u"ng cytOlogy, ""ual,mpectK>I1 or IIVV
te.ring. Only un<: vae 'rIC saf"ty and Immunogeruclty "ud~' "hems ondUl'tcd In !,enegal and
Tanzania. few data arc aval~lhle on vaccme acc.cptah,hty, health \yMen~ rrcp.1redne~ and vae inC
co,t-cffecuvcne" and long-term Impact.
CONCW$lONS AdditIonal data are needed w ,trengthen I .C 0.' a puhh health prlOnry W '"tr()(.Il1~c,
implement and 'U\tam cffa.-lIve cervIcal cancer control In fru:a.
keywords human pap,lInrnavlru" cervIcal aneer, IflV, ,uo-Saharan Af,,(a. cr\'1 '01 ~rcerun);, liP
vacd~
Introduction
2002) and the avallahlhty tlf df :uvt: III' "ocetne<> II)
prevenr mfcetlon and ru!.Ca>e (. 'luller ct a1. 20081. the
OppOrtunlfY of thc,c V.leelnc, lU have nil "flecllvc IInl','~t
m SSA WIll not matenallze unClI the)' h 'on affnrchhle nnd
mtl1lrated wtclun the framework of n.1tltlTlnl,mmuI1I1.lUtln
prllgrnmm" (Karte el (II. 2L)06),lInnllhrr~ crrvllal <llll
cer prcventKln WIll rely on >tX"<Hldof)' prcvcOlMllt rnc.l.,un'\,
Th" reVIeW alTl~ f.() summartze Ih~.:urrell! cp,dellllOI<I':)
of IIPV and CHVIC:l1 carteer nnd the cnmple 'ry of
Implementing prevenClon '" 'Uh-!..lhJr.ln Inca; to Idcnttf)
gap' (,f knowledge and to hIghlight till' ~h,dlenllr, and
opponunloc, for controlling cerVICal cnl'K;cr ,n tht< rl'glon.
.aoccr of the cervIX uten " the mfm .ommon cancer
among women," .,uO-Saharan Afnca SSA). The magnl-
rude of the prohlem has hecn under-recognized and under-
prlOrttlzed compared to competmg health pnom.e, ,uch a,
HlV/ArnS, tuhcr(ul{~'i" and m.,lana. Th" I, due to la k of
eplclcmwloll' 01 dna and poor awarene~, lack of human
and Man<.,al =()urcc~, non-exIStent cancer ""I\'ICC pohde~
and lack (,f politi "I WIll [0 addre.." the complex prohlcm
(lJt'nny el a1. 2006; I'arbn 1'1 a1. 2008).
rganlud scrcerung and early rreatment programme<>
h"vc heen effective," preventing cervI .11canCer In ind'b-
cnahzed counenes but they are emtly and dIfficult to
Implement '" re,our e-comualned setrin~. Despite our
undehtaodlllg of the eau",1 rclatl<ln~htp of the human
papllI()maYlr~ (HPV) and cervIcal can er (Btl!oCh el a1.
Methods
We ondu.:rcd a lomprchell'tVe I'I'VlfW of p' r-revlewed
literature tTl darnhasc. of the ~ mid Ile.llth 1ll,ITlll.lImn
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and lnsurur Camhi dObcologra (WHO/lCOj Inform anon
Centre on HPV and Cervical Cancer (hnp:llwww,wh!J.Inri
hpvccntre], the International Agency for Resear h
on Cancer (tARC) . .recrung Group (http://www .
screerung.sarc.fr}, PubMed/lvfEDLlNI, and reports from
the orld Health Orgaruzarson (WHO). The folklwmg
medical subject heading (MESH) and text word, were used
alone or m combination: 'HPV', 'cervical cancer', 'cervical
screerung', 'HPV vac mauon" and 'sub- aharan Africa'.
This review surnrnarrzes the evidence frum recent
systcrnanc reviews. meta-analyses, narrauve reviews
(non-sysremanc reviews), eprdcrmologrcal studies
modelhng and related analyses and pracnce gurdchnes,
Results
Cervical canccr in .ub-Saharan Africa
An estimated number of 70 722 ocw ca>C.\~of mvaslVe
cerVIcal cancer (ICC) occur annually In .ub-Saharan Africa
and II " rcspon."blc for ooc-qu"rter of all female canee ...
(Parkin et aI, 2008). IC mmicnce In .ub-Saharan AfrICa"
ooc of the h1ghc>'t In the world WIth an estimated overall age-
stanclardlZ£dinCldence rate( R)of31 per 100 000 women
and vancs by regIOn wllh 42. - mEa" Afn a, 38.2 In
Southern Afn a, 28 m Ccmral Africa and 29.3 In We>tcrn
CERVICAL CANCER INCIDENCE
".~
Age-standardized InCidence < 25.1
rate per 100,000
< 29.3
o
HIV prevalence, <r.
fnca (Figure IHhrlayetaf. 2004; Parkin & Bray 20(6). In
contrast, the ASR " 12,1 In orthcm Af n 'a and 11.9 m
Europe (Parkin et al. 2008). However, better cancer
mcrdcnce data are needed to charactcrue the burden of
disease. AI pre sent, only a few populanon-based Cancer
registrje s c xrst In Afrrca , covering II % of the population,
and fewer produce high quality incidence data (Parkin et al.
2008). In the period 1998-2002, only two cancer regrsrnev
In the regron, Kyadondo County In Uganda and Harare In
Zrmbabwc, produced high quality data and reported ASR of
45,8 and 47.3 per 100 000, rcspccrrvely (Cur ado et al. 20071,
It rernams unclear whether the 1 11V epiderm (FIgure II
has affected the mcidcnce of I .C In sub-Saharan Afrx a a,
mcidence rate, appear to have rername d unchanged between
the 1960<. and 1990, a, 'K.'CnIn ",erla and South Afnca or
increasing In Bulawayo, Zimbabwe and Kampala, Uganda
(Parkin et al. 2008). Furthermore, It l, unknown whether
more effective AIDS control mterventlOn., ,uch a, hetter
acce" to antlretr<)vlral treatment (ART) WIll reduce the
mciclcnce of I _C bt'Causc of Immuoc rc IHl,ritU[(On or
mere.", th" inCIdence ...\ a re,uIr of k>ngcr life expectancy
and rotentlal nsk for ru>ea", progre"",,on. It .. prof{' ted
that, Irrt'"!>pcctlVe of changing risk., populanon growth and
ageing, the likely future burden of e!"Vlcal cancer In ,ub-
SaharanAfn'a wlliri.,cruabout 1 18 OOOncwca,es m 2025,
whIch IS a 67% merea", from 2002 ( rla~'el aI, 2004).
HIV PREVALENCE
< 33.6 < 68,6<42.7
o •D •5,; 100,. 2O-2B~.
Fillur~ I Age-sundardi<ed (world) Inciden", ""1'S of "'!"VIeal can er (Feria) J el .1. 2002) and HIV prevalence (UNA IDS, 200 ) In Afrtca.
10,;20%
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Epidemiology of HI'V infection and ICC
Among the 15 high-nsk (HR) oncogenic IIPY genotype>.
that have been Identified, flp 16 and 18, the two
va cine-preventable rypes, show a greater risk of
progres"lOn to pre-cancerous le,iom than other IJR type.
(Khan et al. 2005; Shiffman et al. 200.5). In designmg
effccnvc prevcnuon strategies !-IVY rype-specific data are
therefore essential to esnrnating the impact of Hl'V
vaccine, and cervical cancer screcnmg.
Burden of HPV prevalence and type-distribution in the
general population
ross-secnonnl studses have shown that the overall
prevalence of any !-IPV type m the general population. of
,ub-Saharan Afnca (or women With normal ywlogy"
21.8,}o (HPV Information Centre 2009). The prevalence
of III' type~ 16 and 18 among ICC ca"." range, from
4.).7% on Senegal to 90.2% in Ethiopia (Tahle I)
(I-U' Infurmatlon Centrc 2009). The ovcrall combmed
e'>tirT4nc of HPVI 6/ 18 prevalence am ung I C ca,l"l>
m ,ub-Saharan Africa" 69.2%, wfuch i, cnnsistent
Table I HPVl6118 !,fe"alenre in ea.es of 'n\·•• ive reM',eal canrer
(I • ) from puhl,.hed srucloes ,n sub·Sahar3n AfrICa, accordong to
HIV ua[Us
H1'V16/1S
No. of \ omen Jlre\'aIence,
unLr)' with I tested % (95%0·)
HJV negative women-
Benon 6 66.7 (28.9-100.0)
Gumea 18 44.4 (21.5 7.4)
Edllopta 163 90.2 (85.6-94.8)
eora 261 60.9 (55.0 68)
MOZaJllbique 302 79.1 (74.6 3.7)
Malo 123 S4.5 (45.7 3.3)
Senegal 71 43.7 (32.]-55.2)
South Africa 307 62.9 (57S 8.3)
TalTlanoa 102 72.6 (63.9-81.2)
Uganda JS4 74.0 (67.1-81.0)
Zimbabwe 98 79.6 (71.6-87.6)
oml 1605 69.2 (66.9-71.4)
HIV positive women
Kenyab S1 68.6 (55.9-81.4)
ZambIa' 28 53.6 (35.1-72.0)
Total 79 63.3 (52.7-n.9)
• Estimates from Hrv Infomullon <:em,e, 2009.
hE, ioule from De VuYStet aI., 2008.
'ESli'lUllts from Sahasl2buddhe./ aI., 2007.
• I, cOIIfidcnre inrerval.
WIth the worklwrdc esnmare uf 70°" (III' lniorm.mon
Centre 2009).
Figure 2 !.ho"" the five most common IIR liP\, typc~
among women With normal cyrnl('b'Y, vquarnouv merncpi-
thehal levrnns (Sill and I . In the ~raeral populauon of
sub-Saharan (ncn from n mcra-analys», (14'1> Informn-
tion Centre 2009). The five mm, frcquenr I rPV rypc'
among women With I . accordmg to rankmg order ure
1-Il'V 16, 18,4.5, 33 and 3.5, a drsmbunon which does nm
differ Mgn,f1candy from the worldwide dismbuuon (IIPV
16,18,33,4.5 and 31) (Ill'\' lntonunnon .cmrc2(09). An
ongoing mternanonal survey u~mg J cnrrahred Hl'V
resung and pathology laboratory ro evaluate a ullccnon of
10000 archived cervi al can er U'SlIt' sarnplcv worldwide
confirmed a snnilar divnburon (or the ~uh-. aharan Inca
regron although tlus only m ·Iudcd vampks from three
counrrres, Mozambique, 'gena and l1gand'l dt' ~(lnlo
el 01. 2009).
While I-IT'V prevalen e and type-dmnhutlon have heen
aggrcgpted and ~ummanud for the va\! reg",n of ,uh-
Saharan Afnea, there arc, however, large gap> In [hl~
epldemioluglcal pIcture With vlnually 00 dam uv,lIlnhlc for
Central Afn an countne" and::t pau Iry of ctluntry-'ph.'IX
data m ~umc !.ub-rcglc)rL'. Thc<,t data would ldeall) he
reqUIred tl) hcner understand factors mfluenclng kl ·,,1
epldenuulogy of I nnd t() pred,ct the k,C l,mlXKI of
vacClne~.
Scxua.1 and reprooucti\'C bcha\'iour and risk of liP
infection and cervical cDrcinc~cnc>i~
Early age at firM >cxual Intercour>e ( rSI) und enrl
pregnancy have hcen Ick·ntlhed 0' rISk faew .... for I In
devel()p,ng mumnc, (Luulc el oJl. lO(9). AfSI " an
lin porta nl determinant of ex Jl(hUre to III'\' ,nfecllon lind
pregnancy a, a dererm,nam o( mk for I ., P01rti IIbrl) In
those who are hlghl)' parou> (LOUie rl al. 20()<I). Thl\ "
highly relevam m the Afn an conteJo.1, tn whl h you"tl
women intunrr the", twO C"V nt' at an eMI~ :age Jotl
eJo.1>crlcna- high punty. DUfu on ,'>('Ie.tcd \C ·lIlIl nnd
repnxJul'tJyc health filctnr~ are ,helwn to oble 2 n, prill(
mea;urc, that ould he u',cJ tel II1form lin cerv":tll COflCer
prevcntlclO 'tratcgll" (I.e. npprupruHr nge for III' \·Olll-
natIOn). Medinn Ar. I for garl> ennlle, frum H ICl 20 ca"
and (mal fcrtlbry rnngC, from 1.9 ICl 6.9 In M,h-~nhor.HI
Afnca. ",ndom u "nm often rql(m~d hy 'Olllljl
Afri an women except for non-harner methocj, of 'Clnfra
ccpW)O ( leland et al. 2006). If ltnprmh.'ted 0;('\ "
pral"tlced, unclr umcl7rd m n wllh n hl\lClry I) mulrlrl('
\Cxunl partraer , HI partk.ular, may rnLrca;c till' n,k ,If
cervi al cancer in their female panne[\ (( :tHcll"lI1UI' c·t <11.
2002).
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Normal cytology LSIL
n = 4413 n= 358
16 r 16 J13A52 1.7 18 .958 1.6 58 018 1.6 35 953 1.4 52 9
'"~ 0 10 20 30 40 50 60 0 10 20 30 40 50 60
> HSIL ICCn,
n=335 n= 1605J:
16 16 50.1
33 18 Flgu", 1 The fiH mos: frequem. hlglHI>k
18 45 HPV types amo~ women in the general
31 33
po pula Don with normal C)'tolog)'.
low-grade tnuaepltnelial Ie...om (lSIL).
52 35 high-grade inuaepithehallesion (H 11_1.
and mvasive cervical cancer (I ) in
0 10 20 30 40 50 60 0 10 20 30 40 50 60 sub-Saharan N"ca fHPV Informatim
HPV prevalence. ~o entre, 2009).
The role of HTV infection in the development of cervical
cancer
irh the diverse HI eprdermc in mho. aharan fnca, 'we
must onsider how It may affect Hl'Vvrelaeed cervr al
d1!>C3'i1! and other genital neoplasms. Thrs may greatly vary
by region, smce the estimated number of women bvmg
With HIV ranges from <1000 case, m omoros to 3.2
milhon in • outh Africa (Tahle 2) ( AIDS 2008).
LpldemlOlogtc.,1 s-rudIeS,mostly condu ed In developed
eounule., have shown that I D -Infected women are at
higher mk o( being Infected with HR HI' (Sun et 01.
1997; Ahdieh cf al. 2000; JamIeson ef al. 2002), and arc at
a hIgher risk (or per;"tence and a<Sllcl3ted cervical di,caSl'
prngrc'i.~lCln than HJ -unin(cctL-d women (Mayaud et al.
2001; D,delot-RoLts'iCau t!f al. 2006; M",clckt ef al. 2006;
Paldsky cf aI. 2006; Blos;om ef aI. 2007). TIu, ,uggl"S['\
thm CD4' T-Iymphocytc counts may pL1y a rule In the
natural hIStory of HP mfectlOn. However, HP persl'-
rence and SIL have heen observed In young 1n -positive
women With normal D4' cnums, whICh ,"dicat.es that
Immune fact()r~ other than CD4' counts may playa role In
dISease progrclo-Sinn.Clinical StudIes have shown conthcnng
re 'ult~ WIth .ome favounng HP I"aranee and other,
pe~"tence (Mo>ctda el 01. 2(06). In the AfrICan 'Citing,
h'llh prevalence I)f sexually uansmlfted infectK>ns and
other commumcable disease, may Influence Immune Matu~
In crvlcal carcinogenesIs. hut (ew or no data arc avallahle
tt) clanfy these a_'>!i() latUln.'.
Both H and HP InfectiOn> have VIral (aCt()~, and
thnve Uf) hn't factors that impaIr the Immune system,
wluch n cause conslderahle comorbu:Dty and mortality.
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I IlV-related Immune alteration appc3h to In re: e the r"l-
of cervical disease progression (Srrjcklcr 1'1 01. 2001: II. we'
et al. 20061. However, after annretrovrrnl therapy (ART),
rhr Immune W51cm " able to recover and better nhle to
control HI -;"Ia,.d opporrurusnc mfecnons and OI1\:er,.
vuch a' human herpc' vlru,-S (I II IV-B) and ",,,,,c'atl'd
Kaposr's sarcoma (Ahdteh- .ranr et al. 2004; JJcw)lel 01.
2004; hfford I!I 01. 2(06). It ha, been hYI'<Hhe"lcd rhar
ART has the potennal 10 restore the Immune rcspore
against HP ,redllc~ HP pe ....mt'nce. and ,hould thercf()rt·
be ahle to reduce the occurrence ()f prc<nm:cfOU' le'lOn~
and (avour regrl·\SUlO. Some 'lUdtc, have ~hown a hene-
hClal df«t of AR In European (Ileard CI 01_ I 9 ) ltnd U~
cohorrs (Ahdleh- ,ranr et 01.20(4). I[uwI'ver, ofhen.rudtc\
have nut found the same henefks o( AR on regresMon of
IcslOns (Orlando I!t 01. 19 9; Lilln et 01.2001; Moore 1'( 411.
2002; human C!t 01. 2003; Olfford C!t al. 200.5), In n
pooled analYSISo( dnta from ~IX[umpenn centre' where
wumen had a ccs.' IU RT and one commurury-huo,cd
ourh A(rican cohort of In -pmmvt women WIth no
a ~ (() ART, Mmilar ha1..1rd milo; for dev loping high
grade cervical d,l>Cao,cwere oho,crved III the uropean
centre<>and mouth Afnca (Kltcbcncr 1'1 411. 20071. r\nllln~
the"" conflicting dnta, .1c()nscn.u, on the effcc't, of R ,
and on how [() he,r mnnnile and prevent crvl~,,1 clIneer m
HIV-posinve women. remain' ro he found.
The rapId exten."on of ae<:c" to anllrt:trm'lral pro
gramme, m .ul>-. aharan frica, With Its more Intcn>l"C
and ()rganlzed follow-up offer, Ihe opportllOlry to !\\'C"
the effects o( ART on cervlc,,1 d''oCa~c. 0 mform pIMlhle
I> rcening Mrategles. IIPV lIl(e~tlOn .h()uld I>r evaluated at
van()u, '[,~!les of IIIV d,sease. such as ,n women who do
020(9
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Normal cytology LSIL
0=489 0.222
16
'"
1S 15.3
58 7.4 18
31 .8
35 .8
52 .8
~
I I I I0 10 20 30 40 50 20 40 50 60
> HSIL
9: 0= 67
16 29.G 16 0.2
FIll" re 1 The five mo I f qlltnt high II 18 52
HI'\' type!! anlong HlV 1'0 ime women 52 18
wilh lIiltf1ul cytology, low gr de 58 35Intnepirhth.II~lon (I. 11.),hljlh-gr.dr
imraepirheh.1 1~lOn. (HSrL), and inva IV 51 58
eru:al Anctr (I ' ,) in uh S,.haran Africa
I .hfford et .1.,2006; ,aha rabuddhe tl .I~ 0 10 20 30 40 50 60 0 10 20 30 40 50 60
200? dt Vuy r et .I~2008). HPV prGValonoa, "-
O~ ""''''' P\bolwla ltd 1293
nor yet require ART, 10 women mmanng ART, or 10
women With kmg-tcrrn UM' of ART. This will nor onl), help
shed hglu on the c(f~'CCJ.of different level. of I nv
rrnmunosuppressmn On the temporal development (If pre·
neoplasoc change>, hut It Will 31>()help dartfy the porenual
,u'it.IIl,1hlc gains 11\ prevennng cervical cancer with ann-
retrovrral therapy.
HP'V prevalence and gcnorype-disrriburicn in HI positive
women
how studrcs have reported on rhe prevalence of HPV
among HIV-po"uve women 10 SSA. Among the avaslnhle
data Figure ~ sho_ the five most common liR-l-!PV types
among HtV-ponnve women with normal cyrulugy and SIL
fmm a mcta-analym (lIP Information Centre 20(9) and
twO I ~'tudle, ,n Kenya and rhe Zamilia (Saha\rahuddhe
et al. 2007; Dc Vuy" et al. 2008). w \'tudll'l> have
Included I, coses With tW type-~pcclfic dota according
tel In 'erO,taru, In the region (Tahle I). One ,tuuy III
"cnya (n = 204) found no \lgtllhcom d,(ference'> In IIP\I
16/18 prevalence dl'itrihutlon according to HI \CrOSlatu.
(Dc \luY\le/al. 2008). HIV-pl\ltlve women wIth I ,have
more multiple it1(ccnOIl_, than III IIlV-negotlvc women,
which complicates the HI) IYpe d"rnhutl()n c()mJlnrtson
hy r "" ~talU' (Pc Vur.-t et al. 20(8). Ahuu( .50°;, o(
IIN·p)~ItIVC women with I IPVI6 and/or 1S I, case> ore
c()-lIlfectcd With another 1-1 V tyre, \I' II "unclear wherher
(he other HR type, would he I'I.-.poo.lhlc (or anva\lVc
d,..cnM' In rh~ nhllClice of I £1''10'16or II! (I Hr.-t ~I al.
200S). Th<-.c dnw 'ugge'l ,hnt ("rrene HI'V V" une,
conmmmg HJ> Ihll h.IVC the potennnl to prevent
perhaps fewer I , ase among Hl v-posmve women. It
would he unportnnr (() understand the poteuual d,(fcrcmC'>
between III -posmvc and negnuvev With ndwtlllll,.1
Immune correlated dnta urnong III\'-p>"u\'e" ,uth ,"
4' ount,
Cervical cancer screening
eywlng) screenmg programme, have been "l><.~e<.,ful In
curbing the mcrdcrxe o( I , . III dc\cI()ped counrncs
(Snnkurnnnrnynnnn 1'/ oi, 20()J), hUI they hnve lorgely
failed 10 010.1 developmg courunes due I() cornpeung
health pnonnes and lack nf rc\(IIIl'C~' mcludmg henlth
mlrastructurr (rr.uoed ..ytotC1.nnolnW,h, lnboraronev .",J
service (or dlallJlo". and rrearrnenr}, nW'Ilan and finarH:ml
rc.,ourCC'> (D~nn . 1'/0/. _(l()I». i\ wrdlllg to POJllILlIIon-
haM'd ~urvcy" conducred hy II an 200t !lnu 1002,
cervI 01" f'«tlIng uver41c wn .. at ne., 20.2°" of urh.ln
nnd 14.0°" of rural nreo' In the Lnngo, and lit" n ....r, 1.6'\,
()f urhan and 0.4°" ot rural area' III £Inmpla (WH ) 20(2)
(Tahle 2). South Afrl II "Inc only country Itl \uh-~nhar,ln
Inca to have l ... t.1hh,hcd .1 nallon.a! ') mloll -n....e<1
cervi al \I; ....'Cmng progrnmme an 200t. I t"wever, «()\'t'rage
remaan, p>or nnd the Imp.1C( on I( . rate, ... unknown
("aw()ngo &: Fmm 200 ).
VIA {vl'ual in'pe~'flon with (I'co, Kl) tlr VlU (v...un!
Iml'tXlIIHI With 1.111101\ Hldmc) nrc Ie" lohul'llj()t) o.-pcn
dent "m,,'IlIC' lOU hllve been IIdvocnlcd 0' -.:rccrung
altcrnnnvc, III develop"'g ~()untnr' (I nil) "1.1/. 2()O,,). III
\ r~IIl' eva lUlllion ,rudie" VI Iw .. ,hr",m hi hOI ~ II
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M:n~ltlvlty and 'pcClhclt)' of 60-94')" and 74-94%.
respecuvely, to detect high-grade blOru. m Africa; and
VILI ha, shown til have a senvmvuy and spe IhcllY of 90-
97% and 73-91 ')., re specnvely Sankaranarayanan et <11.
200 I). The ,peClhc;ty of VIA l.. however lower among
HI -pO~IDVCwomen. which may he armbured to hrgh
rate .. of coinfecnons 10 the lower general tra (Denny et al.
20(2). A number of completed and ongomg screening
acnvmcs u"ng VlA and VlLI have been evaluated a..
dlHcrcnt \untcll'e\ 10 the region (Table .i) (IAR Screen 109
,rour 2009). Among 20 c()untrlc~ reporting <;CfCenmg
aCtIVltlc .... 11 countrie~ have ongllIrtg programme,. Of the
49 proJcCt~ that have heen Imoated, 27 PCUJt'Ct>arc
ongoing, hut only \IX projct"t were funded h)' the Mml\try
o( Ilcallh 10 the country. MOM "rl'enong programme. In
,uh-Sah.1ran AfrICa have been mitmed "" rc~e:trch or pllm
pruJl'Ct\ (811%). and only a "mlted number of counlne,
(n = 61 have received fin:lOclal "uPP0rt or ha"" the local
pohu 31 .uppon Ul >lalc up ",,[lonal "rcclllng pro-
grnmme ...
While v"ual III-"pc~u(m method, appear dfCtUYC 1M
pnmary .creemng, they are ~oll prone (() ..uhJecnvIIY.
requIring good provider tmonong and ,ustlltOed quality
o .....urancc In order (() aducve ~uhMantml gnlll~ 10 preven·
tKln of cervI 31 cancer 10 routine \Cttlng" (. ankaranara a-
nan cf af. 2007; Muwooge <'I af. 2009).
A more ohJeCtlve and reproduclhle "rcenmg [e ...t I'>
tCMlng or IIPV DNA that ha ~h()wn to be more
«'mlllVC rh.1n crYlcnl cyto~lgy 10 deteCtlnll hIgh-grade
le\loru. ( Pra KC Bulletm 200); Dillner I'f <11.
2(08). A "rcmlOg rnal tl"nll IIP\I te ..lIng for 6) .l
un rttned women (H-6.~ year.) III South frlca ..ho~d
an 80% reductHlO uf ON2+ hy 36 mllnth, of follow-up
among I rN-lIIfccted women. which wn .. ~Imllnr ro the
reduCtIOn nmong HIV-uOlnfectcd women (I...uhn ('I al.
2(09). In adchllon. It dlMcr-rnndomlud trial of ubour
1.32 om women (.10-. 9 year» 111 rural Indta ..howed thor
n ...nllie round of III' () A te"lng \lIlOlhcnntly rt'dlk.ed
[he mtc of ndvnoced "nil!!' of crvlc ..l ancer> und
n~so lared clcarh., ompared fCl IA. yml(lf!)' and nn
.....reemng after 8 )lcaf'> of follow-up (SJrlknran.1I'aY,1n.ln
el 01. 2009). he\C ,ludIC:'. ,uIUle>l th.1I Ill' It"lIng 1\ ,m
npproprtUlc primary \Crcelllllg approach to l(lw re'ollr,c
>Cltlllg, tc) reduce ca,!!' uf high grade Ie>Kln•• adl'ilTk. d
..talle o( I and murrnhty to III -mfe 'led und 1I00n-
(ated wOlllen.
Rapid Ill' D!'lA Icslillll
The hn1llatlUl,' of III' f) A tl'\ttng IIldudc the\: I" (I.e.
llS 20-.~0 per t('\I). IIIfril,tru urt. nnd om nCt'tlrd to
obtaIn a mult. Ilowcvcr Card tI'\! ( IOl;cn ;3" her>hurl:
129-4
\~)llIMI '4 1\11 10 "I' 118- 1101 ex roar M l.OO~
Inc .• MD. U~A) hJ~ h(,(11 developed u, II sunplc, r,lpld und
opcrauonal I Il' V te ..r lor In resource >C!UIIJ.."> thai can
produce re..ull\ wuhrn 1 h ( lao 1'1 "f. 200N). The
ompact , portable aoel h.tl!cr~ operated Ic~hnology hu ..
vrahle .ondmon, ... and the re" can he conducted by worker>
wuh rmmmal trauung, Data from (Juno ..howcd that,
compared to VI , .artllP h.,\ n hlilher \t'n,llmt (90°"
us. 41%) and n rcasonnhly comparable "plXllkllY (84'l ••N.
94°0) to det t high-grade le"on,. Moreover, n model"n!;
anal)", found that .arel ll' hn' the porcnunl to re du e
the In lden'(' of ~ervl .11 :tnur h ,60., on .hlnn If wvrn
lU>! three lime mer n wuman\ hfetlme and C((IX'IVC
rreatment 1\ aV;lIlahlc (U-VIO 1'1 011. 200 I. '~C,Ufl)l Il\
putential Impact In redUCing the hurden of I ItI
,ornparnhle '>('1f1l11:'" Regulatory nprroval" unuClpatrd III
developl"1; C(luntflC In rhe near future. and thl te,t Will he
pNlVlJcd al u In o<;()',l. 'nrclll)\! rcprc '1Il~ II proml\lIlg
alrcmauvc, reenlllSl te>t. however. "' performance and
dlUgn<IMk. vuluc II> Octat pre n,cruu, IC\lom IlCCJ !II hc
cv:1lun[cd In African ..etun!t>.
E(fl'("i\,c rl'ienl \(,T cninlt progrnmmh
Apan from affordahle. n cptohlc und efll--.II\ ....rccll'"g
Will,. the pcrfnrmana III n reroong pl'f'llramm ...
dependent (m multiple fuctllr, ... u..h .l\ 1Il10rnllHlon unu
educotlon fur W(lmen ~nd CllmrnuOlUC' In order !II ohl,lIn
their partl~lpnuon ITIll) ...:=0I01l pmgrJlI1me,. Iter
recnlng. a' ('ptohlr und .. 'C'"ihlr rd rr~1 \('I'\'ll'C' 1m
dlOI;IIO'>'" and rH ~tI~C tr ;lUll!'nt •. 111 II;IX.d 'ullo,,-ur nrt'
rc 11IIrcd for n ..tk:l "ful pnlj;ramn (,fn"ln rf al. 20 IS).
At pre\l·nt. tlu, m.l~ In~()h (I thlt'c-YI II ..tl'il!CSY nh
IOluol, recnlfl)l cv,lluuunn or the fir,t ."'11, pcrfnmlllll;
(olp("<:(lp) for thn wh() r«n PC>WI\C ,It the "'(on I
'11'>11. ,lI1d treatml: hNlp" nntinnl'd u·rvlC.lllc,wn .. ot the
third 1'1\11. In order III (1\ Old l()~ .tIl-follow-lIp. n \(rtrn
and-tfCat' nppro.l·1I ,huuld he l(m'IOcr U. "hcl'<' rrl..-r-
ral/tfC,lrmC'nt I nHcrtd Imme 10.111·1 til "l'fi'n-ptl\lUv ,
(.be'> Irh n l't'oul:eu numh r of dlll"ul \I\It.. (1~I"mcnthlll
t!I al. 100'?). A 'I) t-efllX!I\ modrl for II r OCI II plllj.:
UlIntfiC hl~h lI1'IOOco !'uuth IrK,1 ,h(l\It."u 1h.1I
."reenlll' IIh (lnc VISit !lr I" , VI\II' Ifl II hit-nnw lhtfl)l
vl\ul\lln~pc- nun or III'\' 1 A te .., ~(llIpl('u "Irh IIl1l11eol
,lie cry()(her.lp~ for 'rectted PlhIUV(' .. for wOl11en IIscd
1 ~ YCM' Ill' nlck-r 1111\ rhe 1'01(,1111.1110 r('lIli ( rhe hlt-nllll"
rt,k ul <..11'" rlt _ l. ....I.UIl1P.Irt'o ""h nu 'I'fi'IIUII;
( ,oldie rf ,11. 10() ~). In 'lIh-"nh.]f,ltI Irl .1. \ hcrt' 1111111111[11
<.('rl·I\:,1I 'M.rl'tllltlil ,crvl C\ 01'1:ol.lIl.thlc. th" Illl('(' III n
""'lime ,.!'ten-and rrtJI ,rl',I1(,!;), m.] h.1H· ,In Ifl1pUt'l III
Hnp..I~1 ITI rl'dllllllj; tht' It1<.Id ru' 01 I' all.! tlrr~h fII he
('valu3ted 11l~,111 to dC'u'rmlllt' wherher It I II •...tl~.III)
I~a"hl , a', pt"hl .Intl \olle.
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I'ro.pct"t., of HI' vaccination; oppertunities and
chall cll!Je>
Prophylucu(III'V VII"'IIIe\ ~IVCnew ptlllnJ>I"' lor .1
pnrnarj prrvwlIo/l 'Ir.ll~y for HI>\' ",I",,"on .rrId
cervical cancer. The vr Cllle' have shown h!gh "I(tIY,
effi ocy and ImmunogcOIclty for hoeh !he quadnvalem
HI' 16/1Rl6/11 vnccme ( .~rdn\ll , 'lad &: n.. lnc.I
and the bivalent I II' 16/18 V,lcelnr (C.('rVllrl~'''',
,laxnSm'lhldm. 8101''11,(;,,1,) (Schiller ~r "I. 2(08).
number of .ounrne-, 10 sub-' rhar.in Afr"'" h.lvr
hcenscd rhe III' vac me (Table 41. l lowe ver,
Implementation plans nrc lagging and will depend largely
on the afford.lhtlll)' of the vnccmes, and n clear cnsr
henefil rnuo. e further dl ....u.... sorn of ihe "hlll"'"gc'
thai Will he met prior ro 101roducr ~)n of the III) VOCt 10.'
III vuh-' aharun Inca,
accine efficacy .... (eIY nnd immuniulion scbedules
liP 'Rl:CII1C\ hn'" shown <lS~" effie",,} III rrr> nllog
\ nccme III' Iype, and related pr ec. I11<.'('ro", le\ltln, for lip
10 7 years In large IlIIcmauonol cnhon. 01 wumen,
.1hh()~h ouuccal>i)', e"'dudmll Alma (~hlllrr 1'1 ul, 2()OS).
Ilowever. ""felY and ImmunogtOl II) hmlj;Htg ,n.dlc' arr
currenrl), hculg conducled 10 'Clung I IIV nCI\.lmr ,,~)m('n
10 Stnellol and TaNonlA ( Imcon flol.~m
T.ble. HI ''I ell hcen ure ,n h '>ah'l'Iln AI,,,, •• a III
larch 200Q
80"","n.
lIurk,n. Fa 0
u.mtrOtln
A:lltr.1 Af"un r~ruh",·
b.d
.ool\<l
(ltcd'l\olrt
Dem 0.:1111i Re""h« of ~ngll
F.qualor",1 C.UIIltl
blhlOp ..
•• Ixw,
Kenya
M.t.w,
hur,tolll.
1.'UrifIU
South Alnca
T''I!<I
IJg<lnda
(01\10
<If d'lvOir
( •• 1\)0
,han.
J..t1,ya
"'_fIIlhlO
Iller..
\ruellAl
"',ulh Air",.
UII·n
• ,uI\:e HPV InfntlnJl'"1l "IIU~,200'1
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cr0048 1767), In addinon, these mldle, WIll Jnve'1:Jgulc
the effecr uf the vaccmes In populations whose rmrnuno-
log) al ,)MCm may be challenged by multiple co-mfecnons
such as malana and helrrunth •• which 01") p"'''lbly nl(xhf)
immune response (Lehnncn et al, 2006). Un III recenrly,
there were no data on Ill'V vaccination among rho-e
mfecred With H1V, Chrucal rrinls arc underway m H
posurve women In South fncn ( hrucafl'nal.gov
NcrOOSl!6.339) and results arc eagerly awaited fmm Ih"
endemic regu;n. In addltlun. ImtL11 re,ult, from [I quad·
rivalent VacClI'lI!tml of 126 pcrmatally infecred Inv·
,"fl"Clcd children (7-12 yea .. ) In Nmth AmerICa hal'e
,hown rhm the vac inc 1\ generally ..afc nnd nearl)' 100°"
\Croconvcrrcd although antlhudy tltr~ for HPV 16 and 18
were 10""" than m henlthy children (M(»cl kl t!1 ai, 2009).
In order [[) e,'aluntc the pmentHiI reduCtiC,", m CO,!>, .1
mulll·centr(' study ,"v(JlvIng abour 1 (, 000 girl, aged
10-1 S year~ 10 .valuau thr cffcctlvcnc", nnd \.1(cry of
two· ~'S. three·doM" lIP vae IIlC III preventing u:rvlClIl
cancer" underway ( ankaranarayanJn l!( <11. 2(08) Jnd
tria" of gIVIng IIPV vaccme, In hahl'" a' part of til('
,taodard Infanl ImmuruzatKm "hedllic arc hemg d,,·
u"'>I'd ( ,arlallCll!l ,II. 200N). Rc..ub, from the\(' ,tudle,
nlay fnCllltnlt a Wider rollout nf I rpv "o(un~ III
,uh·Saharnn Afnca.
Vaccine delivery chnlleng~
The nduprKm (If the va (lIle" mto n national munulllW
lIun programme will only he rea hied when the lIP
va ane drop," price ond the hec,,",c P.1rt of lhe
C\M!ntlol WIIO Lxpnnded Ilrnj.lrnm CItInUI1unl7ntlUn (LPI)
vaccine'> ("-nne ~I al. _(06), r PI programm", have h«n
.ucce"flll In Improving ncc" .....and delivery of "OC':II1("
to children and achieVing high ov"r:lge worldwide, In
2()()7, V3CC1I'Iatloncoverage of the wlllel popubllon for
DTP for the thml dme wa .. a' 10\\ a' ll·" In r.ql~1[()nnl
,UIO(m to 99"" III Burkma I'a,o (TahIr 2). Infm\tr\Kturt'
of trained 'taff, wId cham and logl\II", hnll' and
outreach ,erVlce' and Iflforrnfltlon ,)"rcm, ar~ olt'l'ad~
e.ronh,bed f() dehver tht'>c mhnt v Cine" Ilnwt·~r.
even If thl' VOCC,""15 '" nrpotnlcd onto rhe I PI lI,t. Ihert'
till remaim the ch.~lIcngl' of dehvcnnll un 'adol \Ceor'
"aee:mc >lnee: on programme cx"t!> I,'rgellog Ihl\
populntlon. In ordcr 1<1 he h,ghly cffi a~ltllI\, V( ',10""
;hould DC' delivered pnor 10 \('xual mlllallnn wben n,k
of C p()~lIre ro liP IIIcrea\C~,
urrerJI v, Cine, trlq~et pre'adnlc,cenl und younll
women, and d.-vcioplnll 0 ,cbool·h.1.,cd progntrnmr with
th" wrgt'l populatIon Will he h.1I1enKIn):, n.. few continue
their condnry "hool cducotlon heyond pntllnry ....hool.
et "huol enrolment In prllnJry lxlol r.lIlgc, Irorn a, In"
"-' 11·0 In 1)I,I"'lulI ttl I)~."In 1'"n7anll) (To "'e 2). I ven If
the vue lI1e re to he c()mldered at the prlm,lry school
level, !ht)'" who 1I~"Cdthe '.Into the n"'\1 mu) he Ie"
Itkdy w .irrend ....hool (tunc ct aI. 10(6) J, ",,:-u.,1 activity
umnng ndole .. :1'11{' m our-of ....hool frll1ltlc, ., conunon
(Brown ~I at, 2001). Howe,cr, mr."ln .campaIgn' 111 fn~"
u trig ,chool .. u, VJC,ln"IWHl .,lIe" [I) ],rlllg non-school
utlend.-e, 1tI1h.· vnccmaunn 'lie h.1\ been reponed and 1\ .1
,trategy thnr could he explored fm liP\' "'KCIIlt" ("nnr
1'1,./.2006).
Local ~ornmunluc~ w.1I ,...-cd IU Ii"r ,dentlfy (.1<ttl " 1h.1l
Inllllen r v:t«lIlr J <.tptllh.llt~ and upL.ILc llmOt11!ta!,);et
populoutHl' nnd healthc.1rt' prundc". and then dc.'<:lueIhe
IOU" appl'tlpn3r~ w ••)' for tn (inC' deploymcnl. lor c .Im·
pic, P Til, nn IOI(~mallonnl (,0 ",hllh hllllo,c .. nil
reprndu<flve bealth tnca"'h. ha., ~lIndu<.ted lorll1.HI\C'
r(\Carch 10 lJgand til cvnlllotc tbe Jl'vl.hm~lClUl n'pe<:t' of
'""m~n c:cplu],lhty und IU untir"land beaJrh ,y"cm,
that are reljUlred to 1:!1I1<1~ eHe(me "au.lnr dehvery
'trUlegIC,. wmmunl allon and .ld" ...a.:y (I' Tlll0()9).
ThI- r.;ul" frol1l Ihl\ ",,,,a«h are h~III' lhCJ 10 r~plnr<'
twll pn,\slhlr Va((lmllOn Imple-mental KIll .,tralCJ;'C"
(.) '( hlld D.I' Phl" 1\ 0 \('nll·onnl~11 <'Will Ihal .1Irn, III
\'(I"ln3tr l.hlldren 0, pllrt (If an 1Il1t'gr:ltrd heulth ....rvKr
proj.lrammt';.nd (II) ...:hn"l]'u'oCd \J' 'mallOn pr,,!:r mm~
IlIldll1g'> from IhI' dCtI1()J1\!ru!lon projecl IIrc cxpCCted m
2010.
t 1I~ 3M) lur Ihe' fhrec-citl'>e 111'\' nl~me, u 1\ the mn"
e~pen\lvr vnCClrl<'ItI ""fUry. Th" " ,hl!Xult rn O«CPI 'I'
H()~., "I en ,01 (rv,,:ol r=r ()(~llr '" de,dupm'
Ollntrl(' (I'nrkm &: 11(\1),2()()6\. whrrt' hl-ulrh budKrr.. nrr
, ry hl1l1lrd. In (,rdcr l(l O\crl.ome L()\t h:,rncr •• "'()r~ I
helll): dUlle It) In(lll[,nr II1no,nuv hr~lnL~ll rnc.'<:h.lo"nI UI
'I<. C'lrralc rhl- mrrnJIk.flUn (If ''fI<<lII('" "k.h I" IlIhlHk.nl
mar).,rt LOmI11HI11I·nr,.",hl ..h prm IOC'>on 'l"lIr('(1 pro.
\uh\lJ Inr tit-vrinplllj; ..num!) PltrLh..I'It· .. I ,I fUlllrr
\lU '<Int· merltng preddlflrd ,rllndl\r,[, aod III rMl\ldl'
Indu'fry with ,,"r,ln 'e, oj r.lmm' .1 n-o,ono"lr t'l'fllm <In
thcl( HlVl"rrnrrll, nOlh"'r \olmmfl wClultf ],c puhl".
pnhll pJrtne"hlp'. whKh Will "'Iu", hllth lbe puhll orld
p"valr to" I() h.m' Ih m~ and 1.. 1' (II dc\ klplflj.l.
....uht1ll·up fil1d Il1trndui.mg PrH1rlty, .-lIIr' (lIur"lI1 ,'1.1/,
20(6). In .WO • Ihe I I IIl1ln t .1 puhlk. ·pm'lItf
ll!,);onll.lf1()[1 d ..uk.all·d ff) 11lI;n-O\lI1K h,ld","\" ·.r" rn
,';J( me III dncl()l'lt1IIlollntrl~' hll' 111.111 ..... 41 thr III'V
VilC~II)t .lrnlOnW'1 II l'w)nl (If fII.' ,1,~1I1(" to Ix
00 tdrred for IOctodlk;lIon II \uh\ldu I h) th.· (,1\ \'1
limO<. , thr .Ulune ... lIIJ reJ<h uwr SU"" IIf rhr
<(lUllln~' In uh·~Jh.tr,1I1 I\tn ',I.
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An economic analysis evaluanng the rrnpa of vaccmu-
rjon in .A VI chgihle counmes showed that with 70°0
coverage of pre-adolescents, liT'V va CInC> have the
potenr ia] ro reduce the hfenrne n,k of crvjcal cancer by
31-60°/.:. In the region (Goldie et al. 2.008). l lyporbcn ally,
if the OSf ro vaccinate a gltl was U S2 per dose, the
vac me would be cost-effective compared ttl no vaccmn-
uon m all sub-Saharan Afncan counrncs and 11 would be
co-a- ..aving and less than mternnriona] dollars lSI 00 per
dMhlhty-adju;red yea" of hfe (DAL' ,) averted In a lew
CClWltrIC', e.g. rmoros, -umea , Lesotho, Zmlhabwe.
Rwanda, "'mrca, Ugand1 and DJlhOlRl. Ilowever, en h
country willllced to conduct It, own CC(II10lnll analy,e, to
evaluate their budgets for introduction o( the I TPV va l,ne
among ocher new hlldhood vacclOC' (I.e, rotaVIfU~,
pncumoc()cccal. merungococcal mcrungItH.) bemg consld·
credo It I~ mil unknown whether On<:hfetlme cervi 31
"rcenlOg and trcn1l11em may he more c(l\t-dfective th.1n
I fPV vaccinatIOn m preventing cervlcnl ancer death. 10
en h of these ,uh-, nhar;}n Afnean countnc,. runher
I.'ValUnll()n of a number of srraIt-goe, con"ldcrm!; \.1 'cmn-
tK)n and "recnlOll only or 10 omhmaunn will ~I!.() he
needed to In(orm the mrm approprlatc c()M~ffe tlvcne ....
prevcnuon Stralegy,
ummary of gop, in knowledge
In order to 'Ircnl,'fhen the dfort .. (If en'leal can 't>r
pr"vcntilln 10 ,uh·Saharan (rll.a, we highlight IN- '01·
lOWing !;a", In knowledge:
LplciemK,logy:
Bener UltlCCr reglMry dala to u!>.,e", tN- hurd n 01
cervICal cancer;
1I.1,Ic epldemlolugl .11 d11U elf III' prrvalence nnd
gcnmype.<f~trlhutl()n among women 10 the !;encral
populatwn, <>rdln!; to lIN \Crml:ltU, m cmlume
die pOlentlallmpnCI of IIJlV vucunc .. and cerVIcal
cane.:r '>Cfl'Cmng ..tralcglc.,;
• Longlluchnnl data on III IOfe 'Ied women til e".1ll~IIC
the Impact of RT on HPV Infectl()n and ccrvlcul
(hscn~;
Long-term Impa I of III' va In(\ 10 pre ""ntlog
uC'flL11 cU>rS o( crvlcnl anccr,
rvu:al scn-enlng:
Lvnluouon III IA. III HI conjunction Willi liP\,
lemng (c,Il, With .lU'cllP ) n .. "':1'I.'Cnll~ tollb III .1
'"reen·nnd-trcar' nppl'<~llh;
l'voluouon of \(fl-enmg ..rnm'gle, 10 III -p'Nm'e
population,. mduthfllllh()\(' roklng RT,
1300
liP vaccme dehverv:
• • xme trl3l, In mfant' fl) cv.rluut the poienrul
InduMon d' part of .m [PI standard rmmunv lion
schedule;
• .me deployment (on"dermlO"": (I) cornrnunuj
ncceptnbrhry; (II) healrh , srem Jp;!Clt~ and ,h,IOn<:I\
of vnccme dehver ; (III) V.I cmarion "ratcglc'.lnclud·
109appropnare uge nnd sex, and cJrlh-up ~[r.l[e~IC ,
(iv) health economr nd Imp.let rnodcllmg;
.0 ..10('(1«0 ene .... ,rudl'" 01 "O<:(lIlI' flrKl/"r cervicnl
"rcerunl! Mfnlcgle,;
nmparallve lIl1olly,..' ()llervK.d ~I't'en"'g IInJ/nr
v.lL:(inotlOn ,rr:ltcglt" on ""ea'M' Ifill' •. [,
Conclusions
he burden of cm ai, n cr ... porcnnall)' brge 10 ~u"-
. aharan fncn nnd there ... on urgrn )' I() make II n puhll<
health pnumy, SuO- oharan fnca I" vUMI)' hClenljtCnt'Oll'
and ench Ulllnrf} will need tn de.. Ide on n I't'Jh,rlCflll
(cn'lhl(' ((rv!Cal aoerr prcvcnllon nnd wnrrul "rareg ,
LXl..rmg d1ta ..huuld he u<;fd ro mltmlt pL.II1' nnd pl'<llrr ..
In hertl'r IInder'tnnd lhe UITC'nt 'Iwuunn nnd prll!;r,lmmc,
Will need In take tnW comldcrunon the Impn<.t ()f III
cO'In(ectlon to nclequ.'lei nddre" horh he,llth I'I<'<'d" The
avnllublhr~ of 1(I\~·u, ... lcrVll.:al "recmng technologic, of
IIPV te,nnll and "1",,11 ""PCCIKlO melhod, ~nJ III)\'
VI1lxmC' repn:'elll lIlol, Ihm rrovlde re,llt'tll nrptlrtlUUIlt'
(or ({'rvlCol cnllltr pre>t'l1l1()n 10'll" ~nhnrnn Alrll'lI. I"
order !() \l1C (' ...,Iull) mrmdu<.t. Implemtnt nn I 'ml,lIn n
prevenrll)n rN))trnrnm • good d,110 Irtlm n '1'<'," multi·
dl Iplme .. ded" rcd [() rhe prevention of cnlcal canter
nrc nteded,
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Early age at first sexual intercourse and early pregnancy are risk
factors for cervical cancer in developing countries
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Early age at first sexual interc~ (Arsl) has long been assodared with an incrt!a~ ri of '!lII3S",e ct'Mr~ rNl'noma (ICC), Alle 11"
first pregnancy (NP) and ICC hiM! been ,nveStlgat."j less. althour,h ArSI and AI P are strongly n~atNl In most d ...... iop,ng
coum,ries, A pooled analysis of case comral studies on ICC (rom eii1lt developing countnes Wlfh 1861 cases and I 719 controls
investigated the roles of NSI, AI p, and ICC risk, Age at first sexual ntercou~ AI P and age at first ma'na~ (AI M) were t.f,hIy
interrelated and had similar ICC risk estimates. Compared w~h women wnh ArSI 21 yen the odds rane (OR) of ICC wa> 1,80
(95%CI: I.SO 239) among women with AISI I 7-20ye.11S and 231 (95\\.G I.~ 2.8l)forAISI 16 years (P,o'end <0.001),
No statistical interaction was detected between ArSI and any established Ii fll:to for ICC The ICC ri was 2,1.fold among those
who report."j ArSI and Ar Pat .. 16 years compared w~h those v.ith AI SI and ArP at 21 ye.n. 1 hese Ita conimo Arsl and AI S
as risk (actOB for ICC in eight developing countries. but any rodependem elrecu o( these two <!Vents cood not b dst'"p,ullhed
Bnostl Journal c{ Co=r (2009) 100, 1191 I 197, do, I o.I038/~,bjc,66<H974 W\YN,l:jcarar.rom
Ptblished online 10 March 1J)(:fl
C 2009 Cancl!!r ReseArch UK
Keywords: cerviGli leer: irst sex "ntercourse: pf'ql
Earl)' "S' ot fir$t sexual Inler Ourse C AF51) hus h~n assoclatoo
Wllh an In reased risk of high-risk hum.1n papdlOOlLtVlrus (1f1)V)
infection, a sexually t!'llnsmiued infection (51'IS), that III
susceptible women .s responsible for vIrtually an cose. of IOVOSOVO
crvi aI llIl,er (ICC) (Ilo.«h rI ai, 2002), A. !iCxulIl ".hnvlour
dotermon ... exposure to II PV, A PSI IS o( PoUt, "Iar "lIcrest •• It h".
been. 90 i.ted ,,;Ih ri k.er s('J(ual I>ol.,v,oor, ud, as haVIng
ullprtllectoo sex, h.vlOS mulopl. sexual ""rtnero, .. well .. 0
wO!lllln'. pnrtnCl having multIple partnel'>, It loa. al,o bl~"
spe ulated that the increasoo r1S' of II PV " bec.use of. blolo~":1l1
predisposition of the immature ervlx durinf.: adoie tn thai rna)'
b~ IIwe S1L,cep!lblo! tn pe'$i.tent III'V h,l tlnn. "lid therefnr
have a greatC':r fisk of cancer development (Kjner ,., Ill. 199M).
A IIwnber of studies have idelltified an tncrl'1l'ed mk of hlllh.!tJlld~
leslonfl and/or cervical cane r with tarly AI'S1. wherel.l~ others huve
1I0t (tAil ,2007), I lo,,~ver, many of dlese $Iutlle. were mciucted
b,,'(oR' IIPV Ilsses~ncnl WWOfeasible. and thcrt.·(ore, UIl' USSocillhOIl
r moins inwnclusive, Agc., rU'st n",rr,"go (AI'M) IS often u>Cd as "
'Cotl'espondence: KS I.oUIe, Un'l of Infect.ons and uncer, Can,.,
I:pldemlOlogy Researcll Program. In5t~ut QllaU d'On oIog ... AYCta.c..."
V" sin Km 27, Hosp~ let de Uctlt'eg3t. Barcelona 80907, Spain,
L~n'''I: kiouoe@colCololl'lne,
ReeeOl@d 22 lanu,,)' 2009: rev'sed I 1""UdO)' 2009: ac pt 16
Iebruary 009: puill,shed onl,ne 10 March 2009
proxy III " lIt for AI I, alld tho \\110 ollRi18 In tany uI.1
Inter ouI'$,' mal' .bo ,oll."""."dy bl.'\omt [""Itnant ut an cifly I@ ,
lle';des <orly AI'SI. early childl>o.,u,~ 10.., .Iso II, ... , litlked '" • n k
(lICtor fM .. rv",oJ CIlrclllOl\en "nnd attrlbut,'11 to II '~Il I
tr"Ulna txJlcrirn td d\lrin~ tarty e lI.l first p"1t'UUl I (Ail'). or
suh t\lutntly, ~y h'gh 1'''''1)' ~Inl" OAR ~ 2(07),11>0 Inttfl'rOl.tlon
of th tnh.nI~m. by whlth thue atlcuill .,,,' rrp"'<Io tlve C'wnt
(1(, umng c.r~' .n hfe nughl .rr, t ICC 'Ilk tI'I< or 111<'1\' d.,,,,,
1.l<r " not Itr"j\htfo,,,,,n1, n,e obi to", 01 tI... study .. to further
char ... , r.. ond prov"le rooWlI .... unlHC. ,,' d, <Ill or , rvl 81
'8"C"" lind II> OI.ou&llOn wltl, AI SI, 1111rr.""e.! ,hior.<tw.to
.",h •• APP II"d A I'M ,n • j roe ol.,u,U thlll fully ,on Irlt'n'd tho;
"k'lociutl()n or IIPV with l(,r'Vu,,_I,1 I".Mlltr.
MATERIALS AND METHOD
Th rrogrnrmu ot 11I1V ond I;; rVlCul UOI,.cr ,,,110 llllfo \>'\.'(11
co rd,,,.t hy the 1o"..rnll,,,,,,.1 A~ nC) for R•• ,.,,11 1m ( II,,"
(tARC) on I.yon, I'r.".< IIlId the III htut C.... I. d'tl",,~ut:" (lC l)
in lIan.ekJll .. ~p.m, 11,.1' "H,Iu.Jcd • ""n • of •• ;,e·('lInlll~ Iud,
on I (.from "'I~ht ckvcl()l'ul1~ (Ountllc WIth" l'r(Mu.l rIlul(c nfntc
o( IIl"d':IIL< of ,erv".1 .. nL r Ihol were I'IMlllod til< II "<Iy.,,,
ReSioli .OV fed I"dud MOftlt.(,O Whll""k, rI til, I~R) oml
Alw". (11.,"11100<1. " .1, lOO5) tn Atm.: th I'hllll'l'm
(N~.I.n~cl .' •• 1, I 99R), I'lwiland (Ch.dlllfetlil tI .1, 11198) .nd
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Madras in Asia; and Ilrotil [Eluf-Neto 'I al. 1994). olombia
(Munoz., al, 1993), Paraguay (Rolon er al, 2(00) and Peru
(Eluf·Neto et ai, 1994) in South America. Although Spain (Munoz
c. al, 1993) was pan of the series of case-control studies, the
sexual and reproductive behaviour of uti. population was
bctcrogencous 10 the other countries (late AI'SI and 10,,· parity)
and the siudy site was therefore excluded from this analysis,
The methods of each study have been described elsewhere.
BrieDy, women with hislologicaOy onfirrncd incident invasive
squamous cell carcinoma (SCC), adenocarcinoma or ad no-
squamous-cell carcinoma were recruited from reference hospitals
before treatment, Written informed consent was obtained from
those who agreed to participate. Hospital-based controls were
frequency-matched to case patients by 5-year as groupo.
A standardised questionnaire W'olSoominislCr(od to tl-.? J.lUrtici·
punts by a lroined interviewer, whi h in luded queslions about
.sociodemographic (oclors. sexual and reprodul1ive bchaviolU',
smoking habits. pap ,creening history, hygienIC pruClices, and
history of sexuillly transmit1ed diseases.
Two sample. of cervical exfolillied cell. were collected wilh
wooden 'patul"" nnd endocervical brushes. Afler preparatioll of
one Papanicolaou smear. Ute remlllning eD, ,,~re eluded in saline,
celllnfuged and frozen at -70 C until shipmenl to the centro]
Iaboralory for IlPV DNA lesting. A lumor-biopsy sample was
obtailled from cases alld froU'll. Cytology and histology dl.gnoses
"~re «Viewed and cOllfirmed by a panel of ex pen pathologists Ih,ll
agreed on a diagnosis by consensus or majority.
Detailed descriptions of the polymems ·chaln-reacllon (I' R)
.... ay' used in dlese OIudie. have !>cen described el<ewher . IIPV
DNA del,'<lIon w., dewCled by peR ""'plifi allon of a snlolll
frugme.nt of Ih LI f!l'ne using MY09 .lId MYII OllsellSUS primers
for d,e sludy in .olombi. (Ilildesheim rl al. 1994) lind III
GP5 ~ 16 + geneml primer system for the other studies
(Waloonmers PI ai, 1992; Jacobs 1" ai, 1995: Rodu lIu man .., ai,
1995). II-Globin primers W('to u'l-d 10 amplify the /I.globin gene to
assess Ull~quality of die DNA in the 'peclmell. III'V DNA in l' .II
products was analysed u.in8" co killil of IIPV"pecifi probe'llIld
f!l'nolyped by hybridi,alion wilh Iyp ·specific probes for 33 III'V
types. Swnples lhat le.ted positive for IlI'V DNA bUI did nol
hybridis with any of the Iype·specific probes wer< I.belled a'
IIPV X.
Statistical analysis
Un ondilion.llogiSlk rqtression was u ed 10 estlm.t odd. rollOS
(OR.) lind 95% confidellLc inlerv." (951)0 CI). "0 "' ,cos tI,.
'" socialion of APSI with Ihe risk of ICC, thrt" ditTerent statistical
models to adjusl for III'V DNA d<1oolOn "" ..., compuled and
compared: (I) one modd ,"eluded all pallents and control,. lind il
Table I Characlenst<:, or ses oIlrwlSrve C"",o< c.",noma and controll
was nor adjusted for IIPV DNA StlUus. (2) II C<1Jndmodel mcloded
all pauents and ccntrols, and mduded a va"abl.to )U>l (or IIPV
DNA tatus, and (J) a third model was restricted to II I'V - DNA
positive c .... and nntn'lb. To control for 1>Olentll~ nfoundlng.
final models were adju led for a (<; 40. 40). country. lif.lllnt
number of .exu.1 partners (I.> I), purity (0, I 4. 5). and
educational lev I (never, pnm.ry. secondary Or h,gher). Each
variable included in tI. adjustment models .. as.s td for
interaction With AF~J. Test for trend wal rmod out when
appropriate. using th Iog-Itkclihood.rotlo te I. Only sub OOs who
reported ev r having been marri d audior ever having had
children were in luded in til .nllly.es of APM and API'.
We evaluated other potenllal onfounding factor •• uch as
smoking (never, ver), oral contrscepuv u .. (never. I -4 years.
.. 5 years). history of I'a~. ",nea" <xdl."n~ those inttlo 12 monll,
brfor enrolmenl (never. er). h"ving had first eJC""1lilt reou",.
before men."h lind the "minI( of first ,exuIII II11er (lurs. rda"ve
10 ag. al menarche (daro not shown). I>ut thcy were nOt adJusled
for," lhe final analysi. as they did nol <oolribut any chang to
Ih. OR "Iimote. for A I'SI \II th ad)usted model..
RESULTS
T.ble I describes so",,, chanrCl"ml'l> of Ihe 1864 Ie .... ~ .nd
1719 corfl'SI'ondIllS onlrols thai enler,,1 th finol ""oly'"
Ninety·five l)Creenl of a..'Il\\ p"lIent~ and 11 I of tOn1rot!> tested
po .. "v. for IJPV DNA. The llliI)orlly of (lU"" (92") had SC. <
I,ollenl. wert ~Ider than lOlllrols ~'ilh a medi.n IIge of ~9 I'S .8.
r .. pectivdy. Mew." AI'SI w •• ,.. rher III ClISC pallen .. (17 y""t»
compar With control. (19 years). and till> ..... found 10 b
cOnSiSIl'llt in each country.
TaI>Ie 2 show II..• n k of I 'C hy AI' 1 ac ordinlllO tlte th""
different ud,uitmem models. An mcrCll~d rl.k of ICc.; Wh
lOllslSlently ol'$ervl-d With d""reo .. ,,~ AI'SI (I'tr nd ,0.001)
Comp.red W.tI, AI' I 21 ye~n. Ih. OR o( I wus 1.80 (95 ... I:
1.50-2.16) for ArSII7-20 ycat> , and 2.31 (95'10 1'1.85-2.87) (or
AF .. I 16 y,-~n. "fter adju ung for "se, ntr~, tilt-lim numhcr
of !,lIn"ers. ""nly. and IIIlouon Jrvel III Ih IIPV unlld,uOIed
model. According to dt <hff.",nl model odlu",mt'm.. WOlllen
rtponlllgAI'S1 ' 10 years ofagcllold. 2.3-2-\-101<1 rail< o( Ie .and
I.R-l.l-foid ".~ fnr AI'SI 17.20 ye.,. of lilt (1'01>10.- 2). ('Iven
Ih. on iSlem ,,,.O(lill.on nf APSI and the mk nf ICC a"",
the dilT..... nl models. IIPV·un.dJU".d In d. were us,"" lor Ul.
remainder of the rehuh •.
We uIIculated Ih" fI k nf ICC. for eh lOuntry 'Indy, .nd. In
1I."eral. ""h ludy ,howed rill IOcr"'''''1I ".~ of ICC Wllh
decrellS"'~ APSI (dall1 n I shown). Ther Wft no .vid<" e 01
helCt"!lenelty Wllh r peLltll mldy lOWIII')' (I' O. ).
ea..,. Controtl Cale. ,
Cotroy 804 17.9 76' "'"A\'eN 142 145 13l 930
Moroa:o 188 17. 182 .e
M.l_ (I 187 1&4 180 <l(,)
Phil'P""' 304 380 3'19 ~~9"""..-.1 378 259 363 60 4'IhIl .87 190 18 0(, )
CoIorro~ 10 124 87 7'l 2r...._
'2 86 10'1 973 .8r..u 196 '75 !Ill> ""9 )
Abbr~""""" 11"1
humin _10_ 'MedIoVI
S,1IIShJ""'"'' of Co"" ... (2009) 100(7). 1191 1197
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Tabl. 1 Effectof diflerent strategies of multivariate modelaqu,.mentl on the auodation between ~. at fi"t "'>OJ I,ntera>..-.. nd roJ<cI
IARC case-oontrol studies)
Ale! and centre adiulted HPY UNdiu$l~ HPVact;ulted" HPY-pooltlve only'
Sex:ual debut c.... ,. (") Cont",l. n (") Odd. ratio (95" en Odd. ratio (95" ell Odd, ratio (95'" el) Odd. ratio (95" en
>21)'O¥' 3-41(16.9) 656 (354) 100 1.00
17 20 >"''''' 813 (~0.2) 6h7 (36.0) 244 (' 07 287) ..80 (150 216) '7)< 16)'O¥' 710 (35 I) 396 (214) 409 (3 38 494) 231 (185 287) J73)
P-uend <000
Abb~aoons HP\I human plpllO"nawus: ICC. flV~we cefVUl CM'OfOtN..IARC Intem.JtJo'\al Af!!t't<y tOJ"~ on Unce!' a
sWdy country. ,,_. """" ... 01 pa""'" (' > 2). panty (0. 4 >5). _I'd ed"'iloQn (_ prmoy .. <Cr1diry)
We stratified the unalysis according to tile established risk
factors for I C and the positive association of ICC with decreasing
A~~I remained at each level of exposure for each of these
cbaracteristi s (Tool 3). Similar assocratlons were observed for
AFP. No inrera tion was observed between any of the examined
risk foctors and AFSI. Although not statisti ally significant. the risk
linked to A~'SI seemed to be stronger among pnrnus women
compared widl nuDiparous women.
Age at first pregnancy and AFM were both directly correlatoo
with AFSI in dlese populations (P<O.OOII. Approximatel)'. 92'h>of
won"'n reponed AI'SI to be the same as AFM. One·qullner of
women reponed AFl'lo he the $amt a'll AFSL Cumulatively, 62.4%
of ""!lien reported gIving birth within the first year of AT'SI.
Among women with AFSJ -.;;;16 yean., 52.41)0were pregnant Within
the lirst year of sexual intercourse. Figure I shows dl. high
correlation berween AFSI und A1'1', and the similar deere.slIIg risk
of I C wilh Increasing age of AFSIIAPP. Given the high orrelation
between the two vanables. .... did not adjust for APSI in th AI'!'
final model and vice versB.
W. further evaluated d,e combined effoct of API' and AFSI on
the risk of cervical cancer (Table 4). An increased risk emergoo 10
subsequent strata of deereasing API' widl deereasmg AFSI. GIven
this combinoo effect. we asse"ed th. latency period (AFI' A~>l)
between th"",lwo events 10 clarify whether it affecled Ihe .rvi al
aneer risk. Although dlt're was no sUltistiui differen t across
struta. the data suggestoo that ";thln each A~'SI stmt .. women with
nlattney period for a subsl'quent pregnan y of < 2 yeaI'> may be at
a sl'ght 'ncrea.oo risk compared with women with a larger lime
gop (data not shown).
DISCUSSION
The IARCIICO serIes of case-control studic. ",rna," the larg""t
set of aetiologlCal investlgalions on I thaI fully addr"" .. s dl<
role of IIPV DNA and of the independent C5lilblisllt'd cofaclO~.
This is probably also th. ia'1tesl dalllsl1 reporting On ICC III the
d<'Veloping world in I\1lidl early AFSI. AFI' and lUK" p.nt)· arc
prevalent "henolll"nons. 11,. results show Ihat Cdrly AFSI and
curly AFP Art risk factors for cervi aI cancer, Irrespectlve of 01her
known risk factors for the disease. TIl data pr<Jentoo show.
pos.~ible "ddilioulll 111rease in risk \\'h~n the- early tvtnl of flr.tl
s xual intercour •• i, shortly foU"""d by " prcgnan y.
111e mechanism by which the early experu.'ncc of firs, sexual
Inter ourse and first pregnancy auld inOu.n "the rilok of .rvl al
carcinCl8tne,i, may b. <xplamed by Ih stero,d horn .. n81
mflu net on II PV InfcctlOnIlnd on th hosl's imlnun response
to III'V during pre-adDles ence and udolesce.nce. The tr.ndornm
lion zone of the ccJVical epitheliurn hI" been recoj!lII,ed a, Ihe slle
In y,'hiC'h lIPV infection tend~ to cause cun er, And tht . u ptl.
bilily or ttus area h. beJu!vt'd 10 b(' relaled 10 lUI denudation of the
"rutilioo epithehum. thus facililating eXf'ooure afthe b,,,alluyer to
III'V with minimal trauma. Diological immaturity durins tkiolc •
Ci 2009 C,",cor Resean:h
cence has also been proposed as an additional su eptibihty fllClor
(Mooci lei et aI, 1989: Elson" III. 2000: Sin r and Monaghan,
2000). DUClng dolescence and pregnan, y, the cervix ISexp"soo to
augmented level> of hormonal chung • (Smger and Monaghan.
2000), in willch oestrogen sumulauon fllohtul(", aodiliultoon of
the vaginal cavity. a deternunant of squamous met.plll.lla when tll
endocervical epilhelral <verts (HI.on .', 01. 2000). When tI".
ot.S'rogen~stlmuialed nlttllp1astll transformation oc urs In th
pre,en e of ,"'V, tI,e prob.lbilrty of cell tmllsformation In.reases.
resukmg m noopla.lil change. (fl.on rr al. 2000: hal <t al. 2007.
200R: I ""ng " ai, 20(9). Th" phenomenon i. derend..-nt
prrmarily on pnrity. and" 1II0r hkely to o( ur durinf, the "st
p"'gnanc), fRth"r dmn 'Ubsl'qUl'llt p"'Ilnan "'" (~tn8"r and
Monaghan. 2000). Although It ha. heen pO$tulllt d tllat thl".
melapla'lic chongcs iU'C abo Ulfluen ...cJ by th trauma And fepalr
eXl'''rte",oo durmg delrvery. ,.. Incr ••• oo risk for • ",leal
cardnorna was observed In this SIlO1e dUl11Se1 whtn INuma\1
panillon " ,evaluatoo (Mullo, " al. 2002).
InCrtasN rislo. of lervkal 4;an..inOtnll haw bt.'t'lt Identified an
women ~;Ih long·terOl us. of horm n.1 St rOId!. (MorellO ,', III.
2002) and th",e"j, are h'ghly ,,,,cou. (MullO. " 01. 2002).
In addition. II?V-16 transgeru< mou. modeb; have .bown that
tllOse treated witll lonK'''' duratIOn. of oestrogen we,,' more likely
to develop lllrger tumour> and have ... gnilieRntly Illgher nllmt","
of tWIIDUI'$dIan tl108t treated wuh a .hort r dUl'llllon (Eb;IIIl rr .1,
2000: Brake and u.mbcct. 2005). UppOrtlllg the humWl ohleJVa
lions ofa susccptih~ cervix to ..ar U10 ni\. pr~ll'1sI0n h)' (nnlJ
nUOU5 cxOftenou oe trogt'n ttrosur Or Incrtitsoo nMl\cIlOU$
oeSlrOjl.en level... If inde oe tr0sen h ne.:dcd for eJVI<W
carcinOjl n",,"S. dose folio ... ur of ynun~ women .nd Ql theu
early pregnancla rna)' be r lev.nt 10 funher und .... I.ndtnR dl<
role of strmids in thr RC'lul5.ltlOn iuuJ pi"r~ tcnl,,~ of IIP\1
lnfections,
'!lit mtluenL of 0 strOften~ on Ilnmune resron mil)' offer
another explanatory eff ..., (MitranI-ito cnb.ul1l ,., al. 1989. Arl","
r'l (11.1996). p..rt,,:.ulan), during the folllluh,r J\hll of the OVltnBU
cyd" and pn.'gnan , ...hen level, 01 o<.trOl:en •• n' lII.re.. up to
3-8 fold dIe IIonnal "-vel. (nun.an" al. 1994: M.... , rt ,ii, t9'11>:
JallbolU' rl al. 200K). Th lugher den t)' of ""!lnlgen """."111'"
and th.rr cxpreloS,on III tl .. trwI.lnrmotlllll ton m.y ynergil
WIth tllc cff... " of 111'V oncul'.otl,n •• decre'5ing It'VcI, 01 'ytlllo~IL
cytoklllell thol !IIay down rOjlllL1t Ihe lOr"" <ell mL~hlltC\l
IInmun rdpOn,.. \\'hlf.h fovour Jltl1'i~1m "I' Inl lon~ lIu,lttki
01 dellr.nLe (M .... I rI III, 19 : (;18nllllll rI "I. 19'18: 2002:
Ja 0,," ,., .,. 2003). Addltllinal r""",,,,h i. ncedoo ttl furtltc<
undersllt,nd tht interl&\;tlon hetweell Ot\1r(;tL'nllo und 1h t 111,,0(\1)
of IInmunomoduhu(u", wtu",h mar tontrihutt 10 ntl·twnout
IInrnulllly.
nit yu.rY"'R r\_"<iuhshetween SlUf~ II n·Jt.urdlll~thc.· r"I\-, of AI'b1
and AFI' mlly rcO t the tru. dill nct, herw n u,<· IUd
POl,ulotion . In our Oludy. th., ,mll.r IIIl1.~ c~1n;~ hown lor
AI'SI and AI'I' IIIl1y. '" I'.'".rlll .... 0,1 Ih. f... 1 th.I In IIltlit
dcvelol'lng count" Ii women ""wu tI~ rytml ,,' Ii" ~.Ir1 .est..:,
~tsh '''''''" of Can lOO'I) I OO(7~ 1191 1197
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Table 3
Number of CaJft)controlJ O.lch r.,lo (95'" ell' "'lrend
furRY
NUllpolOus
;02 l"'<l'" 1~1O 100 DO
'7 2o.)<¥> 7/1. .8lI (0.53 666) 16 (0.<40657)
.. 1611"'" 716 360 (0.83 1552) 10(0. 17 ,355) 0.5(.
EY!r poroos
;ilt2 ~1"5 32716H 00 00
17 2o.)<¥> 8041645 247 (lJJ7 2 '1-1) 197 ( 63 2.l6)
16ye~J"5 70.31387 ~ 10.(3.36 ~ 99) 59(208 31) '0.
P-ileferoe~l'f berween AFSJ alld t!Vf'f pomus 0.64
P.nty (I 4bnM)
;02 11"'" 711399 IDO 00
7 20 11""" 273f287 258 (: 9 335) 199(,.51 162)
,,1611"'''' 691115 .n(H 65'1) 7 ( eo 387) 0.
Ponry (;> 5 bHl,)
;.2 11".... 1S6n15 1 00
7 20 10.... 5311358 10.1 (,57 59) .7 (' .32 223)
~16ye.lrs 53412n 188 (2JQ 378) 208 ( . .55 78) .0.
P,"''''lOgene'y be,....", AI'5Jand po.'W' I)'O"PS (nulf>orOU1 I -4 bOIh1QIld.. 5 blfl'o) 0.90
Oml corrnxeptw use
N_
;.2 l"'<l" 2181400 100 00
7 20.11"'" 4531364 2.33 (1.87 190) 177 ( <40 225)__ 16ye,,~ 3701184 428 (329 5 55) H5 \ 82 329) 0.
1-4 years
.. 1 11"'" ~162 100 00
7 2O)<¥> 711 4 264 ( 76 J'I-I) 167 ( 0.7 161)
,,1611"'" 1189 3~ (253 613) 195 (I 15 JlO) 0.0.
;o5ye""
;'1. )tat'S 3615 00
7 2O)<¥> W72 326 (185 5n) 210\ 30 4 )
,,16 )to" 96149 4018 (l.3O 8 ) 80\ 18 565) 0.
Wokilg
N"""
;.2 l"'<l" 2721569 100
7 2O)<¥> 5871552 b8 ( J6 106)
C; 16~~rs 5501348 206 (61 2.64)
£",r
;.2 )t." 67185 100 100
7 2o.)t"" 2211 3 273 (:.8 • ,3) 13 \. SO liO)
16 ye.1;1"$ 52M3 ~63 (341 9 7) 362 (210. 616) ·0.00
Uferime nu_ rt ,...uol pclm6'S
MO'IO_
.. 2 )tars 27()'569 00
17 2o.)'e<l" 529/-iqq 233 (192 283) 180 ( 10 U)
16 )to'" 3~91214 38" (3OS H6) H8(.83 1 ) .0.
PonnefS > J
.,.2 )'eolf"S 69f74 I 00
7 2O)t .... 2En 51 10.3 ( 37 0.') H( ,5 63)
(j 16 )'CArs 35li.5(. 215(84 4 ) 2 4 ( 12) 0.
p·he1e<"q:..-.c4Y 0.36
Educm",n
Nev" go to IdlIJtJI
.. 2 )t .... ~7 1 00
7 20.10'" 2551155 168 (10'l I/J) '10 (OQl nO)
.. j6)1f!.l~ 4Clil73 2~1 ( 55 J 7;) O'l( 1 J ',) 0
Prmay ,,1'001
;. 2 )t." 641238 I 100
7 20)'C<ll'S 100II3, 199 (1.!>oI 5(.) I t>l \1 H ~12)
16 )to'" 2361'67 51 (187 339) 17 (I 4 2 ) 0
Semnday sd100J
;0 2 )ti" 8135 1 100
17 20 ye.n ~198 268 (I ~~ 368) 1l"\1 ~ 320)
'6."e~~ 7215~ 11'1 (307 741) JJ6(Hl7 ~11) ,0
p."" ....q"'.rty 006
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Table] (Conbnuod)
Cervical cance,. in developlna counrrie.s
KSLOOt er d
Numbe,. o( eases/controls Odds ratio (95" el)' Odds ,.tio (f CI)"
1.00
220 (174 179) 9 C 65 HOl
365 (279 478) )36(207 547)
I 00
2.65 (20l-346) Inc ... U7)
449 (3n 606) 2.30 (163 321)
EW'f rove 0 pop gnau J2 mantis be{l>Ie sUJ4' etromeu......"
.. 21 re'"
7 20 re>"
.. 16re ....
&'"
>21re>"
17 20 re>"
.. 16 reors
1831320
434/371
4161205
158/336
379f296
2941191
Abbf"t'lollat.cm-a to'lrdenc.e;rieN AfSI •• alrnl!lelWlt'lterc~ 'AdJUSI.t!!dfO"ageandsbJdyt~ "Actustedfor._ sttdYCOJnlry
(I. >2) P"'Y (0 -. >5) ar<j e6.x,aOOn (........ pn""'Y secondo<y)
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,,'3 '4 IS 1. 20 >2116 17 18
Age
• Age at tIM MlCuallntoroourlo (A,FSI) .,....__.. 05". ContkklllO(l irwUNOI (el)
• Ago .. fir1l _IAFPI __ 05% Corlldonco 1nI0000aI(CII
Figure I Aif' at rrst sexual ,nt."")"",, and ge at fm pregnancy
are highly cOfTelattd with the ri of invasove cervical canc.r (P
trend<O.OOI). Mode. were adtusted (or age. centre. "r.lme nurrt>er or
5e><ual partners (I. > I). pa-ty (0. 1-4 ... S~ and .ducal,on (never.
pri:'nary. secondary).
Table 4 Inter I,on between a&e at firsl pre~anty and .ge ii first 5elQJal
intercolne In the ri* cI c~cal cancer
Ate at flrlC prelnancy
Ale at sexual d but 17-10 C; I.
100
,58(122 2.03) 193(158 236)
2.17(135 147) U8( 74 299) 2J6(182 307)
"nd eKpenen high pnrity. making their .ffecls diffi lilt 10
di.linguish (nom on anolher. In ontra.t, resulu of Sludiei on
mort developed COUIl"I... where there I, • longer Inl ncy period
bel ween .""uW inilialion and AFP .... in Spain. Ihe S (Brinton
et al. 1987) or Ilwy (I'.ro .. ino ., ai, 1989) tend 10 .how an
11l<..... ed risk with early Af.'S1 !>tit nOI with AFP. fi .. 1
pre~nuncies tend to occur much hiler. It is interesting thall 10
countries likt th UK, whe .. the rates of letnage pregn ncl ar.
high. women wilh AFSI of <17 yenr. had. 2 -J·fold in r .sed risk
for cervi al aner omp.roo w,th Ihose with AFSI 20 yeor.
(Gr ... n ., ai, 2003). Consl!ttntly, ""men with an early AFI> of
15-19 yenrs had a Iwo-fold in .... sed risk for ccrvi<al <a" cr
compared with those with AFI' 15 years (Green et al. 2(03).
Thes. observnllons merit further explor.tion hul. in a88regate.
Q 2009 emetr Resea~h UK
..
lend 10 indicate D signifieDnl Increa In nsk ot neoplastic di.c.
when early AF I occurs (surrogate of e.r~· IIPV exposur and.
period of increased ervi I usceptibiluy) and IS followoo clo>cly
by an early pregnancy (surrogate of carly exposure 10 lugh
oestrogen levels).
Irrespective of Iheir lifetime number 0{ sexual partners, wumen
hove a s imil .. increased risk of Ie wilh ellfly AF I shown by
lhe 2A-fold risk among monogamou> women wllh AI'SI 16 years
as compared with the 2.2~(old n.w.. among women with :-.1 h(elim~
number of sexual partners, It h long ""<n tlSS' 1,'<'1that II
ervical can or risk wiD also depend on the .OKlial hiilorr of the
woman', mill partner in addition 10 her own behaviour (Skegg
et td, 1982). This is par1icularly relevant in socleu !o wher ",lUI
women are Virgins BI marriage ood n,onogomou~ thereafter. wh r
I~ in ldonee of (crvl aI can <t for a populalion may vary
depending on the behaviollr of th mait I",nner. Of ollr llltdy
women. 701)u werr loonogl1moul. In a('"Verlll swdl among
11l0nosaonou ""men, th risk of (rvil.1 neer was r portoo 10
b. twO 10 eighl bon •• for ...,mon with hllllbBnd. who Iwd multiple
panners (I)ridnn and Ulltnfdd, 1971; Budd<y fl ai, 1~81; nrtnton
et QI. 1989). The sexlI"1 hislory of Ihe mn! panner W"' 0<)1
evaluBltd in this unatysis; howt'Vtr. promliCwty, hi ory 01 other
STIS .• nd ill k of malt Ircunld,lon or f~cto" thai have been
o.. o"aloo with til male mit in cervi aI <or "no!!,'n, i (CAstcll'"
gu ft al. 2003).
In Int('rpreling OUI resuhs. we must emphRMM' Iht" dlflh.uhy III
fully di.entanghng a woman' sexual and r<rrodlkllv pnom III
r lalion 10 her cnnc.r rlsl< (S hrooer tI ai, 2OOJ)" W. ,0nn<>1
dude mllcia . I atlon b, If AI'SI and th numher 01. uRi
pnnne .. we", InuC<lIr.ltiy reportcd. leJdill 1(1 00111' r Idual
onfoullwng. II"wevcr, tile preo..n , of, ",b1 ••h<d" fa or ~ r
Ie u of oral (Olltr",.pUVCii. mokong. and pop .. " ar hi tory
did nol rem 10 signlfi antiy ntr... 1 Ihe wellSlh of Ihr "'8ocllllion
b lwe<n APSI. AI'P .• nd "'k of Ie .
We eXAmlnoo Ih direr."I tratified m thodoloj!l ... (unadltaled,
III' .djll.ted. and IIPV-positiv< rcot" 1<'<1)".00 10 eval..,,,· tho
a 0 iUllon belween AI'SI nd rilk of I C t",dlllonlUy mployoo In
lhe litenllur<. Thi WII> do lie 10 e dltdt allY puriou ."Oliollflll
rduled 10 lIati!tical.djuslrn<nt .nd 10 darlfy Inum.lst nl findlnil'
o(lh ilssocl.llon ("Iuld In artl r studl . Ahhour;h In ,rI"1 tern>!
rCilrlclion o{an Y5<sIO IIPV p(lmiv , , .nd «lIlI"') em,.)
prefer.ble. th <on Illen<y of Ih r ulu "r08$ th 111f' dit1(r~nt
method. provide. convln ins vldell« o( Ih ri k II sod81oo with
A 1'51. Fur~,trm()r • lioes,- r .. ult. ,",It •• I thai for til ewlu.tlon {If
olher ri,k fact ro•• djU.till~ for IIPV .Wlli' i. nOI n .. ry
lhe II<Iju.IIIlCnIS do nOi on",hUil' III remove 0" lon(ollJldlJl~
effeeL
Sexulll Pi'll lic In th world Indlt I Ihul \. fly IIlI 1\0111
mlghl be Il«urring in .dol.,.<enlo with 44, .5 and 52110 (RlrI"
bel we n the <Ill" of 13-19 Yed" repOrtllI1l h inll .<xutlDy
rJ;pencncoo in Ar~n"fh\. Rouwnnu untt N Rcnll. r fte\II"rly
8nt.n )OU'TIIIor Once< (20()9) IOO(7~ 1191 1197
Pa
•1195
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(Drown et al, 2001). In several CIl« studies among young females,
first sexual intercourse has been reported as forced in 5-15% of
cases, and in some extreme cases worldwide, tht estimates rangt'
from 21% among out-of-school adclescents in Botswana, 20%
among se ondary schools in Peru, and 41% among young urban
females attending night schools in Peru, Among 15-30% of
sexually active girls aged 15-19 rears report forced first sexual
intercourse (Brown er ai, 2001). II is likely !hal the partners of
these adolescents who report sexual coer ion art adul1 males who
are sexwlly experienced (WeUings tI .1, 2006) and al high risk of
III'V exposure. Globally, these exposures might affccl a high
proportion of very young girls in area. of human Stri~ • thus
adding child sexual abuse 10 the burden of a lifetime increased nsk
of genital cancer.
ur study shows Uta1 women who initiate first sexual
intercourse and experience !heir flCSI pregnancy at a young age
are al an in ceased risk of cervical cancer. The importance of
IIPV·vaccinalion programmes targeting young adolescents before
first scxwl intercoune can have a great effect in decreasing the
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Smoking and Passive Smoking in Cervical Cancer Risk:
Pooled Analysis of Couples from the IARC Multicentric
Case-Control Studies
Karty S. Louie',:!, Xavier Castellsague3,4. Silvia de Sanjose3•4. Rolando Herrero'. Chris J. Meijer·.
Keertl Shah7• Nubia MUnoz·, and F. Xavier Bosch', tor the International Agency tor Resea-ch
on Cancer Mu~icenter Cervical Cancer Study Group
Abstract
Background: The Independent role of tobacco smoking in invasive ervical cancer (I ) bas been
established. We evaluated the potential impact of pa ss rve ~moking (PS).
Methods: A pooled analysi' of 1.919 couples enrolled in one of '<even case-control .tud; .... Invol'ing
cervical carcmoma lit Situ (aS) Or JC \,\18S investigated. Information on smoking and sexual behavior was
collected from mterviews, Specimens were taken from the cervix and pt'l'" for human paprllomaviruv OWV)
DNA testing. Three PS risk model> were constructed with all couples.couples with m"n"gomou, women. and
couples with liteume nonsmoking monogamous women. For the third model, the .n"ly~i' considered
potential misl'lassification of smoking status and was r strirted to the risk period for which th~ woman
was exposed to both HPV, a necessary cause of I ,.nd T'S. Multivarrable uncond,honallog,st, regression
was used to estimate associations between a Or IC and PS.
Results: An incr eased risk was found among couple. with both ever smoking men and women (OR 226;
95% I: 1.40-3.64). No statistically incr ea sed risk of IS "'a' found with PS in the models analyzed, S,milar
significant increased risks of I with PS "'ii, found among all couples (OR 1.57; 95~ a: 1.15-2.15) and
couples with monogamous women (OR .. 1 ,;; 95'l I: 1 07-2.2Jl but not am nl\ lif,·time non,mokinl\
monogamous WOmen marned to ever smokmg men.
Con lusion: PS could not bedetected •• an independent nsk factor of I 111the ••bsenee of acuve .11I0 .... "S.
Impact: The combined effects of exposure to active and rs suggest It!. potential adverse role in 'rvlul
carcinogenesis. Concer (,.dr,mol BIll/tark..,." Prer; 20(7); 1379-90 CUJlJ AA R
Introduction
Men play an important role in tbe tral~'mission of
hwnan papillomavirus (HPV), Ihe etiologic faclor for
invaSIve cen'ieal cancer ( '). As HPV. lI",olved in
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Preventl~ Medicine, Oueen Mary Univeralty 01LOMon; 'Department ot
Clinical R... ,..cIl. Faculty ot tnfectious and Tropical Otoea_. London
School of Hygien. and Tropical Medicine. London, UnIted Kingdom;
Itunft of InhtctW:w. and Cancw, Cancer Epdemiology R.. oarch Pro-
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Now: St(>pIomenlary data tor this anicto are avalable at Cancer Ellido-
mlotogy. Biorrarl<er1l & POIVenI,,,,,()rjlna (http://.,..,.aac~oumaia org~.
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cervical cardnogenl"* An? sexually trnnsmitted, it I~
entral to understand patterns ci sexual behavior in
riP transmission including the behav" ". of bolh men
and women. It ha been deb.1led !hal til(' rvical can r
ri.~ for a womnn will drp<'nt1 mo~ 011 tho:> full ",>;ual
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history of the male partner than on her own behavior (1).
This is particularly relevant in societies where women
tend to be virgins at marriage and monogamous there-
after. Epidemiologic studies have tried to characterize
the male role and tile consequent female partner risk of
HPV acquisition and of cervical cancer (2-5). Although a
number of studies mostly involving monogamous
women have observed an association between the num-
ber o( sexual partners o( the husband and his wife's risk
for cervical cancer (6--8), other studies have not (9-12).
Other incondusive associations with prostitution have
been identified (9-12).
Besides sexual behavior, other male factors, such as
tobacco smoki ng has been less explored despite it being a
well-established risk factor for cervical precaneer and
cancer (13, 14). Several reviews have summarized the
epidemiologic and biological association of passive
smoking (PS) on the risk of cervical cancer (15-17), how,
rver, the evidence has been suggestive rather than suffi-
cient to implicate the role of PS in tile etiology of cervical
cancer among lifetime nonsmoking wom n. Among the
studies identified, tile recognized limitations include
small sample sizes of nonsmoker controls and cases of
cervical cancer, lack of specific information on HPV
and sexual behavior and mosl studies obtained spousal
history of smoking throegh questioning of tile women
rather than the men. Furthermore, most of the studies
involved cervical intraepithelial neoplasia grade 3 (C1N,
3)/carcionoma ill situ (OS) rather than invasive disease,
which is a relevant distinction since evidence suggests
that smoking acts in the stages of progression from IS
to invasive cancer (14).
To evaluate the male role in the etiology of cervical
cancer, specifically the risk related to 1'5, we carried out a
pooled analysis of five case-control studies involving I
and twocase--controlstudiesinvolving I ,of couples in
which husbands or stable partners of I and a case
and control women participated. The studies were con-
ducted in three continents. mainly in developing coun-
tri ,and were coordinated by tile International Agency
for Researdl C»lCancer (iARC) In Lyon, France, and tile
atalan Institute of Oncology (J 0) in Barcelona, Spain.
The IA /1 0 series of case-control studies remain the
largest data t of sexual couples on etiologic investiga-
tions of ICC thai fully addresses the role of HPV D A
and of ind pendent comctoTS. Some of the as,<;()Cialions
with ri k factors (i.e., penil HPV infection and mal
circumcision) l\8ve been assessed in ",b<;et, of th sub-
jects in this a'\8lys.is (9,11, 14, IS-20). ror this study, we
characterize in depth the role of 1'5 with the (ull dataset
on HI'V and risk factors of the men and th ir associations
with I
Materials and Methods
The IAR /1 0 case-control prOllram included a
series of studies on I and IS from leven countries
with a broad range of ceTVlcal cancer incidence rates.
Among these.seven studies conducted in five countries,
enrolled husbands or stable partners of women with IS
or cervical cancer and control women were pooled for
these analyses. Methods of each study and primary
results related to women have been published pre-
viously. ountries included Brazil (21) and Colombia
(9.11.22). Philippines (23), Thailand (24). and Spain (9,
25). Briefly, women with histologically confirmed inci-
dent cervical CI , invastve squamous cell carcinoma,
adenocarcinoma, or adenosquamous-cell carcinoma
were recruited from reference hospitals before treat-
ment. onlrol women were recruited from the general
population in two of th studies of IC in pain and
Colomb;', and from the same hospitals as the cases for
the other studies. Control women were frequency
matched to case patient by 5-year age groups.
urrent husbands or stable partners (herein refer·
red to as husbands) of enrolled women were defir d
as men who reported having had regular sexual inter-
course with the women for at least 6 months, irrespec-
tive of whether or not they were married or lived
together.
Informed consent was obtained from both men and
women who agreed to participate.
Questionnajre
A standardized questionnaire was administered to
participants by a trained interviewer that included ques-
tions about socio-demograpb ic factors, sexual behavior.
hygienic practices, and history of sexually transmitted
in Iecnons (STO. For specific questions on smokmg habits,
subjects were first asked to dassify themselves as lifetime
never smoker, e -srnoker (defined as a former smoker
who stopped smoking at leas I one year prior to th
intervi w) or current smoker, Ever mokers were also
asked ,1t what age they started smoking regularly, th
duration and how many cigarelll?S per day they smoked.
Additional questions were asked on thr tyJX' of tobacco
(blond, black, or other) and t)'lX' of filter (filler, no filt r.
or both) used Ex-smokers were a,ked the ag at which
IlleY stopped smoking.
Penile and cervical HPV DNA sampling
Two samples of (' foliated c,,11 were obtain j ffl m
the peni : One fmm the dLstal ur thra with the u of a
very thin, wet, cotton-tipped swab, and OtIC from the
exlernal suna eof lhe glansand coronal suleu, with the
lISI? of a standard-si7ed wpt, cotton-tipped swab
Two snmples of cervical folia ted cells we'" collect~'<i
WIth wooden spatulae and endocervical brushes After
preparation of one Papanicolaou smear, Ihe remaming
cells were eluh.>d in salin~, c~nlrifllg>'d and fro7<'11 at
-70" until shipment to the centrallaoorntory for HI'
OAt, ting. A tumor-biopsy sample wa obtamed ir m
cases and /ro7.l'n at 70" ytolng)' and hi.tology diag-
nosl. lVerE' reviewed and ronfirrned b n pc1lICIo( c"P.'rt
palhologist. thai agreed 01\ a diagnosi~ by COllscnStt or
",njonty
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Detection of HPV DNA
Detailed descriptions of the PCR assays used in these
studies have been described elsewhere. HPV D A was
detected by PeR amplification of a small fragment of the
Ll gene by using MY09 and MYll consensus primers for
the studies in pain and Colombia (26) and GP5+ /6+
general primer system for the other studies (27-29).
fl-Globin primers were used to amplify the fl-globin gene
to assess the quality of the DNA in the specimen. HPV
D A in peR products was analyzed with the use of a
cocktail of HPV-specific probes and genotyped by hybri-
dization with type-specific probes for 3.1 HI'V types in th
case of cervical samples and for at least 6 HPV types (b,
11, 16, 18, 31. and 33) in the case of the penile samples.
amples thallesled positive for HPV D A bul did not
hybridize with any of the type-spedfic probes wen?
labeled as HPV X.
Statistical analyse<
To evaluate the association between smoking habits,
and risk of CIS or ICC, we first used age- and country-
adjusted univariate logistic regression analyses to deter-
mine the effects of each of the Following potential male
factors by using an a-level of 0.05: age, history of smoking
(nonsmoker, current smoker, Q' ex-smoker, lifetime pack-
years, and use of tobacco and filter type), education,
sexual history (ag at first sexual intercourse, lif time
number of sexual partners, history of contact with sex
workers, hL.toryofSTls,and history of anal sex), hygienic
practices (i.e., pay attention to uncover penis and to wash
th region, able to fully uncover spontaneously or by
pulli ng the penis from the skin prepuce, and wash before
and after sexual intercourse), male circumcision status,
and to control for potential confounding of I'S character-
istics and ri~k of cervical cancer, final models were
adjusted for male factors that contributed cha nge to
any of the estimated OR and 95% I. To control for
additional potential confounding by characteristics of
the women, female risk factors (education, age at first
sexual intercourse, lifetime number of sexual partners,
history of pap smear 12 months prior to study enrolment,
use of oral contraceptives, parity, and smoking) for cer-
vical cancer were fitted into the final multivariate models
(i) for the I adjusted models if they contributed to any
change to the OR estimates for male characteristics; and
(Ii) for the final ICC adjusted models as they are well-
established risk factors known to be associated with ICC.
However, when we adjusted the OR estimates with all
female risk fadoN in the IS model, the esumates did not
significantly differ (data not shown). We identified life-
time number of sexual partners (a Significant risk factor of
eXp<l&ure to HPV) to be heterogeneous aero s study
countries (Supplementary Table 51) and an interaction
term combining lifetime number of sexual partners and
country were included 11\ the fully adjush.>d multivariate
models.
In addition, we found a statistically significant inter-
action between some male risk factors (e.g., aile at first
sexual intercourse, lifetime number o( sexual partners,
history of sexual intercourse with a sex worker, and
HI'V-positivity status) and case status (i.e, I vs. IS),
which justified the use of 2 separate models for each
disease stage. This is in agreement with our current
understanding of the natural hivtory or CI , as it has
been estimated that about 31 % of CIS cases will develop
caneer within 30 years, leaving a proportion of CI
cases that will not advance to invasive disease (30).
Thus, some of the risk factors associated with as
incidence may differ from those associated with pro-
gression (rom I to I
Furthermore, to better clari fy the relationship
between PS characteristics and cervical cancer in their
female partners, we removed the potential eff t or
previous mnle pertners Ihe woman may have had by
calculaling and compering 3 differenl statistics! models
(or IS and I : one included all study couples, the
second model included only couples with monogamous
women, and the third model included couples with
lifetime nonsmoking monogamous women. For the
third model restricted to 765 couples with ltf etime
nonsmokmg monogamous women, we further reclassi-
fied the husband's smoking history according to the risk
period for which the woman would have been exposed
to HPV infection (a no?Ces..ary factor in cervical carci-
nogenesis), [OS and risk of progression to cervical cane r
(Fig. 1). inety male ex-smokers (II 44 cao;e<;and II
43 controls) of couples with monogamous women
were reclassified as nonsmokers, and the durauon of
exposure to passive smok and smoking pack-years
were recalculated ( upplementar Table 2).
Results
Patient characteristics
Table 1 describes selected characteristics 01 the
male and fema Ie ubjects. Of the 291 'IS and 6'12
I cases and 9~tl control women, SQ.8\'l, 70.9%, and
81.2?:, wer monogamous, respectively. In general,
husbands were older than their wives, and husbands
and wives of I cases and controls were younger than
those of I
Table 2 shows penile HPV prevalence among husband.
of cases and controls of CI and I by hlstory 01
SlnokinA and country. Penile HPV detection was doubled
in husbands of cases than ontrols of CI and was higher
among cases than controls of x-smok rs (2.4'.l vs. 00/.)
and current smokers (13.')'* vs.3.8'n. imilar perulc HI'V
detection was found in husbands of casesand controls of
I (17.6'!'; vs. 16.2<:;), which was aL.o similar among
cases and controls of x-smokers and Clirrent smokers.
However, penile HPV was mOr<' prl'valent .me,,); hUT-
bands 01 c...... than controls of 1 (9J~ \IS. n 6'*),
respectively.
Table 3 pres'>I1ls selected male risk fa tors and their
univariate associations with ri>kof IS and I ,tratified
by all couples and couples with monogomous women. In
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~---~i:'~~':"':'---- • moking. d progr .. ion '0 ICC A
!.----~--------- i ® ®i ®I i @:.____.i
~.-.-.-.-,-.-.-.-.-.-.-.-.-.-.-.-.-.-.>
Risk of exposure 10 smoking
AFS, and MS,. ag' at lilllt ."""",;ASS, and ASS" all" at mop .moking. AGE",. "9" ofhusbond
ot time of 00& at first 88xual inl:eroour88 of th4ilwaa: AGEM!' OS'" of hUeOOnd nt time of oervical
cancer diagno.ie 01 the wile.
®
Flfura 1 Model 01risk of expo ..... '0 HPV and PS and prOgr8OolOl1to ICC among nonsmokng monogamous woman ecoording to tho hus_d's f1Istory
of husband Period 01 risk Is defined between age at frst sexuallntorc:o.n<l 01 tho w~.and cervical cancer diagnosis. Duration ot expos .... to PS Is
defiled .. ; 1') c......,t sma • .,. (AGEw~FP) if N's,; (B) cun-ent snoker ~ I'GE .. rAFS,); (C) ""-amoker _ (ASS ..... GE,.,) WAFSI,; (D) e.,.mok",
(ASSr-AFs.). Women "'" not at risk fa HPII and PS if (E) e.-anokor • (ASS,-AFS,) a their lu!band Is • (F) nonsnoker. Smoking statue of tho
husband Is das.led as tolows: ClmInt smokers A ~ B: ex..smokers C ... 0; and ncnsmokers E t F,
general, similar a ssociat ions were observed in all couples
and couples with monogamous women models. except
lor associations 01 CI with education and smoking
status. Hygienic practices (able to lully uncover sponta-
neously or by pulling lhe penis Irom the prepuce and
washing belore and alter sexual intercourse) and history
01 ana I sex were nol associated wi th CIS or I C in
univariate analyses (data not shown). The following risk
(actors o( husbands were found to be associated with an
increased risk o( CI or I early age al (irsl sexual
intercourse. history o( sexual intercourse with a sex
worker (ever and while with current wile). history o(
gonorrhea. increasing number of STls. being a current
smoker and increasing Iiletime smoking pack-years. Lack
o( education was associated with an increased risk o( I
but not IS, whereas being uncrrcumcrsed and HPV
positive were associated with an increased risk 01 5
but not ICC. An inverse relation between lISE' a "black'
tobacco type. as compared wiU, "bl nd' tobacco Iypt'
among smokers, and the risk o! I was observed, as
well as some hygienic practices such as lack (If attention
to uncover the penis to wash the region and the risk of
I
Table 4 shows lhe association between selected male
smoking characteristics and cervical CIS and I In
multivariat analyse. Generally. similar associations
were identified in the 2 analyses of all couples and only
couples with monogamous women. therefor, we will
describe our findings herein (orward accon:ling to the all
couples model. 0 talistically si,';nifi • nt increased risk
Tolal no, of husbands Age of husbands" Age of 'NNe"
Cases Controls Cases Controls Case. Controls
a. CIN-31CIS
Colombia 127 164 40 41.5 36 35
Spain 164 184 36 37 34 35
Pooled 291 348 36 39 34 35
b.ICC
Brazil 72 76 52 53.5 46 48
Colombia 91 89 47 52 43 44
Phllppines 155 111 46 46 46 44
Spain 146 139 50 50 50 52
Thaiand 228 173 46 46 48 47
Pooled 692 588 50 50 45 46
"Median.
Table 1, CharactenstlCS of both corresponding husbands of women with and without (8) CIN-3/CIS or (b) ICC
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HPV positive among those tested
Table 2. Penile HPV prevalence among husbands of cases and controls of CIS and ICC by history of
smoking and country
HPV testecf HPVpositi"" Nonsmokers Ex-smokers Current smokers
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
CIS 165 186 35(21.2) 14 (7.5) 8 (4.8) 7 (3.8) 4 (2.4) 0(0.0) 23 (13.9) 7 (3.8)
Spain 102 106 22 (21.6) 4 (3.8) 2 (2.0) 0(0.0) 4 (3.9) 0(0.0) 16 (15.7) 4 (3.8)
Colombia 63 80 13 (20.6) 10(12.5) 6(9.5) 7 (8.8) 0(0.0) 0(0.0) 7 (11.1) 3 (3.8)
ICC 444 348 78 (17.6) 56 (16.2) 16 (3.8) 18(52) 19(4.3) 15 (4.3) 43 (9.7) 23 (6.6)
Brazl 53 56 19(35.8) 22 (39.3) 4 (7.5) 5 (8.9) 7 (132) 8 (14.3) 8 (15.1) 9 (16.1)
Colombia 49 48 16(32.7) 14 (29.2) 6(122) 10(20.8) 2 (4.1) 1 (2.1) 8 (16.3) 3 (6.3)
Philippines 149 106 9(6.0) 5 (4.7) 2 (1.3) 1 (0.9) 0(0.0) 2 (1.9) 7 (4.7) 2 (1.9)
Spain 84 62 10(11.9) 2(32) 0(0.0) 0(0.0) 3 (3.6) 1 (1.6) 7 (8.3) 1 (1.6)
Thailand 109 74 24 (22.0) 13 (17.6) 4 (3.7) 2 (2.7) 7 (6.4) 3 (4.1) 13 (11.9) 8 (10.8)
'HPII testing of adequate specimens that were ~'illobin positive.
of CI was observed for women whose pa rtners had a
history of smoking. An increasing risk of ICC was
observed with decreasing time since smoking cessation
with current smokers having the highest risk (OR = 1h1;
95% I:1.1&-2.24), suggesting PS as a potential risk factor
(or cervical cancer. 0 increased risk o( I was
observed (or women with male partners who used a
specific tobacco type or filter An increased risl. o( ICC
was observed (or women with partners who smoked at
least a low number of smoking pack-years (R 1.62;
95% CI: '1.14-2.29).
Table 5 hows the association between passive and
active smoking history and nsk o( I after reclas.sifying
smoking status of men according to Figure 1. A.s com-
pared with the active smokmg model, we did nol observe
an association between male smoking habits and risk of
cervical cancer.mong couples with li(etimenoJlSmoking
monogamous women. Although r was not indepen-
dently associated with risk of I , there was an increased
R from 1.23 to 2.26 when women were exposed to PS
alone or to both active and PS.The interaction term was,
however, not statistically significant (P 0.77; Table 6)
Discussion
This study show. no independent association o(PS and
risk o( cervical cancer in the absence of a tive smoking, In
the first 2 models of all couples and couples WiU,mono-
gamous women, the lack o( association with I and the
SIgnificant as.sociation WIth IC suggests that passive
cigarette smoking could polentia lIy acts as a lale can:ino-
gen in the transition from persistent infection/preinva-
sive lesions to invasion. These findings are not new and
are consist nt with previous findings (15-17, 31-33).
However, when wecOllsidered the possibility o( misclas-
sifrcation bias in our third model of couples with lifetime
nonsmoking monogamous women and reclassified the
smoking status o( men according 10 the risk period for
which the woman would be exposed to both HPV infec-
tion and PS, no independent a sociation could be found
The greatest risk estimate was more than 2-fold for
couples who were both ever smokers.
The conlradicting results as SllOWlIin Ihe dillerent
models highlight the distortion of estimal probably
resulting from misclassification cO smoking status This
suggests that a model consideri ng only the time period of
exposure to H f'V and PS should be used to detennine
susceptibility to carcinogenesis. The hmmg of exposure to
tobacco smok relative to cervical can er development is
important in defining exposure. Because we had detailed
information on smoking and sexual history, we were able
to define and calculate exposure based on a series of
responses. The strict definitions of expo! lire to t baceo
smoke in our analyses showed assoctations with risk of
cervical cancer that were obscured b u lng. impler d fi-
nltions. onsmoking monogamous women with men
cia ifi\'d as ex-smokers who have quit smoking before
initiating a sexual relationship may not ~ as susceptible
to PS. In addition, the man's lifetime dural ion of
smoking does no! necessarily include thE'whole f>t'riod
of the couple's if he stops smoking during thcrelationshtp
or he starl .. and stop~ smoking during the relatiunship
Although the pos.sibility of mtsclnssificatioa o( tho
woman's smoking status cannot be xcJuded, wI'do not
beheve In lusion o( nonsmokers who were actua It)' true
smokcT&would cauS<' sub!.tantial bias beeau ... I('male
smoking pr valence in th study countries Is low (34).
In epidemiologi studies of cervical an cr etiology, the
definitions of exposure should reneet a model of tlsl. to
HPV infection and cervical c,\n:inogel'W1Si"
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Overall, more than three-quarters of couples were with
monogamous women. allowing us to explore the male 1'5
factors in depth and to Iimil any potential residual con-
founding that may exist if women were largely not mono-
gamous. Our results may predominanUy represent
societies in which women report lifetime monogamy and
multiple partnerships are more common among men.
which is a pattern that is generally more cemmon in deve-
loping countries rather than in developed countries (35).
This study strengthens the current evidence for several
reasons. First, this study has the largest dataset of couples
with nonsmoking women to measure 1'5. Because our
study obtained direct information from interviews with
both the husband and wife, our results are considered
reliable as previous studies have found good agreement
in responses concerning spousal smoking status 10 range
from 90 to 100 percent (17) and previous cotinine studies
of never smokers have validated the use of spousal
history as a marker of exposure 10 tobacco smoke and
people who live with smokers tend 10 mix wilh smokers
outside the home (15). In contra t, previous studies had
sma II sample sizes wi th sma II nu mbers of nonsmokers
Table 4. Multivariate assocrations between selected male smoking cnaractensncs and nsk of CIN-3/CIS
or ICC
OR (95% en
Male smoking characterisllcs An coup ... Couples with
monogamous women
CIN-3ICIS"
Time since smoking cessation
Nonsmoker
EII8f smoker
Ex-smoker> 11 yealS
Ex-smoker $10 years
Current smoker
Use of tobacco type "'" smokers
Blond
Black
Both
Othefs
Us. of smoking filter type by smokers
Filter
No filter
Both
Olhefs
Smoking lifetime peck-years"
Nonsmoker
Low no. of peck-years
Medlumlhlgh no. of pack-y ....
ICC·
Time since smoking cessation
Nonsmoker
EII8f smoke<
Ex-smoker >11 yealS
Ex-smoker $10 years
Current smoker
Ptrend
Use of tobacco type "'" smokers
Blond
Black
Bah
Othefs
1.00
1.33 (0.BS-l.99)
1.51 (0.53-4.31)
1.17 (0.58-2.34)
1.36 (0.86-2.07)
1.00
1.16 (0.71-1.88)
0.84 (0.22--3,19)
0.67 (0.24-1.87)
126 (0.76-2.09)
1.00
0.49 (O.~1.06)
0.49 (0.24-0.99)
0.89 (0.12-'<;.39)
1,00
0.33 (0 12-0.88)
0.36 (0.14-0.91)
1.03 (0.07-15.53)
1.00
0.76 (0.211-1.96)
0.78 (O.4!.-1.32)
1.63 (O.2!.-10.73)
1.00
0.49 (0.14-1.66)
0.61 (0.31-1.18)
2.79 (0.21-36.93)
1.00
1.18 (O.7!.-1,85)
1.52 (0.93-2.4 7)
1.00
0.89 (0.51-1.57)
1.45 (0.53-2.56)
1.00
1.57 (1.1!.-2.15)
1.46 (0,84-2.52)
1.50 (O.9!.-2.37)
1.61 (1.16-224)
0.006
1.00
1.55 (1.07-223)
1.11 (0.60-2.07)
1.59 (O.9S-2.67)
1.63 (1.11-2.40)
0.01
1.00
0.91 (0.27-3.04)
1.42 (O.~5.IO)
0.85 (0.32-227)
1.00
0.63 (0.17-2.33)
0.83 (0.21--3.31)
0.66 (0.21-2.08)
(Continued on the following page)
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OR (95% CI)
Table 4. Multivariate associations between selected male smoking characteristics and nsk 01CIN-3/CIS
or ICC (Cont'd)
Male smoking characteristics Allco~lel Couples with
monogamous women
Use of smoking filter type by smokers
Filter
No filter
Both
Others
Smoking IWetimepack-years"
Nonsmoker
Low no. of pack-years
Medium!high no. of pack-years
1.00
1.34 (0.55-3.27)
1.41 (0.72-2.72)
0.98 (0.38-2.55)
1.00
0.95 (023-2.69)
1.31 (0.63-2.71)
0.63 (027-2.54)
1.00
1.62 (1.14-2.29)
1.48 (1.03-2.12)
1.00
1.64 (1.09-2.47)
1.39 (0.91-2.10)
'CIS multivariate model was adjusted for age of the husband and wife, study country, interaction terms ~lfetlmenumber of sexual
partners of husband x study country and circumcisioo status x study country), age at first sexual Intercourse of the wife (~21 years,
17-20 yeers, !S;16years), ifetime number of sexual partners of wWe(1, 2:2);and husbands with monogarrous woonenmodel was
adjusted fOfall variables In the table except for Circumcision, tnteracton term (lifetime number of sexual pertnersof husband x study
country), age of the wWeand age at first sexual interoourse of the wife.
blCC model for all husbands and husbands with monogamous woonenwere adjusted for age of the husband andwife, study country,
interaction term (IWetlmenumber of sexual partners of husband x study oountry), level of education of the husband and wife
(2:secondarylevel, primary level, no schiOoIing), history ofSTls, age at first sexual intercourse of the wife (2:21years, 17-20 years, $16
years), lifetime smoking pack-years of the wife (nonsmoker, low, medum, and high smoking lifetime-peck-years). oral contraceptive
use (never,1-4 years, 2:5years), perity (nulliparous, 1-6. 2:7),pap smear history 12months prior to study enrolment (never,ever),and
lifetime number of sexual partners of the wife (1, 2:2).
cCIN-3fCIS model:Smoking lifetine pack-years for anhusbands model is defined as low (36.5-6,022.5 pack·years)and medium/hlgh
(6,132-66,611.5 pack-years); and for the husbandswith monogamousWOfnenmodel, low (36~, 716 paCk-years)and medlum/hlgh
(6.625.5-36,963.6 pack·years).
dlCC model: Smoking lifetime pack-years lor the all husbands modE>Is defined as: low (36.5-7,300 pack-years) and medium/high
(7,354.8-43,435 pack-years); and for the husbands with monogamous w0fn9n model, low (36.5-7.665 peck-years) andmediumlhlgh
(7,629.3-43,435 peck-years)
Second, previous studies la ked adequate Inforrnatlon on
HPV and sexual behavior indicators to control for poten-
tial confounding, and w were able to control for both
male and fema I risk factors Third, as we currently
understand the natural history of cervical cancer, not
all precancerous lesions will progress to ICC (30), o
we were able to valuate th effect of PS by slag of
disease (preinvasive vs. invasive).
Previous studies did not evaluate the combined effects
of different exposure of active and passive smok€' (both
nonsmokers, female ever smoker Imal nonsmoker, and
female nOMmoker/male ever smoker). Although the
other combinations showed an in reased risk, only the
combination of ever-smoking couples showed a statisti-
cally significant increased ris J.... The lack of an indepen-
dent association with T'S does not necessarily discount Its
contribution to I C risk. This may sugs 5t that tl direct
effect of active smoking outweighs II indirect carcino-
geniC effects PS may hav . One of the limitations o(
epidemiologic .tudie« by u,ing questionnaire data I.
its decrea In sensitivity or power of a study to how
a positive association when the effect may only be mod-
emtely related to (17). Llfetimc number of sexual
1'" rmers of the men largely allen till ted the observed (fed
of PS on I risk. tudles have suggested that we need t
consider the contribution of occupational xposure to
tobacco smoke in addition to spousal/household smok-
ing as 76% of nonsmokers wh report no exposure to
tl bacco smok .. at horne have reported" posure at work
(17) and about 75% c:I women in our study worked
outsid the hom , which could hav lead to additinna I
miscla<;siflcation of exposure and und resrlrnated the
impact of PS. In addition, although the possibilit of
coupl s not cohabiting together could lead to all over-
estimated T'S impact, we believe the contribution is rniru-
mal as only 1.6<;,of couples with monogamous women
reported periods of separation. To (ully evaluate the
impact of Ps, measurclll Ilt of exposure n s to take
inlo II counl all environmental e"p<l;ul\.'$ within tl
household and workplace.
A biological mechanism by which acliV(> and PS
could Influ nc cervical carcinogenesi i not clearly
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Table 5. Association between passive and active smoking history and risk of ICC
Passive smoking' Actille smoking"
Couples with nonsmoking Couples wHh monogamous women
monogamous women
Male smoking charac1eristics Cases/controls OR (95% CQ" Cases/controls OR (95% CIJ"~
Smoking status
NonsmokEr' 1121167 1.00 357/407 1.00
Ever 2461240 128 (0.88-1.85) 134/84 1.77(123-2.56)
Ex·smoker 39/54 1.01 (0.56-1.83) 38/31 1.48 (O~2.65)
Current smoker 207/166 1.34 (0.91-1.96) 96/53 1.94 (126-2.98)
Duration of eXp<l5ureto smoking
o years 1121167 1.00 357/407 1.00
1-20 years 101/108 1.51 (0.93-2.45) S2J35 1.58 (0.91-2.73)
~21 years 137/124 1.13 (0.73-1.75) 43130 1.56 (0.88-2.79)
No. of cigarettes per day
NonsmokEl' 1121167 1.00 3571407 1.00
1-10 cigarettes/day 96/84 1.51 (0.95-2.39) 73/46 1.63 (1.07-2.46)
~ 11 cigarettes/day 1441152 1.10 (0.73-1.66) 24117 1.30 (0.91-1.84)
Smoking lifetimepeCk-years·
Nonsmok... 1121167 1.00 357/407 1.00
Low nIBI 1.44 (0.88-2.36) 29/24 0.56 (0.12-2.56)
Medium 72178 1.12 (0.88-1.83) 35118 4.14 (0.9&-17.8)
High 84170 125 (O.76-2.OS) 31121 0.55 (0.14-2.25)
"For the pas91vesmoking modals, characteristics of the husband'asmOklng history wasclssslfled according to the wife's risk period
of 8I<p<l5ureto HPII and passive smoking as outlined In Figure 1.
bFor the active smoking models, the risk of C8IVlcaicancer Is based upon the woman'S history of smokhg.
cModels were adjusted for age of the husband and wife,study country ,level of education of the husband and wife, IIfetlne numberof
sexual partners of the husband. historyof $'ns, age at firstsexual htercourse of the wife,oral contraceptive use, parity,and pap arne r
history 12 months prior to study 8fY01iment.
"Male smoking characteristics (smokingstatus, duration of smoking, no. of cigarettes per day, and smokng Ifetlmepack-years)were
adjusted In the fhal mod&!accordingly to the woman's smoking habits.
"Husband S lifetimesmOkingcack-yeas for the passive smoking model Is defined as: low (36.5-3.832.5 pack-yearSj,medium (3,942-
7,884 pack-years), and high rr ,936.75-67 ,890 pack-years); and the smoking ifetlme pack-years of women for the active sm.Oking
model is defined as' low {182S-Q3().75 peck-years!. medium (1,022-3558.75 P8ck'years), and high (3,5n-19,710 pack-years).
understood. However, tobacco smoke contains
known carcinogen such as polycyclic aromatic
hyd rocarbons that could potentially have a direct trans-
formation effect on the cervix or could cause immuno-
suppression, allowing HI'V infections to persist and
progre&~ 10 cancer (15). Detectable levels o( rucotine
and cotinin • a m a urement of smoke xposure, have
been found In cervical mucus and 0 A adduct levels in
the cervical epithelium of nonsmokers, supporting the
evidence that the;;" chemi als can reach distant sites
such ns the cervix (16). Anoth r hypothesis includes
mutagenic semen due to smoking is piau. ible and direct
cervical contact with semen of smoking partners rna)'
represent another .ouree of exposure (17). This study
lacked data measurement levels of colinin /nimdne in
t1,,~ cerv;', therclore, additional studies ar n cdcd to
obtain these data to complement our epidemiologic
findings.
Penile HPV detection was more prevalent among
current sm kcrs compared with ex-smokers and non-
smokers which is consistent to previous findings (JO).
This sugg tJ that smokers Illay be more iiI.. Iy t
have persistent infect! I~~compared with nonsm kers,
maklns them more Itkely to expose therr wives to
HI' infeeuon. However, the interprctanon of penile
HI'V det tlon at study nrolmeru IS not strmght-
forward as it does not neces rily repres lit thl' nme-
point of exposure R' the current understandlnl\ ,)( th~
natural history o( HI'V In m,," ,how;. that H PV" more
readily tran~mittcd (rom III n t women than from
women to "' n. and these In(('Cllon ore less II!.. I to
pel'Si,t anll nl\ men with approximutl!l} 75'l lik ..( to
clear infection at one year (37) ther ,tudi", have
not (ound smnklng to be a ....oclotcd with penile HI'V
acquisition nor p !'Sist nee (3 , 39). In addItion, we
cannot exclude Ihe possibility ot rl'v rse CIlusnllty sine
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Smokng and Passive Smoking In Cervical Cancer Risk
Table 6. RISk of cervical cancer according to
the smoking status of husbands and wives
among couples with monogamous women
Cases! OR" (95% en
controls
Both nonsmokers 112/167 1.00
Female nonsmokerlmale 2451240 123 (0.85-1.77)
ever smoker
Female eve< smoker/male 30127 1.63 (0.83-322)
nonsmoker
Both ever smokers 104157 226 (1.40-3.64)
P trend 0.001
• Model was adjusted for age of the husband and ";fe. study
country.Ievel of education of the husband and wife, lifetime
number of sexual partnB's of the husband, histOl)' of STls,
age at «rst sexual Intercourse ofthe ";fe. oral contr~Uve
use, parky, and pap smear history 12 months.
HPV-infected husbands could clear HPV, and be rein-
fecled by their wives who have cervical cancer and
have been replicating HI'V prior to the onset of cancer.
Among 116 ICC case husbands who reported no
history of sex wilh a sex worker or a casual partner
while living with their wife, 6 were HI'V positive (of
whom 5 women reported lifetime monogamy), making
it impossible to know who was the source of HPV
exposure if there was no underreporting. Second.
detection of penile HPY 0 A 117%) in our study
was lower than recently reported prevalence estimates
in men and this may result from incomplete sampling
of the male genitalia as it has been suggested that for
oplimal HPV detection, sampling should include multi-
ple anatomic subsites (40).
In conclusion, there are 1 billion active smokers
worldwide and one-third of adults are regularly
exposed to passive smoke with the burden of
tobacco-relaled disea<e, dL<abilily, and death belOg
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ETHICS COMMITTEE
APPROVAL. FORM
Application number: 5819
Nameof Principal Investigator Karly Louie
Faculty Infectious and Tropical Diseases
Head of Faculty Professor Simon Croft
Title: Sexual and reproductive health risk factors and risk of cervical
cancer In developing countries
This application is approved by the Committee.
Chair of the Ethics Committee ......
Date 22 September2010 .
Approval Is dependent on local ethical approval having been received.
Any subsequent changes to the application must be submitted to the Committee
via an E2 amendment form.
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Appendix 9. Letter of request for data transfer for the Costa Rican
Natural History Study ofHPV and Cervical Neoplasia for StudY2
analysis
Av GrllJ"lVIl.W'n J(nI.2,]
OI907l'MOJPIItIIeI •&rce4on.
T.I,'3 16Dn 3lf93JJ5TOII
~."'~n6l
WWWJ(-on~Mt
9 February 20 I 0
Mark Schiffman. MD MPH
Hormonal and Reproductive Epidemiology Branch
National Cancer Institute. National Insntures of Health
6120 Executive BLvd., Room 706
Bethesda, MD 20892 USA
Deal' Dr. Schiffman.
As the NO Co-Principal Investigator of the Proyecro Eprdemiologtco Guanacaste
on the Natural History of HPV and Cervical Cancer Study, I am requesting data to
complete 3 collaboranve data analysis between NO. Catalan Institute of Oncology
(leO), and the London School of Hygiene and Tropical Medicme (LSHTM).
I will be w,ing these data for a study enntled "Sexual and reproductive behaviour
de-te-rminants of human papillomavirus persistence in a prospective cohort from
Guanacaste. Costa Rica". The objecuve of this study IS:
• To evaluate the assocrarion between sexual and reproductive behaviour factors (age- at
first sexual mtercourse, age at first birth, and parity) and the prospective risk for type-
specific HPV persistence at 2-years among women positive for pre-valent and mcieent
HPV infection.
HPV persisrence will be evaluated according to viral co-factors of rype-specific
persrsteace of HPV DNA. HPV viral load, and HPV serology Other confouodmg nsk
factors such as hfetnne number of sexual partners, smoking history, use of oral
contraceptives. hi story of pap smear. and etc. will be considered.
Specsfically, ram requestlDlZ the followmg Guaaacaste colton data
• Enrollment questionnaire: Sections (A) demographic and residential hrsrory, (8)
pregnancy lustory, (C) sexual history, (0) contracepnve history, (E) medical ~tot)',
(F) smokmg history, and (G) manral/income information
• Referral quesuonnaire: Sections (B) vaginal douching and (C) Sexual history
• Follow-up questionnaire I: Sections (B) smoking history, (e) pregnancy mformatiou,
(D) vaginal douchmg, (E) Sexual hisrory, (F) Contraceptive History. (G) MedicaL
History
• Follow-up questiounaire 2: Sections (8) smoking bist01)', (C) pregnancy information,
(D) vaginal douclung, (E) Sexual history. (F) Contraceptive History. (G) Medical
History
• Viral HPV da~a' HPV DNA. HPV viral load. and HPV erology
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Co-autho:rship from tim analysis will \J( mutually agreed upon between the
Investigators at NCI (Mark Schiffman). Guanacaste (Ana Cecilia Rodnguez). ICO (Silvia
de Saniose and Xavier Bosch) and LSHTM (Karly Louie also amllated with ICO).
Thank you in advance for your attention to thts data request and we look forward to this
collaboranon.
Sincerely,
Karlv Lome, MSc
elmiral Research Uoil
o.pattm~t of Infecnous & Tropical Dsseases
London School ofHy~~e and Tropical MediCIne
Keppel Street
London WC1E 7HT
United Kingdom
+442076368636" 2181
Email: Karly.Lowe@lshllll.ac.1lk
cjJJii~/~~
Sihu dr SanJOse, MD PhD
Umt oflnkctlons and Canc-er (UNIC)
Cane er Epulelll1olollY R~arch
Progran:uue
Inndut Catala Oncclogu. IDffiEll ..
cmERESP
Gran VLa km 2.7
08907 L' Hospuslet <It LI.. B arcelcca
Spain
ru (34) 93 26071112
Fax (34) 93 2607787
Email: ~.sanJose®coD.CologJa.net
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Appendix 10.3 Risk of r-year follow-up persistence of prevalent HR-HPV
infection (alpha species 5 and 6) according to patient characteristics
AlEha 5 (HPV 51) AlEha 6 (HPV 56)
Subject No. of No. of
characteristics infections OR (95% CI)* infections OR (95% CI)*
Age at first menarche
15+ years 26 1.00 12 1.00
14 years 24 14 1.00 (0.27-3.77)
13 years 40 21 0·76 (0.22-2.59)
S12 years 56 30 0-44 (0.12-1.64)
Age at first sexual intercourse
21+ years 23 1.00 7 1.00
18-20 years 49 18 1.00 (0.27-3.78)
16-17 years 40 28 0.76 (0.22-2.59)
S15 years 34 24 0.44 (0.12-1.64)
Missing
Time of first sexual intercourse from first menarche
<0 yrs 137 1.00 70 1.00
oyrs 6 4
,,1 yrs 3 3
Lifetime nubmer of sexual partners
69 1.00 35 1.00
2 29 20 0.89 (0.28-2.84)
3+ 48 22 0.89 (0.31-2.57)
Pregnancy
Never 15 1.00 5 1.00
Ever 131 72
Age at first pregnancy
21+ years 36 1.00 15 1.00
18-20 years 60 27 1.29 (0.36-4.59)
16-17 years 27 25 2.34 (0.66-8.28)
S15 years 8 5 0.65 (0.07-6.14)
Number of pregnancies
0 15 1.00 5 1.00
1-3 73 37
4-5 29 12
7+ 29 23
Live Births
0 15 1.00 5 1.00
1-2 59 29
3-5 48 23
6+ 24 20
Still Births
0 124 1.00 70 1.00
7 2 0.92 (0.19-4.41)
2+
Misearriages/abortions
0 97 1.00 50 1.00
20 12 0.70 (0.18-2.66)
2+ 14 10 1.58 (0.48-5.18)
Tubal Or ectopic pregnancy
0 122 1.00 69 1.00
1+ 24 8
Cesarean section
No 100 1.00 64 1.00
Yes 31 8
STI
No 136 1.00 76 1.00
Yes 9
-. no convergence
OR. odds ratio; CI. confidence interval
*Age-adjusted odds ratio
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Appendix 11. Permission granted to include the Chapter 5 Study 3 in
this thesis
Karly Louie
From:
Sent:
To:
Subject:
Attachments:
permissions[Permissions@aacr.orgj
28 August 2011 18:23
Karlylouie
FW: Louie I Request forpermissiontoreproducearticleinPhD thesis
CEBP _Permission_Form_lOUIE.pdf
Dear Karly,
RE: Permission to reuse/republish Cancer Epidemiol Biomarkers Prev; 20(7) July 2011; 1379-
1390.
Authors of articles published in AACR journals are permitted to use their article or parts
of their article in the following ways without requesting permission from the AACR. All
such uses must include appropriate attribution to the original AACR publication.
Authors may:
1. reproduce parts of their article, including figures and tables, in books,
reviews, or subsequent research articles they write;
2. use parts of their article in presentations, including figures downloaded into
PowerPoint, which can be done directly from the journal's website;
3. post the accepted version of their article (after revisions resulting from peer
review but before editing and formatting) on their institutional website, if this is
required by their institution. The version on the institutional repository must contain a
link to the final, published version of the article on the AACR journal website. The
posted version may be released publicly (made open to anyone) 12 months after its
publication in the journal;
4. submit a copy of their article to his or her university in support of a doct or-el
thesis.
Hope this helps, please let me know if I can further assist.
Kind regards,
Karola
(Ms) Karola Rac,
Assistant Director, Circulation & Fulfillment American Association for Cancer Research
615 Chestnut Street - 17th Floor
Philadelphia, PA 19106
www.permissions@aacr.org
Tel: 215.440.9300
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